
TTD - Therapeutic Targets Database Full Data Download File
Version 5.1.01 (2015.09.02)
Provided by BIDD   BioInformatic and Drug Design Group
                   Department of Pharmacy
                   National Unviersity of Singapore
                   http://bidd.nus.edu.sg/group/bidd.htm
Any question about data provided here, please contact with:
Prof. Chen (csccyz@nus.edu.sg) and Prof. Zhu (zhufeng@cqu.edu.cn, http://idrb.cqu.edu.cn/Peoples-PI.php)

--------------------------------------------------------------------------------------------------------

BIOMARKER_REC_ID    BIOMARKERNAME   DISEASE ICD9    ICD10
BIOMARKERREC000001	4-MDRD	hiv infection	042	B20	
BIOMARKERREC000002	albumin (ALB)	hiv infection	042	B20	
BIOMARKERREC000003	Beta-2-microglobulin (B2M)	hiv infection	042	B20	
BIOMARKERREC000004	CKD-EPI	hiv infection	042	B20	
BIOMARKERREC000005	Cockcroft-Gault	hiv infection	042	B20	
BIOMARKERREC000006	Creatinine	hiv infection	042	B20	
BIOMARKERREC000007	Cystatin C	hiv infection	042	B20	
BIOMARKERREC000008	Cystatin C	hiv infection	042	B20	
BIOMARKERREC000009	Glomerular filtration rate	hiv infection	042	B20	
BIOMARKERREC000010	N-Acetyl-?-D-Glucosaminidase (NAG)	hiv infection	042	B20	
BIOMARKERREC000011	HNL	hiv infection	042	B20	
BIOMARKERREC000012	human neutrophil lipocalin	hiv infection	042	B20	
BIOMARKERREC000013	lipocalin 2	hiv infection	042	B20	
BIOMARKERREC000014	Neutrophil gelatinase associated lipocalin (NGAL	hiv infection	042	B20	
BIOMARKERREC000015	phosphate	hiv infection	042	B20	
BIOMARKERREC000016	phosphorus tubular reabsorption (RTP)	hiv infection	042	B20	
BIOMARKERREC000017	proteins	hiv infection	042	B20	
BIOMARKERREC000018	Retinol Binding Protein (RBP)	hiv infection	042	B20	
BIOMARKERREC000019	BZLF	epstein barr virus	075	B27	
BIOMARKERREC000020	Latency related Membrane Protein 1 (LMP-1)	epstein barr virus	075	B27	
BIOMARKERREC000021	DNA Polymerase I (DNA-Pol)	cytomegalovirus	078.5	B25	
BIOMARKERREC000022	the Major Immediate Early Protein (IEP)	cytomegalovirus	078.5	B25	
BIOMARKERREC000023	MCM2	advanced stage oropharyngeal carcinoma	146	C10	
BIOMARKERREC000024	circulating EBV derived DNA	nasopharyngeal carcinoma (npc)	147	C11	
BIOMARKERREC000025	ERCC 1	esophageal adenocarcinoma	150	C15	
BIOMARKERREC000026	XPD 156	esophageal adenocarcinoma	150	C15	
BIOMARKERREC000027	XRCC1 399	esophageal adenocarcinoma	150	C15	
BIOMARKERREC000028	Tumor budding	esophageal squamous cell carcinoma (escc)	150	C15	
BIOMARKERREC000029	SPARC	esophageal adenocarcinoma	150	C15	
BIOMARKERREC000030	TSPAN	esophageal adenocarcinoma	150	C15	
BIOMARKERREC000031	Thymidilate synthase (TS)	esophageal adenocarcinoma	150	C15	
BIOMARKERREC000032	EGFr/TGF-a	esophageal cancer	150	C15	
BIOMARKERREC000033	Glutathione s-transferase	esophageal cancer	150	C15	
BIOMARKERREC000034	HER2/neu	esophageal cancer	150	C15	
BIOMARKERREC000035	p53	esophageal cancer	150	C15	
BIOMARKERREC000036	P-glycoprotein	esophageal cancer	150	C15	
BIOMARKERREC000037	PCNA	esophageal squamous cell cancer (escc)	150	C15	
BIOMARKERREC000038	VEGF	esophageal squamous cell cancer (escc)	150	C15	
BIOMARKERREC000039	p53; bcl-2; gluthathione S transferase-p; thymidylate synthase; vascular endothelial growth factor (VEGF)	advanced gastric cancer treated with 5-fu + cddp (fp) and 5-fu continuous infusion (ci)	151	C16	
BIOMARKERREC000040	Transcription factor NFkB	esophageal/gastroesophageal junction adenocarcinoma (e/gejac)	151.0	C16.0	
BIOMARKERREC000041	carcinoembryonic antigen (CEA)	gastric cancer	151	C16	
BIOMARKERREC000042	Thymidilate synthase (TS)	inoperable gastric cancer	151	C16	
BIOMARKERREC000043	CEA	r0 resected gastric cancer	151	C16	
BIOMARKERREC000044	cyclin D1	r0 resected gastric cancer	151	C16	
BIOMARKERREC000045	excision repair cross-complementing group 1 (ERCC1)	advanced gastric cancer (agc)	151	C16	
BIOMARKERREC000046	CA72-4	curatively resected advanced gastric cancer	151	C16	
BIOMARKERREC000047	CEA	curatively resected advanced gastric cancer	151	C16	
BIOMARKERREC000048	CA72-4	gastric cancer	151	C16	
BIOMARKERREC000049	CEA	gastric cancer	151	C16	
BIOMARKERREC000050	preoperative plasma levels of CEA	gastric cancer	151	C16	
BIOMARKERREC000051	sialyl-Lewis(a)	gastric cancer	151	C16	
BIOMARKERREC000052	CA 72-4	gastric cancer	151	C16	
BIOMARKERREC000053	CA 19-9	metastatic or recurrent gastric cancer	151	C16	
BIOMARKERREC000054	ERK1/2	primary stomach cancer	151	C16	
BIOMARKERREC000055	p38	primary stomach cancer	151	C16	
BIOMARKERREC000056	Topoisomerase I	locally advanced rectal cancer	154	C20	
BIOMARKERREC000057	CD133	rectal cancer	154	C20	
BIOMARKERREC000058	DPD	locally advanced rectal cancer	154	C20	
BIOMARKERREC000059	EGFR	locally advanced rectal cancer	154	C20	
BIOMARKERREC000060	SURVIVIN	locally advanced rectal cancer	154	C20	
BIOMARKERREC000061	VEGF	locally advanced rectal cancer	154	C20	
BIOMARKERREC000062	Ki67	rectal adenocarcinoma	154	C20	
BIOMARKERREC000063	glucose transporter-1 (GLUT-1)	rectal cancer	154	C20	
BIOMARKERREC000064	PlGF	rectal cancer (rc)	154	C20	
BIOMARKERREC000065	VEGF	rectal cancer (rc)	154	C20	
BIOMARKERREC000066	a-Fetoprotein (AFP)	hepatocellular cancer (hcc)	155	C22.0	
BIOMARKERREC000067	AFP-L3	hepatocellular cancer (hcc)	155	C22.0	
BIOMARKERREC000068	glypican 3 (GPC3)	hepatocellular cancer (hcc)	155	C22.0	
BIOMARKERREC000069	Î±-Fetoprotein (AFP), des-gamma- carboxyprothrombin (DCP), cystatin C	hepatocellular carcinoma	155	C22.0	
BIOMARKERREC000070	Excision repair cross-complementation 1 (ERCC1)	pancreatic cancer treated with platinum-based chemotherapy	157	C25	
BIOMARKERREC000071	a multiple marker RT-PCR assay (c-MET (HGF receptor)	pancreatic carcinoma	157	C25	
BIOMARKERREC000072	beta-HCG	pancreatic carcinoma	157	C25	
BIOMARKERREC000073	GalNAc (carbohydrate synthetase)	pancreatic carcinoma	157	C25	
BIOMARKERREC000074	Muc-18	pancreatic carcinoma	157	C25	
BIOMARKERREC000075	18q22.3/CNDP2	resected pancreatic cancer	157	C25	
BIOMARKERREC000076	CA19-9	advanced pancreatic cancer	157	C25	
BIOMARKERREC000077	KRAS	advanced pancreatic cancer (apc)	157	C25	
BIOMARKERREC000078	CA19-9	locally advanced pancreatic cancer	157	C25	
BIOMARKERREC000079	Cytokeratin 18 (CK18)	pancreatic cancer	157	C25	
BIOMARKERREC000080	eotaxin	pancreatic cancer	157	C25	
BIOMARKERREC000081	HGF	pancreatic cancer	157	C25	
BIOMARKERREC000082	IL-6	pancreatic cancer	157	C25	
BIOMARKERREC000083	IL-8	pancreatic cancer	157	C25	
BIOMARKERREC000084	IP-10	pancreatic cancer	157	C25	
BIOMARKERREC000085	regenerating islet-derived 4 (REG4)	pancreatic cancer (pc)	157	C25	
BIOMARKERREC000086	Early hypertension (HTN)	pancreatic cancer patients treated with  bevacizumab and gemcitabine	157	C25	
BIOMARKERREC000087	SSR2A	islet cell carcinoma	157.4	C25.4	
BIOMARKERREC000088	VEGF	islet cell carcinoma	157.4	C25.4	
BIOMARKERREC000089	VEGF-R	islet cell carcinoma	157.4	C25.4	
BIOMARKERREC000090	EGFR and c-kit	islet cell carcinoma	157.4	C25.4	
BIOMARKERREC000091	immunohistochemical staining patterns for the epidermal growth factor receptor (EGF-R)	neoplastic progression in the larynx	161	C32	
BIOMARKERREC000092	or cyclin D1	neoplastic progression in the larynx	161	C32	
BIOMARKERREC000093	p53	neoplastic progression in the larynx	161	C32	
BIOMARKERREC000094	EGFR	advanced non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000095	osteopontin (OPN)	advanced non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000096	plasminogen activator inhibitor-1 (PAI-1)	advanced non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000097	vascular endothelial growth factor (VEGF)	advanced non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000098	CA125	advanced non-small lung cancer	162	C33,C34	
BIOMARKERREC000099	carcinoembryonic antigen (CEA)	advanced non-small lung cancer	162	C33,C34	
BIOMARKERREC000100	C-reactive protein (CRP)	advanced non-small lung cancer	162	C33,C34	
BIOMARKERREC000101	cytokeratin 19 antibody (Cyfra 21-1)	advanced non-small lung cancer	162	C33,C34	
BIOMARKERREC000102	pMAPK	advanced nsclc	162	C33,C34	
BIOMARKERREC000103	K-RAS	bronchioalveolar carcinoma (bac) patients (pts) treated with gefitinib	162	C34	
BIOMARKERREC000104	ADAM9.	lung cancer	162	C33-C34	
BIOMARKERREC000105	TTF1	lung cancer	162	C33-C34	
BIOMARKERREC000106	UPA	lung cancer	162	C33-C34	
BIOMARKERREC000107	vimentin	lung cancer	162	C33-C34	
BIOMARKERREC000108	CEA; NSE	lung cancer	162	C33-C34	
BIOMARKERREC000109	18F-fluorodeoxyglucose (FDG)	lung carcinoma	162	C33-C34	
BIOMARKERREC000110	CEA	non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000111	MDM2	operable non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000112	RRM1	resectable nsclc	162	C33,C34	
BIOMARKERREC000113	Thymidilate synthase (TS)	resectable nsclc	162	C33,C34	
BIOMARKERREC000114	pEGFR	resected non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000115	antigen A	resected stage i and ii non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000116	mucin	resected stage i and ii non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000117	CEA	stage i nsclc	162	C33,C34	
BIOMARKERREC000118	RRM1	stage iib-iii nsclc patients treated with induction platinum/gemcitabine	162	C33,C34	
BIOMARKERREC000119	C-reactive protein (CRP)	advanced  non small lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000120	E-cadherin	advanced non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000121	vimentin (vim)	advanced non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000122	p-EGFR	advanced non-small-cell lung cancer	162	C33,C34	
BIOMARKERREC000123	TXR1/TSP1	advanced/metastatic non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000124	KRAS	lung cancer	162	C33-C34	
BIOMARKERREC000125	VEGF-D	early-stage nsclc	162	C33,C34	
BIOMARKERREC000126	IL-6	local lung cancer	162	C33,C34	
BIOMARKERREC000127	IL-18	local lung cancer	162	C33,C34	
BIOMARKERREC000128	IL-8	local lung cancer	162	C33,C34	
BIOMARKERREC000129	EGFR	lung cancer	162	C33-C34	
BIOMARKERREC000130	COX-2	lung adenocarcinoma	162	C33-C34	
BIOMARKERREC000131	let-7b	lung adenocarcinoma	162	C33-C34	
BIOMARKERREC000132	miR- 643	lung adenocarcinoma	162	C33-C34	
BIOMARKERREC000133	miR-215	lung adenocarcinoma	162	C33-C34	
BIOMARKERREC000134	miR-629	lung adenocarcinoma	162	C33-C34	
BIOMARKERREC000135	miR-665	lung adenocarcinoma	162	C33-C34	
BIOMARKERREC000136	miR-98	lung adenocarcinoma	162	C33-C34	
BIOMARKERREC000137	MMP-9	lung adenocarcinoma	162	C33-C34	
BIOMARKERREC000138	chromosomal aneusomy	lung cancer	162	C33-C34	
BIOMARKERREC000139	tenascin-C isoform	lung cancer	162	C33-C34	
BIOMARKERREC000140	big endothelin-1 levels (big ET-1)	lung cancer	162	C33-C34	
BIOMARKERREC000141	nitrite	lung cancer	162	C33-C34	
BIOMARKERREC000142	NO	lung cancer	162	C33-C34	
BIOMARKERREC000143	Sputum cytology	lung cancer	162	C33-C34	
BIOMARKERREC000144	TGT (TURTEST)	malignant lung tumor	162	C33,C34	
BIOMARKERREC000145	A549 in LUNX	non small cell lung carcinoma	162	C33,C34	
BIOMARKERREC000146	B-CPAP in TTF1	non small cell lung carcinoma	162	C33,C34	
BIOMARKERREC000147	CAPAN1 in CK19 and 7	non small cell lung carcinoma	162	C33,C34	
BIOMARKERREC000148	MCF7 in MUC1	non small cell lung carcinoma	162	C33,C34	
BIOMARKERREC000149	Intraepithelial T cell tumor infiltration	non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000150	vimentin	non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000151	CA 15.3	non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000152	CA 19.9	non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000153	CA 72.4	non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000154	CA 72.4	non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000155	CA 125	non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000156	CEA	non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000157	CYFRA	non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000158	NSE	non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000159	SCC	non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000160	Bcl2	non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000161	p63	non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000162	11Î±-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostane-1,20-dioic acid (PGE-M)	non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000163	C-reactive protein (CRP)	non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000164	CYFRA 21-1, carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCCa)	non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000165	EGFR intron 1	non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000166	ERCC1	non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000167	Keratin 19	non-small cell lung cancer (nsclc) and small cell lung cancer (sclc)	162	C33,C34	
BIOMARKERREC000168	survivin	non-small-cell lung cancer	162	C33,C34	
BIOMARKERREC000169	IL-2	non-small-cell lung cancer	162	C33,C34	
BIOMARKERREC000170	Interleukin-6 (IL-6)	non-small-cell lung cancer	162	C33,C34	
BIOMARKERREC000171	leptin	non-small-cell lung cancer	162	C33,C34	
BIOMARKERREC000172	TNF-alpha	non-small-cell lung cancer	162	C33,C34	
BIOMARKERREC000173	EGFR	non-small-cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000174	IL-10	non-small-cell lung cancer with concurrent chemoradiation	162	C33,C34	
BIOMARKERREC000175	IL-6	non-small-cell lung cancer with concurrent chemoradiation	162	C33,C34	
BIOMARKERREC000176	sTNF-R1	non-small-cell lung cancer with concurrent chemoradiation	162	C33,C34	
BIOMARKERREC000177	ALK	nsclc	162	C33,C34	
BIOMARKERREC000178	EML4/ALK	nsclc	162	C33,C34	
BIOMARKERREC000180	number of mediastinal lymph nodes resected	operable non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000181	patient age	operable non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000182	Pgp	operable non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000183	cross-linked carboxyterminal telopeptide of Type I collagen (ICTP)	primary lung cancer	162	C33,C34	
BIOMARKERREC000184	VEGF-C	primary nsclc	162	C33,C34	
BIOMARKERREC000185	VEGFR-3	primary nsclc	162	C33,C34	
BIOMARKERREC000186	CEA	resected stage i nsclc	162	C33,C34	
BIOMARKERREC000187	PLUNC	resected stage i nsclc	162	C33,C34	
BIOMARKERREC000188	CK19	resected stage i nsclc	162	C33,C34	
BIOMARKERREC000189	bFGF	stage i  non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000190	UPAR	stage i  non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000191	VEGF	stage i  non-small cell lung cancer	162	C33,C34	
BIOMARKERREC000192	CEA	stage i nsclc	162	C33,C34	
BIOMARKERREC000193	PLUNC	stage i nsclc	162	C33,C34	
BIOMARKERREC000194	ACE	stage i-iii nsclc	162	C33,C34	
BIOMARKERREC000195	IL-6	stage i-iii nsclc	162	C33,C34	
BIOMARKERREC000196	TGF-?21	stage i-iii nsclc	162	C33,C34	
BIOMARKERREC000197	miR-145	surgically resected non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000198	miR-367	surgically resected non-small cell lung cancer (nsclc)	162	C33,C34	
BIOMARKERREC000199	neuron specific enolase	small cell lung cancer	162.9	C34.90	
BIOMARKERREC000200	Pro-gastrin-releasing peptide (31-98)	small cell lung cancer	162.9	C34.90	
BIOMARKERREC000201	D5S679 Allele 6	small cell lung cancer (sclc)	162.9	C34.90	
BIOMARKERREC000202	CEA	malignant pleural mesothelioma	163	C45	
BIOMARKERREC000203	CA-125	malignant pleural mesothelioma	163	C45	
BIOMARKERREC000204	CYFRA 21-1	malignant pleural mesothelioma	163	C45	
BIOMARKERREC000205	osteopontin (OPN)	malignant pleural mesothelioma	163	C45	
BIOMARKERREC000206	epidermal growth factor (EGF)	malignant pleural mesothelioma	163	C45	
BIOMARKERREC000207	platelet-derived growth factor (PDGF-AB)	malignant pleural mesothelioma	163	C45	
BIOMARKERREC000208	megakaryocyte potentiating factor (MPF)	malignant pleural mesothelioma	163	C45	
BIOMARKERREC000209	Soluble mesothelin (SM)	malignant pleural mesothelioma	163	C45	
BIOMARKERREC000210	EWS/ERG	ewing's sarcoma	170	C41	
BIOMARKERREC000211	EWS/FLI1	ewing's sarcoma	170	C41	
BIOMARKERREC000212	EWS-FLI	ewing's sarcoma	170	C41	
BIOMARKERREC000213	nucleophosmin	ewing's sarcoma	170	C41	
BIOMARKERREC000214	CD-69	neoplastic bone disease	170	C40-C41	
BIOMARKERREC000215	HLA-DR	neoplastic bone disease	170	C40-C41	
BIOMARKERREC000216	peroxiredoxin 2	osteosarcoma	170	C40-C41	
BIOMARKERREC000217	EWS/WT1	small round cell desmoplastic tumors (srcdt)	171	C49	
BIOMARKERREC000218	Microvessels density	adult soft tissue sarcoma	171	C49	
BIOMARKERREC000219	p4EBP1	high-grade undifferentiated pleomorphic sarcoma (hgups)	171	C49	
BIOMARKERREC000220	Ki67	high-grade undifferentiated pleomorphic sarcoma (hgups)	171	C49	
BIOMARKERREC000221	pERK	high-grade undifferentiated pleomorphic sarcoma (hgups)	171	C49	
BIOMARKERREC000222	PAX3/FKHR	rhabdomyosarcoma	171	C49	
BIOMARKERREC000223	PAX7/FKHR	rhabdomyosarcoma	171	C49	
BIOMARKERREC000224	SYT/SSX1	synovial sarcoma	171	C49	
BIOMARKERREC000225	SYT/SSX2	synovial sarcoma	171	C49	
BIOMARKERREC000226	FOXP3	advanced melanoma	172	C43	
BIOMARKERREC000227	indoleamine 2,3-dioxygenase (IDO)	advanced melanoma	172	C43	
BIOMARKERREC000228	Micropthalmia transcription factor (Mitf)	intermediate-thickness cutaneous malignant melanoma	172	C43	
BIOMARKERREC000229	circulating malignant cells (CMCs)	malignant melanoma (mm)	172	C43	
BIOMARKERREC000230	AIB1	melanoma	172	C43	
BIOMARKERREC000231	Nuclear receptor coactivator-3 (NCOA3	melanoma	172	C43	
BIOMARKERREC000232	SRC-3)	melanoma	172	C43	
BIOMARKERREC000233	rs11615 at the ERCC1 locus	melanoma	172	C43	
BIOMARKERREC000234	Melanoma-Inhibiting Activity (MIA)	metastatic melanoma	172	C43	
BIOMARKERREC000235	S100B	metastatic melanoma	172	C43	
BIOMARKERREC000236	NKG2D ligand	metastatic melanoma	172	C43	
BIOMARKERREC000237	soluble MICA	metastatic melanoma	172	C43	
BIOMARKERREC000238	NY-ESO-1	response to anti-ctla-4 (ipimilumab) treatment	172	C43	
BIOMARKERREC000239	the Inducible T cell Co-Stimulator (ICOS)	advanced melanoma	172	C43	
BIOMARKERREC000240	eomesodermin (EOMES)	advanced melanoma	172	C43	
BIOMARKERREC000241	CD163	ajcc stage i/ii melanoma	172	C43	
BIOMARKERREC000242	CD68	ajcc stage i/ii melanoma	172	C43	
BIOMARKERREC000243	tyrosinase; MART1; gp100;Mage3	cutaneous melanoma	172	C43	
BIOMARKERREC000244	MelanA/MART1	malignant melanoma	172	C43	
BIOMARKERREC000245	p97	malignant melanoma	172	C43	
BIOMARKERREC000246	tyrosinase	malignant melanoma	172	C43	
BIOMARKERREC000247	a multimarker (tyrosinase, Pmel 17, TRP1, and MUC18) reverse transcriptase-polymerase chain reaction (RT-PCR) plus Southern blot assay	melanoma	172	C43	
BIOMARKERREC000248	HMB-45	melanoma	172	C43	
BIOMARKERREC000249	S-100	melanoma	172	C43	
BIOMARKERREC000250	Microphthalmia	melanoma	172	C43	
BIOMARKERREC000251	BRAF V600E	melanoma	172	C43	
BIOMARKERREC000252	BRAF V600	melanoma	172	C43	
BIOMARKERREC000253	tyrosinase, MART1 (MelanA), uMAGE	melanoma patients (pts) after lymph node dissection (lnd)	172	C43	
BIOMARKERREC000254	YKL-40	metastatic malignant melanoma	172	C43	
BIOMARKERREC000255	MIB-1	male breast cancer	175	C50	
BIOMARKERREC000256	AR	male breast cancer	175	C50	
BIOMARKERREC000257	cyclin D1	male breast cancer	175	C50	
BIOMARKERREC000258	YKL-40	adenocarcinoma of the uterine cervix	180	C53	
BIOMARKERREC000259	TSP-1	cervical cancer	180	C53	
BIOMARKERREC000260	CD 31	cervical cancer	180	C53	
BIOMARKERREC000261	CD-105	cervical cancer	180	C53	
BIOMARKERREC000262	cervical acid phosphatase (CAP)	cervical cancer	180	C53	
BIOMARKERREC000263	VEGF	cervical cancer	180	C53	
BIOMARKERREC000264	CD44 exon v7-8	cervical cancer	180	C53	
BIOMARKERREC000265	Lymph Vascular Space Involvement (LVSI)	early cervical cancer	180	C53	
BIOMARKERREC000266	CKS2	locally advanced cervical carcinomas	180	C53	
BIOMARKERREC000267	LSM3	locally advanced cervical carcinomas	180	C53	
BIOMARKERREC000268	MRPL11	locally advanced cervical carcinomas	180	C53	
BIOMARKERREC000269	MRPS23	locally advanced cervical carcinomas	180	C53	
BIOMARKERREC000270	PDK2	locally advanced cervical carcinomas	180	C53	
BIOMARKERREC000271	KLF3 and TBX3	locally advanced cervical carcinomas	180	C53	
BIOMARKERREC000272	MSN	locally advanced cervical carcinomas	180	C53	
BIOMARKERREC000273	VEGF	squamous cell carcinoma of the uterine cervix	180	C53	
BIOMARKERREC000274	VEGF-C	squamous cell carcinoma of the uterine cervix	180	C53	
BIOMARKERREC000275	hCG	placental tumor	181	C58	
BIOMARKERREC000276	Abl	mixed mesodermal tumor (mmmt) of the ovary	182.0	C54.9	
BIOMARKERREC000277	C-kit	mixed mesodermal tumor (mmmt) of the ovary	182.0	C54.9	
BIOMARKERREC000278	estrogen receptor (ER)	mixed mesodermal tumor (mmmt) of the ovary	182.0	C54.9	
BIOMARKERREC000279	HER2/neu	mixed mesodermal tumor (mmmt) of the ovary	182.0	C54.9	
BIOMARKERREC000280	platelet derived growth factor-b (PDGFR-b)	mixed mesodermal tumor (mmmt) of the ovary	182.0	C54.9	
BIOMARKERREC000281	progesterone receptor (PR)	mixed mesodermal tumor (mmmt) of the ovary	182.0	C54.9	
BIOMARKERREC000282	E2F1	endometrial cancer	182.0	C54.1	
BIOMARKERREC000283	p16	endometrial cancer	182.0	C54.1	
BIOMARKERREC000284	RALDH2	endometrial cancer in obese women	182.0	C54.1	
BIOMARKERREC000285	SPFR4	endometrial cancer in obese women	182.0	C54.1	
BIOMARKERREC000286	EIG121	endometrial cancer in obese women	182.0	C54.1	
BIOMARKERREC000287	EGFR	persistent or recurrent endometrial cancer	182.0	C54.1	
BIOMARKERREC000288	BETA 2-MICROGLOBULIN	advanced epithelial ovarian cancer	183	C56	
BIOMARKERREC000289	Rs tumor volume	advanced ovarian cancer	183	C56	
BIOMARKERREC000290	HER receptors and ligands	advanced ovarian cancer	183	C56	
BIOMARKERREC000291	C12.5	epithelial ovarian cancer stage i and ii	183	C56	
BIOMARKERREC000292	C19.9	epithelial ovarian cancer stage i and ii	183	C56	
BIOMARKERREC000293	inhibin	granulosa cell ovarian tumor	183	C56	
BIOMARKERREC000294	maspin	ovarian cancer	183	C56	
BIOMARKERREC000295	p55	ovarian cancer	183	C56	
BIOMARKERREC000296	p75	ovarian cancer	183	C56	
BIOMARKERREC000297	VEGFR-3	ovarian cancer	183	C56	
BIOMARKERREC000298	basic fibroblast growth factor	ovarian cancer	183	C56	
BIOMARKERREC000299	CA125	ovarian cancer	183	C56	
BIOMARKERREC000300	Cln101	ovarian cancer	183	C56	
BIOMARKERREC000301	Ovr110	ovarian cancer	183	C56	
BIOMARKERREC000302	p75	ovarian cancer	183	C56	
BIOMARKERREC000303	transthyretin, Apo-A1, transferrin, hepcidin, ??2M, CTAP3, ITIH4, CA125	ovarian cancer	183	C56	
BIOMARKERREC000304	E-selectin	ovarian cancer	183	C56	
BIOMARKERREC000305	vascular cell adhesion molecule-1 (VCAM-1)	ovarian cancer	183	C56	
BIOMARKERREC000306	neuropillin-1	ovarian cancer	183	C56	
BIOMARKERREC000307	VEGF-A	ovarian cancer	183	C56	
BIOMARKERREC000308	VEGFR-2	ovarian cancer	183	C56	
BIOMARKERREC000309	BRCA1/BRCA2	ovarian cancer	183	C56	
BIOMARKERREC000310	transthyretin, apolipoprotein A-1, beta2-microglobulin, transferrin, cancer antigen 125	ovian cancer	183	C56	
BIOMARKERREC000311	YKL-40	recurrent ovarian cancer	183	C56	
BIOMARKERREC000312	CA125II, CA72-4, CA15-3, macrophage colony stimulating factor (M-CSF)	stage i epithelial ovarian cancer	183	C56	
BIOMARKERREC000313	EGFR	advanced prostate cancer	185	C61	
BIOMARKERREC000314	HER2	advanced prostate cancer	185	C61	
BIOMARKERREC000315	The simultaneous use of a 50% decline of  acid phosphatase  with prostate specific antigen	androgen independent prostate cancer	185	C61	
BIOMARKERREC000316	OVX1	androgen-independent prostate cancer	185	C61	
BIOMARKERREC000317	CA- IX	localised prostate cancer	185	C61	
BIOMARKERREC000318	HIF-1 alpha	localised prostate cancer	185	C61	
BIOMARKERREC000319	VEGF	localised prostate cancer	185	C61	
BIOMARKERREC000320	Bcl2	prostate cancer	185	C61	
BIOMARKERREC000321	cMYC	prostate cancer	185	C61	
BIOMARKERREC000322	ERCC1	prostate cancer	185	C61	
BIOMARKERREC000323	p53	prostate cancer	185	C61	
BIOMARKERREC000324	Thymidilate synthase (TS)	prostate cancer	185	C61	
BIOMARKERREC000325	Topoisomerase I	prostate cancer	185	C61	
BIOMARKERREC000326	Topoisomerase II	prostate cancer	185	C61	
BIOMARKERREC000327	Gleason Score	advanced prostate cancer	185	C61	
BIOMARKERREC000328	bone-specific alkaline phosphatase (BSAP)	advanced prostate cancer	185	C61	
BIOMARKERREC000329	N-telopeptide (NTX)	advanced prostate cancer	185	C61	
BIOMARKERREC000330	Interleukin-6 (IL-6)	androgen-independent prostate cancer (aipc)	185	C61	
BIOMARKERREC000331	methylated glutathione s-transferase 1 (mGSTP1)	castration-resistant prostate cancer (crpc)	185	C61	
BIOMARKERREC000332	D-dimer	chemotherapy refractory prostate cancer (crefracpc)	185	C61	
BIOMARKERREC000333	PSA percent tumor dimensional marker	clinically localized prostate cancer	185	C61	
BIOMARKERREC000334	deoxypyridinoline [DPD]	hormone refractory prostate cancer (hrpc)	185	C61	
BIOMARKERREC000335	N-telopeptide (NTX)	hormone refractory prostate cancer (hrpc)	185	C61	
BIOMARKERREC000336	osteocalcin [OCN]	hormone refractory prostate cancer (hrpc)	185	C61	
BIOMARKERREC000337	procollagen N-terminal propeptides (PINP, PIIINP)	hormone refractory prostate cancer (hrpc)	185	C61	
BIOMARKERREC000338	pyridinoline [PYD]	hormone refractory prostate cancer (hrpc)	185	C61	
BIOMARKERREC000339	beta-catenin	localized prostate cancer	185	C61	
BIOMARKERREC000340	AZGP1	margin-positive localized prostate cancer	185	C61	
BIOMARKERREC000341	beta-catenin	metastatic hormone refractory prostate cancer	185	C61	
BIOMARKERREC000342	receptor for urinary plasminogen activator (uPAR)	metastatic hormone refractory prostate cancer	185	C61	
BIOMARKERREC000343	Wnt-1	metastatic hormone refractory prostate cancer	185	C61	
BIOMARKERREC000344	chromogranin A (CGA)	metastatic hormone resistant prostatic cancer (hrpc)	185	C61	
BIOMARKERREC000345	MMP-9	metastatic hormone resistant prostatic cancer (hrpc)	185	C61	
BIOMARKERREC000346	PAP	metastatic hormone resistant prostatic cancer (hrpc)	185	C61	
BIOMARKERREC000347	PSA	metastatic hormone resistant prostatic cancer (hrpc)	185	C61	
BIOMARKERREC000348	VEGF-D	metastatic prostate cancer	185	C61	
BIOMARKERREC000349	VEGF-D receptor	metastatic prostate cancer	185	C61	
BIOMARKERREC000350	IGF binding protein 3 (IGFBP-3)	metastatic prostate cancer (pca)	185	C61	
BIOMARKERREC000351	amino-terminal procollagen propeptides of type 1 collagen (PINP)	prostate cancer	185	C61	
BIOMARKERREC000352	bone specific alkaline phosphatase	prostate cancer	185	C61	
BIOMARKERREC000353	citrate	prostate cancer	185	C61	
BIOMARKERREC000354	citrate derivatives	prostate cancer	185	C61	
BIOMARKERREC000355	a specific kinase target of dasatinib ( EphA2)	prostate cancer	185	C61	
BIOMARKERREC000356	androgen receptor (AR)	prostate cancer	185	C61	
BIOMARKERREC000357	cytokeratin 5 (CK5)	prostate cancer	185	C61	
BIOMARKERREC000358	prostate specific antigen (PSA)	prostate cancer	185	C61	
BIOMARKERREC000359	urokinase-type plasminogen activator (uPA)	prostate cancer	185	C61	
BIOMARKERREC000360	fPSA/tPSA	prostate cancer	185	C61	
BIOMARKERREC000361	N-telopeptide (NTX)	prostate cancer	185	C61	
BIOMARKERREC000362	total DPD	prostate cancer	185	C61	
BIOMARKERREC000363	osteocalcin	prostate cancer	185	C61	
BIOMARKERREC000364	1CTP	prostate cancer	185	C61	
BIOMARKERREC000365	P1NP	prostate cancer	185	C61	
BIOMARKERREC000366	TRAP	prostate cancer	185	C61	
BIOMARKERREC000367	PSA; HGF	prostate cancer	185	C61	
BIOMARKERREC000368	procollagen amino-terminal propeptide 1 (P1NP)	prostate cancer (pc)	185	C61	
BIOMARKERREC000369	APC	prostate cancer (prca)	185	C61	
BIOMARKERREC000370	GST-P1	prostate cancer (prca)	185	C61	
BIOMARKERREC000371	Interleukin-6 (IL-6)	prostatic carcinoma	185	C61	
BIOMARKERREC000372	Ki67	retroperitoneal lymph node dissection (rplnd)	186	C62	
BIOMARKERREC000373	p53	retroperitoneal lymph node dissection (rplnd)	186	C62	
BIOMARKERREC000374	C-reactive protein (CRP)	testcular cancer, long term survivors	186,140-229	C62,C00-C96	
BIOMARKERREC000375	IL-1Ra	testcular cancer, long term survivors	186,140-229	C62,C00-C96	
BIOMARKERREC000376	EGFR	penile squamous cancer (psc)	187	C60	
BIOMARKERREC000377	KRAS	penile squamous cancer (psc)	187	C60	
BIOMARKERREC000378	Serum tissue polypeptide antigen (S-TPA)	bladder carcinoma	188	C67	
BIOMARKERREC000379	beta HCG	advanced bladder cancer	188	C67	
BIOMARKERREC000380	CA125	advanced bladder cancer	188	C67	
BIOMARKERREC000381	CA19.9	advanced bladder cancer	188	C67	
BIOMARKERREC000382	CEA	advanced bladder cancer	188	C67	
BIOMARKERREC000383	apolipoprotein A-IV	bladder cancer	188	C67	
BIOMARKERREC000384	FK506 binding protein 6 isoform	bladder cancer	188	C67	
BIOMARKERREC000385	lipid binding protein	bladder cancer	188	C67	
BIOMARKERREC000386	paraliprotein	bladder cancer	188	C67	
BIOMARKERREC000387	Telomerase	patients with favorable histology (fh) wilms tumor (wt)	189.0	C64	
BIOMARKERREC000388	VEGFR3	renal clear cell carcinoma	189.0	C64	
BIOMARKERREC000389	CCL5	localized clear cell renal cell carcinoma (ccrcc)	189	C64	
BIOMARKERREC000390	CXCL9	localized clear cell renal cell carcinoma (ccrcc)	189	C64	
BIOMARKERREC000391	EMCN	localized clear cell renal cell carcinoma (ccrcc)	189	C64	
BIOMARKERREC000392	NOS3	localized clear cell renal cell carcinoma (ccrcc)	189	C64	
BIOMARKERREC000393	tumour perfusion	metastatic renal cell cancer	189	C64	
BIOMARKERREC000394	IL6, IL8, HGF, OPN, TIMP1, VEGF, E-Selectin	metastatic renal cell carcinoma (mrcc)	189	C64	
BIOMARKERREC000395	MMP-9	metastatic renal cell carcinoma (mrcc)	189	C64	
BIOMARKERREC000396	TNF-Î	metastatic renal cell carcinoma (mrcc)	189	C64	
BIOMARKERREC000397	gelsolin	papillary renal cell carcinoma (prcc)	189	C64	
BIOMARKERREC000398	Ki-67	papillary renal cell carcinoma (prcc)	189	C64	
BIOMARKERREC000399	p21	papillary renal cell carcinoma (prcc)	189	C64	
BIOMARKERREC000400	p27	papillary renal cell carcinoma (prcc)	189	C64	
BIOMARKERREC000401	proteins of the VEGF family	papillary renal cell carcinoma (prcc)	189	C64	
BIOMARKERREC000402	p27	papillary renal cell carcinoma (prcc)	189	C64	
BIOMARKERREC000403	p53	papillary renal cell carcinoma (prcc)	189	C64	
BIOMARKERREC000404	pAkt	papillary renal cell carcinoma (prcc)	189	C64	
BIOMARKERREC000405	MET	papillary renal cell carcinoma (prcc)	189	C64	
BIOMARKERREC000406	HIF1A	renal cell carcinoma	189	C64	
BIOMARKERREC000407	IL8	renal cell carcinoma	189	C64	
BIOMARKERREC000408	VEGFA	renal cell carcinoma	189	C64	
BIOMARKERREC000409	VEGFR2	renal cell carcinoma	189	C64	
BIOMARKERREC000410	Thymidilate synthase (TS)	renal cell carcinoma	189	C64	
BIOMARKERREC000411	miR-21	renal cell carcinoma conventional type t 2-4	189.0	C64	
BIOMARKERREC000412	miR-29c	renal cell carcinoma conventional type t 2-4	189.0	C64	
BIOMARKERREC000413	integrin ?±Iib	glioblastoma multiforme (gbm)	191	C71	
BIOMARKERREC000414	integrin Î±V	glioblastoma multiforme (gbm)	191	C71	
BIOMARKERREC000415	integrin Î²3	glioblastoma multiforme (gbm)	191	C71	
BIOMARKERREC000416	IGFBP-2	glioblastoma multiforme (gbm)	191	C71	
BIOMARKERREC000417	YKL-40	high-grade gliomas (hgg)	191	C71	
BIOMARKERREC000418	creatine	malignant primary brain tumors	191	C71	
BIOMARKERREC000419	EGFR	anaplastic glioma	191	C71	
BIOMARKERREC000420	p53	anaplastic glioma	191	C71	
BIOMARKERREC000421	PTEN	anaplastic glioma	191	C71	
BIOMARKERREC000422	Choline/Creatinine	cerebral glioma	191	C71	
BIOMARKERREC000423	Choline/NAA	cerebral glioma	191	C71	
BIOMARKERREC000424	NAA/Creatinine	cerebral glioma	191	C71	
BIOMARKERREC000425	MMP-9	gbm;anaplastic astrocytoma (aa)	191,191,191	C71,C71,C71	
BIOMARKERREC000426	increased p53 immunoreactivity	glioblastoma multiforme	191	C71	
BIOMARKERREC000427	IDH1	glioblastoma multiforme (gbm)	191	C71	
BIOMARKERREC000428	Temozolomide (TMZ)	glioma	191	C71	
BIOMARKERREC000429	spermidine	glioma disease	191	C71	
BIOMARKERREC000430	EGFR	malignant glioma	191	C71	
BIOMARKERREC000431	MDM2	malignant glioma	191	C71	
BIOMARKERREC000432	p16	malignant glioma	191	C71	
BIOMARKERREC000433	ERBB2	medulloblastoma	191	C71	
BIOMARKERREC000436	IDH1	recurrent high-grade glioma (hgg)	191	C71	
BIOMARKERREC000437	MGMT	recurrent high-grade glioma (hgg)	191	C71	
BIOMARKERREC000438	urokinase plasminogen activator (uPA)	recurrent malignant glioma	191	C71	
BIOMARKERREC000439	99mTc-Sestamibi	metastatic medullary thyroid cancer	193	C73	
BIOMARKERREC000440	ch11q	patients <18 months of age at diagnosis of inss stage 3 mycn-na nb	194	C74	
BIOMARKERREC000441	ferritin	patients >=18 months of age at diagnosis of inss stage 3 mycn-na nb	194	C74	
BIOMARKERREC000442	KI-67	parathyroid carcinoma	194.1	C75.0	
BIOMARKERREC000443	PCNA	parathyroid carcinoma	194.1	C75.0	
BIOMARKERREC000444	CA 125	peritoneal carcinomatosis of appendiceal origin	197.6	C78.6	
BIOMARKERREC000445	CA 19-9	peritoneal carcinomatosis of appendiceal origin	197.6	C78.6	
BIOMARKERREC000446	CEA	peritoneal carcinomatosis of appendiceal origin	197.6	C78.6	
BIOMARKERREC000447	N-telopeptide (NTX)	bone metastase	198.5	C79.51	
BIOMARKERREC000448	bone alkaline phosphates (B-ALP)	bone metastase	198.5	C79.51	
BIOMARKERREC000449	deoxypyridinoline (DXP)	bone metastase	198.5	C79.51	
BIOMARKERREC000450	pyridinoline (PYD)	bone metastase	198.5	C79.51	
BIOMARKERREC000451	Osteoprotegerin (OPG)	bone metastases	198.5	C79.51	
BIOMARKERREC000452	Î²-crosslaps	bone metastases	198.5	C79.51	
BIOMARKERREC000453	Procollagen-I-propeptide	bone metastases	198.5	C79.51	
BIOMARKERREC000454	N-telopeptide (NTX)	bone metastases	198.5	C79.51	
BIOMARKERREC000455	deoxypiridinoline (DPD) and the collagen cross-link associated N-Telopeptide (NTX).	extent of metastatic bone disease	198.5	C79.51	
BIOMARKERREC000456	Serum bone-specific alkaline phosphatase (B-AP)	extent of metastatic bone disease	198.5	C79.51	
BIOMARKERREC000457	serum concentration of the collagen cross-link associated C-Telopeptide (ICTP)	extent of metastatic bone disease	198.5	C79.51	
BIOMARKERREC000458	urine concentration of the pyridinium cross-links pyridinoline (PYD)	extent of metastatic bone disease	198.5	C79.51	
BIOMARKERREC000459	carboxyterminal telopeptide (ICTP)	bone metastases (bm)	198.5	C79.51	
BIOMARKERREC000460	Ntx	metastatic bone disease	198.5	C79.51	
BIOMARKERREC000461	C-telopeptide	osteolytic bone metastase	198.5	C79.51	
BIOMARKERREC000462	N-telopeptide (NTX)	osteolytic bone metastase	198.5	C79.51	
BIOMARKERREC000463	N-telopeptide of type I collagen (NTX)	patients (pts) with bone metastase	198.5	C79.51	
BIOMARKERREC000464	MRP	head and neck squamous cell carcinoma	199	C44	
BIOMARKERREC000465	Thymidilate synthase (TS)	head and neck squamous cell carcinoma	199	C44	
BIOMARKERREC000466	E-cadherin	head and neck squamous cell carcinoma (hnscc)	199	C44	
BIOMARKERREC000467	EGFR; Survivin; Bcl-2; Bak; Hsp70;Smad4	head and neck squamous cell carcinoma (hnscc)	199	C44	
BIOMARKERREC000468	ERCC1	head and neck squamous cell carcinoma (hnscc)	199	C44	
BIOMARKERREC000469	CXCR4	oral cavity squamous cell carcinoma	199	C44	
BIOMARKERREC000470	Cyclin D1	patients with esophageal squamous cell carcinoma and neoadjuvant radiochemotherapy	199	C44	
BIOMARKERREC000471	Manganese Superoxide Dismutase (Mn-SOD)	head and neck squamous cell carcinoma	199	C44	
BIOMARKERREC000472	Osteopontin (OPN)	head and neck squamous cell carcinomas (hnscc)	199	C44	
BIOMARKERREC000473	RAR?± +/ p53+	oral squamous cell carcinoma	199	C44	
BIOMARKERREC000474	cyclin D1	oral squamous cell carcinoma	199	C44	
BIOMARKERREC000475	RAR?± +	oral squamous cell carcinoma	199	C44	
BIOMARKERREC000476	p16	oral squamous cell carcinoma	199	C44	
BIOMARKERREC000477	RAR?± +/p21-	oral squamous cell carcinoma	199	C44	
BIOMARKERREC000478	RAR?2	oral squamous cell carcinoma	199	C44	
BIOMARKERREC000479	c-Met	oropharyngeal squamous cell carcinoma	199	C44	
BIOMARKERREC000480	pAkt	oropharyngeal squamous cell carcinoma	199	C44	
BIOMARKERREC000481	Bcl2	squamous cell carcinoma (scc)	199	C44	
BIOMARKERREC000482	p63	squamous cell carcinoma (scc)	199	C44	
BIOMARKERREC000483	international prognostic index (IPI)	diffuse large b cell lymphoma (dlbcl)	200.0	C83.3	
BIOMARKERREC000484	Beta-2-microglobulin (B2M)	diffuse large cell lymphoma (dlcl)	200.0	C83.3	
BIOMARKERREC000485	Bcl2	diffuse large b-cell lymphoma	200.0	C83.3	
BIOMARKERREC000486	IPI	diffuse large b-cell lymphoma	200.0	C83.3	
BIOMARKERREC000487	P53	diffuse large b-cell lymphoma	200.0	C83.3	
BIOMARKERREC000489	BCL-6	primary cns lymphoma (pcnsl)	200.5	C83.3,C83.8	
BIOMARKERREC000490	P-STAT6	primary nervous system lymphoma (pcnsl)	200.5	C83	
BIOMARKERREC000492	VEGF	hodgkin's diseas	201	C81	
BIOMARKERREC000493	Soluble interleukin-2 receptor	malignant lymphomas	202	C81-C96	
BIOMARKERREC000494	severe neutropenia in cycle 1 (C1SN)	high grade lymphoma (ihl)	202	C81-C96	
BIOMARKERREC000495	Ferritin	malignant lymphoma	202	C81-C96	
BIOMARKERREC000496	Peripheral blood CD20 (+) lymphocyte	malignant lymphoma	202	C81-C96	
BIOMARKERREC000497	TNF-Î	malignant lymphoma	202	C81-C96	
BIOMARKERREC000498	Hepatocyte Growth Factor (HGF)	multiple myeloma	203.0	C90.0	
BIOMARKERREC000499	Osteopontin (OPN)	multiple myeloma	203.0	C90.0	
BIOMARKERREC000500	CA15-3	multiple myeloma (mm)	203.0	C90.0	
BIOMARKERREC000501	Plasmablastic morphology	myeloma	203.0	C90.0	
BIOMARKERREC000502	Ctx	myeloma bone disease	203.0	C90.0	
BIOMARKERREC000503	DPD	myeloma bone disease	203.0	C90.0	
BIOMARKERREC000504	Cardiac Troponin T	childhood acute lymphoblastic leukemia	204.0	C91.0	
BIOMARKERREC000505	cardiac troponin T (cTnT)	children with acute lymphoblastic leukemia (all)	204.0	C91.0	
BIOMARKERREC000506	NT-pro-brain natriuretic peptide (NT-pro-BNP)	children with acute lymphoblastic leukemia (all)	204.0	C91.0	
BIOMARKERREC000507	alpha4-integrin/CD49d	b-cell chronic lymphocytic leukemia (b-cll)	204.1	C91.1	
BIOMARKERREC000508	CD38	chronic lymphocytic leukemia	204.1	C91.1	
BIOMARKERREC000509	Ig V	chronic lymphocytic leukemia	204.1	C91.1	
BIOMARKERREC000510	BBC3	acute myeloid leukemia (aml)	205.0	C92.0	
BIOMARKERREC000511	CDKN1A	acute myeloid leukemia (aml)	205.0	C92.0	
BIOMARKERREC000513	BAALC	cytogenetically normal acute myeloid leukemia (cn aml)	205.0	C92.0	
BIOMARKERREC000514	BCR/ABL	chronic myeloid leukemia (cml)	205.1,205,208.9	C92.1,C92,C91-C95	
BIOMARKERREC000515	ABL	cml	205.1	C92.1	
BIOMARKERREC000516	circulating endothelial cell (CEC)	patients with neuroendocrine tumors enrolled in a phase ii trial of endostatin	209	D3A,C7A	
BIOMARKERREC000517	Musashi-1	intestinal adenoma	211	D12,D13	
BIOMARKERREC000518	molecular grade index (MGI)	ductal carcinoma in situ (dcis)	233.0	D05.9	
BIOMARKERREC000519	HOXB13/IL17BR	ductal carcinoma in situ (dcis)	233.0	D05.9	
BIOMARKERREC000520	ABCA5	prostatic intraepithelial epithelial	233.4	D07.5	
BIOMARKERREC000521	RIL	patients with myelodysplastic syndromes	238.7	D46	
BIOMARKERREC000522	Bcl2	post-transplant lymphoproliferative disorder	238.77	D47.Z1	
BIOMARKERREC000523	Bcl2	post-transplant lymphoproliferative disorder (ptld)	238.77	D47.Z1	
BIOMARKERREC000524	heart fatty acid–binding protein	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000525	Adiponectin	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000526	albumin (ALB)	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000527	Cystatin C	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000528	FGF-232	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000529	kidney injury molecule-1 (KIM-1)	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000530	liver fatty acid-binding protein	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000531	N-Acetyl-β-D-glucosamindase (NAG	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000532	Nephrin	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000533	neutrophil gelatinase-associated lipocalin (NGAL)	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000534	Podocalyxin	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000535	Podocin	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000536	Synaptopodin	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000537	TNFR11	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000538	TNFR2	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000539	Type IV collagen	diabetic nephropathy	250.4	E10.2,E11.2,E12.2,E13.2,E14.2	
BIOMARKERREC000540	5-HIAA	malignant carcinoid syndrome	259.2	E34.0	
BIOMARKERREC000541	chromogranin A (CGA)	malignant carcinoid syndrome	259.2	E34.0	
BIOMARKERREC000542	Immunoglobulin free light chain	waldenstrom's macroglobulinemia	273.3	C88.0	
BIOMARKERREC000543	2-aminoacetophenone	cystic fibrosis	277.0	E84	
BIOMARKERREC000544	hydrogen cyanide	cystic fibrosis	277.0	E84	
BIOMARKERREC000545	8-isoprostane	cystic fibrosis	277.0	E84	
BIOMARKERREC000546	prostaglandin E2 (PGE2)	cystic fibrosis	277.0	E84	
BIOMARKERREC000547	CO	cystic fibrosis	277.0	E84	
BIOMARKERREC000548	Bis(monoacylglycero)phosphate	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000549	Brain MRI images	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000550	Brain MRI images	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000551	Dipeptidyl peptidase IV	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000552	Ganglioside 2 (GM2)	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000553	Ganglioside 3 (GM3)	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000554	Ganglioside 2 (GM2)	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000555	Ganglioside 3 (GM3)	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000556	glycosaminoglycans	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000557	glycosaminoglycans	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000558	glycosaminoglycans	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000559	glycosaminoglycans	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000560	glycosaminoglycans	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000561	glycosaminoglycans	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000562	glycosaminoglycans	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000563	Hair morphology	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000564	Heparin cofactor II-thrombin complex	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000565	Heparin cofactor II-thrombin complex	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000566	matrix metalloproteinase (MMP)	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000567	oligosaccharides	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000568	oligosaccharides	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000569	oligosaccharides	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000570	TNF-alpha	mucopolysaccharidoses (mpss)	277.5	E76	
BIOMARKERREC000571	IL-10	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000572	TGF-β1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000573	IL2R	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000574	IL-8	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000575	albumin (ALB)	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000576	albumin (ALB)	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000577	albumin (ALB)	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000578	albumin (ALB)	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000579	CCL5	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000580	CXCL10 TNFR1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000581	CCL8	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000582	CCL8	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000583	CCL8	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000584	CCL8	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000585	CD8, IL2R, TNFR1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000586	CK18Fs	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000587	CK18Fs	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000588	Collagen α-1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000589	Collagen α-1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000590	CXCL10	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000591	CXCL10	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000592	Cystatin SN	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000593	Elafin	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000594	Elafin	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000595	Elafin	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000596	Elafin	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000597	Elafin	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000598	GRO-α	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000599	GRO-α	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000600	sc-kit	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000601	sICAM-1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000602	TNF-alpha	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000603	TNFR1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000604	NULL	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000605	HGF	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000606	HGF	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000607	HGF	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000608	HGF	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000609	HGF	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000610	HGF	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000611	HGF, IL2R, IL-8, TNFR1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000612	IFNγ	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000613	IFNγ	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000614	IFNγ	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000615	IL-12	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000616	IL-18	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000617	IgA	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000618	IL-10	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000619	IL-12	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000620	IL-12	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000621	IL-12	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000622	IL-12	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000623	IL-15	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000624	IL-15	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000625	M-CSF	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000626	IL-10	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000627	IL-15	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000628	M-CSF	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000629	TNFR1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000630	TNFR2	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000631	IL-18	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000632	IL-18	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000633	IL-18	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000634	IL-18	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000635	IL-18	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000636	IL-18	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000637	IL2R	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000638	IL2R	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000639	IL2R	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000640	IL2R	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000641	IL2R	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000642	IL2R	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000643	IL-2Ra	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000644	IL-2Ra	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000645	IL-8	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000646	IL-8	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000647	IL-8	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000648	Lactoferrin	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000649	Leukotriene A4 hydrolase	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000650	M-CSF	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000651	REG3a	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000652	REG3α	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000653	Salivary amylase	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000654	sc-kit	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000655	Serum albumin	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000656	sFas	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000657	sFas	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000658	sICAM-1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000659	SLPI	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000660	Syndecan-1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000661	Syndecan-I	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000662	IL2R	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000663	Syndecan-I	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000664	IL2R	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000665	Syndecan-I	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000666	TGF-β1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000667	TNFR1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000668	TNFR1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000669	TNFR1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000670	TNFR1	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000671	TNFR2	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000672	TNF-alpha	acute graft-versus-host disease (agvhd)	279.5	D89.8	
BIOMARKERREC000673	IL-10	agvhd, chronic gvhd (cgvhd), infection, relapse	279.50,001-139,279.50	T86.0,A00-B99,T86.0	
BIOMARKERREC000674	REG3a	gi gvhd	279.5	D89.8	
BIOMARKERREC000675	albumin (ALB)	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000676	C-reactive protein (CRP)	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000677	HGF	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000678	IL-6	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000679	IL-8	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000680	KRT18	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000681	KRT18	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000682	REG3a	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000683	REG3a	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000684	REG3a	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000685	TNF-alpha	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000686	TNFR1	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000687	TNFR1	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000688	Tryptophan metabolites	graft-versus-host disease (gvhd)	279.5	D89.8	
BIOMARKERREC000689	KRT18	refractory gvhd; gi gvhd	279.50,279.5	T86.0,D89.8	
BIOMARKERREC000690	bone marrow	iron deficiency caused anemia	280	D50	
BIOMARKERREC000691	Ferritin	iron deficiency caused anemia	280	D50	
BIOMARKERREC000692	red cell morphology	iron deficiency caused anemia	280	D50	
BIOMARKERREC000693	serum iron	iron deficiency caused anemia	280	D50	
BIOMARKERREC000694	soluble transferrin receptors	iron deficiency caused anemia	280	D50	
BIOMARKERREC000695	40-amino acid VGF peptide	schizophrenia	295	F20	
BIOMARKERREC000696	glucose	schizophrenia	295	F20	
BIOMARKERREC000697	lipid	schizophrenia	295	F20	
BIOMARKERREC000698	glycine	schizophrenia	295	F20	
BIOMARKERREC000699	amyloid peptide	schizophrenia	295	F20	
BIOMARKERREC000700	5-HT2 receptor	schizophrenia	295	F20	
BIOMARKERREC000701	D2 receptor	schizophrenia	295	F20	
BIOMARKERREC000702	dopamine metabolite	schizophrenia	295	F20	
BIOMARKERREC000703	electrophysiological signatures	schizophrenia	295	F20	
BIOMARKERREC000704	extrapyramidal signs	schizophrenia	295	F20	
BIOMARKERREC000705	impairments in cognitive tests	schizophrenia	295	F20	
BIOMARKERREC000706	sedation	schizophrenia	295	F20	
BIOMARKERREC000707	GlyT1 ligand [3H] RO5013853	schizophrenia	295	F20	
BIOMARKERREC000708	prolactin	schizophrenia	295	F20	
BIOMARKERREC000709	transthyretin	schizophrenia	295	F20	
BIOMARKERREC000710	anterior temporal hypometabolism	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000711	anterior temporal hypoperfusion	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000712	frontal temporal hypoperfusion	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000713	frontal temporal hypoperfusion	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000714	amyloid beta	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000715	ptau	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000716	tau	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000717	C9ORF72	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000718	chemokine	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000719	cytokines	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000720	anterior temporal atrophy	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000721	frontal temporal atrophy	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000722	chromatin-modifying 2B (CHMP2B)	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000723	microtubule associated protein tau gene (MAPT)	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000724	progranulin (GRN)	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000725	TAR- DNA binding protein 43 encoding gene (TARBDP)	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000726	valosin-containing protein 1 (VCP-1)	frontotemporal lobar degeneration (ftld)	331.1	G31.0	
BIOMARKERREC000727	6-[18F]-fluoro-l-3,4-dihydroxyphenylalanine (18F-dopa)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000728	aromatic amino acid decarboxylase (AADC)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000729	6-[18F]-fluoro-l-3,4-dihydroxyphenylalanine (18F-dopa)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000730	aromatic amino acid decarboxylase (AADC)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000731	6-[18F]-fluoro-l-3,4-dihydroxyphenylalanine (18F-dopa)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000732	aromatic amino acid decarboxylase (AADC)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000733	Monoamine oxidase-B (MAO-B)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000734	Transcranial sonography (TCS)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000735	Transcranial sonography (TCS)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000736	Transcranial sonography (TCS)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000737	[11C]dMP	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000738	[11C]dMP	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000739	[11C]DTBZ	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000740	[11C]DTBZ	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000741	[11C]DTBZ	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000742	[11C]RAC	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000743	[11C]RAC	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000744	[123I]-2β-carbomethoxy-3β-(4-iodophenyl tropane) ([123I]b-CIT)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000745	[123I]-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)-N-tropane ([123I]FP-CIT)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000746	[123I]b-CIT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000747	[123I]b-CIT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000748	[123I]b-CIT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000749	[123I]b-CIT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000750	[123I]FP-CIT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000751	[123I]FP-CIT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000752	[123I]FP-CIT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000753	[123I]IPT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000754	[123I]IPT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000755	[123I]IPT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000756	[123I]PE2I	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000757	[18F]-2-fluoro-2-deoxyglucose (FDG)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000758	[18F]-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)-N-tropane ([18F]FP-CIT)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000759	[18F]FP-CIT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000760	[18F]FP-CIT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000761	[99mTc] TRODAT-1	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000762	[99mTc] TRODAT-1	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000763	[99mTc] TRODAT-1	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000764	[99mTc]ECD	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000765	[99mTc]ECD	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000766	[99mTc]-hexamethylpropylene amine oxid (HMPAO)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000767	102 plasma proteins	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000768	18F-fluorodeoxyglucose (FDG)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000769	5-hydroxytryptamine (5-HT)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000770	8-hydroxy-2-deoxyguanosine (8-OHdG)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000771	Ab	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000772	Ab	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000773	Ab	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000774	Amygdala volume	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000775	amyloid β42	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000776	p-tau	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000777	tau	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000778	Arginine	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000779	a-Synuclein	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000780	a-Synuclein	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000781	a-Synuclein	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000782	a-Synuclein	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000783	Tau	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000784	Biceps burst duration variability	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000785	Cardiac autonomic dysfunction	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000786	Cardiac autonomic dysfunction	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000787	Cardiac autonomic dysfunction	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000788	Ceruloplasmin	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000789	Cholinergic function	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000790	Cholinergic function	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000791	Cholinergic function	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000792	Cholinergic function	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000793	cholesterol	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000794	Coenzyme Q10	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000795	Contralateral lateral SN pars compacta R2*	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000796	Contralateral phase shift values of SN	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000797	Contralateral posterior GP R2*	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000798	Contralateral SN R2'' relaxation rate	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000799	Copper	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000800	D3 dopamine receptor	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000801	β-actin	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000802	Delayed H/M ratio of 123I-MIBG uptake	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000803	Dihydroxyphenylacetic acid (DOPAC)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000804	DJ-1	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000805	DJ-1	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000806	DJ-1	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000807	Dopamine	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000808	Dopamine transporter (DAT)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000809	Dopamine transporter (DAT)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000810	Dopamine transporter (DAT)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000811	Early H/M ratio of 123I-MIBG uptake	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000812	EEG total power	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000813	F2-isoprostanes (F2-IsoPs)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000814	FDG network	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000815	FDG network	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000816	FDG network	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000817	FDG network	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000818	FDOPA	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000819	FDOPA	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000820	FDOPA	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000821	Free Carnitine	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000822	Glutathione	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000823	glycine	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000824	GP ?R2''	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000825	Heart rate variability: low frequency (LF) power spectrum densities	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000826	Heart rate variability: very low frequency (VLF) power spectrum densities	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000827	High sensitivity C-reactive protein (Hs-CRP)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000828	Hippocampal volume	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000829	HMPAO	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000830	Homocysteine	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000831	Homovanillic acid	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000832	Hydroxyeicosatetraenoic acid products (HETEs)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000833	Interleukin 6 (IL-6)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000834	Interleukin 6 (IL-6)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000835	Leucocyte 8-hydroxy-2-deoxygyanosine (8-OHdG)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000836	levodopa	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000837	Malondialdehyde (MDA)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000838	Mean amplitude after rare stimuli	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000839	Mean area of bilateral substantia nigra hyperechogenicity	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000840	Mean intensity score of SN pars compacta	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000841	Mean PU R2	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000842	Mean width of frontal horns of lateral ventricles	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000843	Mean width of third ventricle	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000844	iron deposit)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000845	MRI (DWI	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000846	iron deposit)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000847	MRI (DWI	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000848	iron deposit)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000849	MRI (DWI	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000850	iron deposit)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000851	MRI (DWI	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000852	MSNA of peroneal nerve fascicles in right popliteal fossa	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000853	Neural thread protein	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000854	N-isopropyl-P[123I]-iodoamphetamine ([123I]IMP)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000855	Nitrate	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000856	Non-Ceruloplasmin bound Copper (NCBC)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000857	Noradrenaline	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000858	P3 amplitude	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000859	P3 latency	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000860	Percentage of short 1st agonist burst durations	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000861	Perfusion SPECT	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000862	Phenanthroline-copper	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000863	PU ?R2''	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000864	Regulated upon activation of normal T cell expressed and secreted (RANTES)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000865	S100B	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000866	Slope of power law relation (slope of HRV)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000867	SN fractional anisotropy (FA) value	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000868	Structural MRI	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000869	Tau	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000870	Tau	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000871	Tau	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000872	tumour necrosis factor	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000873	Unilateral area of substantia nigra hyperechogenicity	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000874	uric acid	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000875	uric acid	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000876	Vesicular monoamine transporter 2 (VMAT2)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000877	Vesicular monoamine transporter 2 (VMAT2)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000878	Vesicular monoamine transporter 2 (VMAT2)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000879	Vesicular monoamine transporter 2 (VMAT2)	parkinson's disease	332	F02.3,G20	
BIOMARKERREC000880	(TAR)-DNA-binding protein (TDP-43)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000881	3-Nitrotyrosine (3-NT)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000882	3-nonenal (HNE)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000883	4-Hydroxy-2	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000884	8-hydroxy-2-deoxyguanosine (8-OHdG)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000885	albumin (ALB)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000886	aspartate	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000887	glycine	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000888	Amyloid-beta 1-42	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000889	Anti-neural antibodies agains GM1- gangliosides	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000890	Anti-neural antibodies against asialo-GM1- gangliosides	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000891	Anti-neural antibodies against sulfatides	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000892	Complement factors C3	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000893	Complement factors C4	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000894	Cystatin C	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000895	Erythropoietin (EPO)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000896	glutamate	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000897	Glutamine synthetase	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000898	Glutathione	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000899	Glutathione peroxidase	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000900	granulocyte colony stimulating factor (G-CSF)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000901	IgG	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000902	Interleukin-6 (IL-6)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000903	Interleukin-8 (IL-8)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000904	iron	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000905	Markers of the neuroprotection	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000906	MMP-2	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000907	MMP-9 metalloproteinase	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000908	Monocyte chemoattractantprotein-1 (MCP-1)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000909	Neopterin	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000910	Neurofilament heavy chain (NfH)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000911	Neurofilament light chain (NfL)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000912	Nitrate	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000913	Peroxynitrite	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000914	Pigment epithelium-derived factor (PEDF)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000915	Progranulin (PGRN)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000916	Prostaglandin E2	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000917	S100b	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000918	SOD1	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000919	Tau protein	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000920	Total protein	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000921	Transglutaminases activity (TGases)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000922	uric acid	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000923	vascular endothelial growth factor (VEGF)	amyotrophic lateral sclerosis	335.20	G12.2	
BIOMARKERREC000924	CD14	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000925	S100β	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000926	Complement C3	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000927	Cystatin C	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000928	Cystatin C	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000929	neurosecretory protein VGF	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000930	Cystatin C	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000931	neuroendocrine protein 7B2	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000932	transthyretin	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000933	Diffusion tensor imaging	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000934	Electrical impedance myography	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000935	Fetuin‐A	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000936	transthyretin	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000937	IL‐2, IL‐6, IL‐10, IL‐15, GM‐CSF	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000938	Magnetic resonance spectroscopy	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000939	CC‐chemokine ligand 11 (CCL11)	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000940	CCL24	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000941	CCL26	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000942	IL‐8	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000943	IL‐8	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000944	monocyte chemoattractant protein‐1 (MCP‐1)	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000945	Motor unit number estimation	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000946	Neurophysiological index	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000947	phosphorylated neurofilament heavy chain (pNfH)	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000948	complement C3	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000949	pNfH	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000950	Voxel-based morphometry	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000951	α2‐glycoprotein	amyotrophic lateral sclerosis (als)	335.20	G12.2	
BIOMARKERREC000952	TLR4	multiple sclerosis	340	G35	
BIOMARKERREC000953	TNF-alpha	multiple sclerosis	340	G35	
BIOMARKERREC000954	IFNγ producing CD8+ T cells	multiple sclerosis	340	G35	
BIOMARKERREC000955	TNFα  producing CD8+ T cells	multiple sclerosis	340	G35	
BIOMARKERREC000956	β-1 adrenergic receptor	multiple sclerosis	340	G35	
BIOMARKERREC000957	β-2 adrenergic receptor	multiple sclerosis	340	G35	
BIOMARKERREC000958	GFAP	neuromyelitis optica (nmo)	341.0	G36.0	
BIOMARKERREC000959	albumin (ALB)	neuromyelitis optica (nmo)	341.0	G36.0	
BIOMARKERREC000960	IgG	neuromyelitis optica (nmo)	341.0	G36.0	
BIOMARKERREC000961	BAFF	neuromyelitis optica (nmo)	341.0	G36.0	
BIOMARKERREC000962	IL-17	neuromyelitis optica (nmo)	341.0	G36.0	
BIOMARKERREC000963	IL-6	neuromyelitis optica (nmo)	341.0	G36.0	
BIOMARKERREC000964	NMO-IgG	neuromyelitis optica (nmo)	341.0	G36.0	
BIOMARKERREC000965	thiopurine S-methyltransferase	myasthenia gravis	358.0	G70.0	
BIOMARKERREC000966	Acetylcholine receptor (AChR) antibody	myasthenia gravis	358.0	G70.0	
BIOMARKERREC000967	acetylcholine receptor (AChR) antibody	myasthenia gravis	358.0	G70.0	
BIOMARKERREC000968	muscle-specific kinase (MuSK) antibody	myasthenia gravis	358.0	G70.0	
BIOMARKERREC000969	DR3	myasthenia gravis	358.0	G70.0	
BIOMARKERREC000970	HLA-B8	myasthenia gravis	358.0	G70.0	
BIOMARKERREC000971	muscle-specific kinase (MuSK) antibody	myasthenia gravis	358.0	G70.0	
BIOMARKERREC000972	Single-fiber EMG	myasthenia gravis	358.0	G70.0	
BIOMARKERREC000973	TPMT	myasthenia gravis	358.0	G70.0	
BIOMARKERREC000974	ADRB2	glaucoma	365	H40-H42	
BIOMARKERREC000975	antibodies against human vimentin and humanglial fi- brillary acid protein (GFAP), anti-Ro/SS-A (Sjogren syndrome A; also commonly called Ro antigens), serum anti- bodies that bind to human optic nerve head proteoglycans, including chondroitin sulfate and heparin, serum autoanti- bodies against gamma-enolase(y-enolase) in retinal ganglion cells of glaucomatous patients and glutathione S-transferase (GST) antibodies	glaucoma	365	H40-H42	
BIOMARKERREC000976	brain derived neurotrophic factor (BDNF)	glaucoma	365	H40-H42	
BIOMARKERREC000977	citrate	glaucoma	365	H40-H42	
BIOMARKERREC000978	cytotoxicity	glaucoma	365	H40-H42	
BIOMARKERREC000979	DARC (detection of apoptosing retinal cells)	glaucoma	365	H40-H42	
BIOMARKERREC000980	glucocorticoid receptor GRβ	glaucoma	365	H40-H42	
BIOMARKERREC000981	matrixmetalloproteinase 9 (MMP-9; gelatinase B; 92-kDa type IV; collagenaseprecursor) ;membrane-type matrix metalloproteinase1 (MT1-MMP, MMP-14 precursor) ; metalloproteinase inhibitor1 precursor 1 (TIMP-1)	glaucoma	365	H40-H42	
BIOMARKERREC000982	ADRB2	glaucoma	365	H40-H42	
BIOMARKERREC000983	GLC1A	glaucoma	365	H40-H42	
BIOMARKERREC000984	Myocilin	glaucoma	365	H40-H42	
BIOMARKERREC000985	bone morphogenetic proteins (BMP)	glaucoma	365	H40-H42	
BIOMARKERREC000986	nitric oxide (NO)	glaucoma	365	H40-H42	
BIOMARKERREC000987	Serum Amyloid A (SAA)	glaucoma	365	H40-H42	
BIOMARKERREC000988	tubulin alpha-1A chain, SAPS domain family member 1, lim and SH3 domain protein 1, synaptosomalassociated protein 23, latent-transforming growth factor beta-binding protein, isoform lL, drebrin, proto-oncogene tyrosine-protein kinase Src, thymosin beta-10, zinc finger protein 185, dynamin-1-like protein, protein phosphatase 1 regulatory subunit 12A, platelet endothelial cell adhesion molecule, transgelin-2, AP-2 complex subunit sigma-1 and exportin-7	glaucoma	365	H40-H42	
BIOMARKERREC000989	conjunctival cell viability	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC000990	proliferative capacity	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC000991	a-antitrypsin	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC000992	Calcitonin gene-related petide (CGRP)	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC000993	Calcitonin gene-related petide (CGRP)	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC000994	CCL3/MIP1a	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC000995	CCL4/MIP1b	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC000996	CCL5/RANTES	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC000997	CCR5	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC000998	Conjunctival cell proliferative capacity	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC000999	Conjunctival cell viability	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001000	Conjunctival intraepithelial CD19+ B cells	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001001	Conjunctival intraepithelial CD3+ T cells	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001002	Conjunctival intraepithelial T cells CD4/CD8 ratio	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001003	Cystatin SN	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001004	IFN-g	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001005	IL-1b	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001006	IL-6	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001007	IL-8	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001008	Lipocalin-1	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001009	metalloproteinase-9	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001010	MMP1	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001011	MMP-10	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001012	MMP-2	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001013	MMP-7	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001014	MMP-9	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001015	MUC-1	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001016	MUC-16	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001017	MUC-2	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001018	MUC-4	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001019	MUC-5AC	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001020	mucin-1	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001021	Nerve growth factor(NGF)	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001022	Nerve growth factor(NGF)	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001023	Neuropeptide Y (NPY)	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001024	Neuropeptide Y (NPY)	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001025	OAHFA	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001026	OAHFA	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001027	Phosphatidylcholine (PC)	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001028	S100A8 (CalgranulinA)	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001029	S100A9 (CalgranulinB)	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001030	Sphingomyelin (SM)	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001031	TNF-alpha	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001032	Triacylglycerides (TAGs)	dry eye disease (ded)	370.33	H16.229	
BIOMARKERREC001033	ATPase 1 gene (ATP2B1)	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001034	BAT2	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001035	BAT5	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001036	CACNB2	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001037	FLJ32810	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001038	TMEM133	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001039	EDN3 CACNB2	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001040	GNAS	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001041	UMOD	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001042	Adducin 1 ( ADD1 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001043	Adducin 2 ( ADD2 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001044	Adducin 3 ( ADD3 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001045	Adrenergic, beta-1-, receptor    ( ADRB1 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001046	Adrenergic, beta-2-, receptor    ( ADRB2 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001047	Adrenergic, beta-3-, receptor    ( ADRB3 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001048	angiotensin I converting enzyme (ACE)	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001049	Angiotensin II receptor, type 1    ( AGTR1 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001050	Angiotensin II receptor, type 2    ( AGTR2 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001051	Angiotensinogen    ( AGT )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001052	apolipoprotein B (ApoB)	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001053	ATP-binding cassette, sub-family B   (MDR/TAP), member 1    ( ABCB1 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001054	Cytochrome P450 family 3, subfamily A,   polypeptide 5    ( CYP3A5 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001055	Cytochrome P450, family 11,   subfamily B, polypeptide 1    ( CYP11B1 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001056	Cytochrome P450, family 11,   subfamily B, polypeptide 2;   aldosterone synthase    ( CYP11B2 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001057	Dopamine beta-hydroxylase   (dopamine beta-mono-oxygenase; DBH)	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001058	Dopamine receptor D1    ( DRD1 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001059	Dopamine receptor D2    ( DRD2 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001060	Dopamine receptor D3    ( DRD3 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001061	endothelin-1 (ET-1)	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001062	Guanine nucleotide binding protein   (G protein), beta polypeptide 3    ( GNB3 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001063	hemochromatosis (HFE)	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001064	Hydroxysteroid   (11-beta) dehydrogenase 2    ( HSD11B2 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001065	Lipoprotein lipase    ( LPL )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001066	Natriuretic peptide precursor A    ( NPPA )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001067	Natriuretic peptide precursor B    ( NPPB )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001068	Natriuretic peptide precursor C    ( NPPC )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001069	Natriuretic peptide receptorC  (guanylatecyclase C; NPR3 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001070	Neuropeptide Y    ( NPY )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001071	Neuropeptide Y receptor 1    ( NPY1R )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001072	Nitric oxide synthase 3    ( NOS3 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001073	C5orf23	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001074	NPR3	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001075	Nuclear receptor subfamily 3, group C,   member 2 (NR3C2); mineralocorticoid receptor  (MLR)	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001076	Peroxisome proliferator-activated receptor gamma      ( PPARG )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001077	Phenylethanolamine   N-methyltransferase    ( PNMT )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001078	PLCE1	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001079	Renin    ( REN )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001080	Sodium channel, nonvoltage-gated 1   alpha (alpha ENaC;  SCNN1A)	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001081	Sodium channel, nonvoltage-gated 1   beta (beta ENaC;  SCNN1B )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001082	Sodium channel, nonvoltage-gated 1   gamma (gamma ENaC;  SCNN1G )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001083	Solute carrier family 12 (sodium/  chloride transporters), member 3    ( SLC12A3 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001084	Solute carrier family 12 (sodium/  potassium/chloride transporters),  member 1    ( SLC12A1 )	hypertension (htn)	401	I10,I11,I12,I13,I15	
BIOMARKERREC001085	H-FABP	acute myocardial infarction	410	I21-I22	
BIOMARKERREC001086	miR-1	acute myocardial infarction	410	I21-I22	
BIOMARKERREC001087	miR-133a	acute myocardial infarction	410	I21-I22	
BIOMARKERREC001088	miR-208a	acute myocardial infarction	410	I21-I22	
BIOMARKERREC001089	miR-499-5p	acute myocardial infarction	410	I21-I22	
BIOMARKERREC001090	Mrp-14)	acute myocardial infarction	410	I21-I22	
BIOMARKERREC001091	Myeloid-related protein-14 (MIM 123886 S100A9	acute myocardial infarction	410	I21-I22	
BIOMARKERREC001092	troponin T (TnT)	acute myocardial infarction	410	I21-I22	
BIOMARKERREC001093	B-type natriuretic peptide (BNP)	myocardial infarction	410	I21,I22	
BIOMARKERREC001094	CD40 ligand	myocardial infarction	410	I21,I22	
BIOMARKERREC001095	copeptin	myocardial infarction	410	I21,I22	
BIOMARKERREC001096	C-reactive protein (CRP)	myocardial infarction	410	I21,I22	
BIOMARKERREC001097	C-reactive protein (CRP)	myocardial infarction	410	I21,I22	
BIOMARKERREC001098	heart-type fatty acid-binding protein (H-FABP)	myocardial infarction	410	I21,I22	
BIOMARKERREC001099	heart-type fatty acid-binding protein (H-FABP)	myocardial infarction	410	I21,I22	
BIOMARKERREC001100	ischaemia-modified albumin (IMA)	myocardial infarction	410	I21,I22	
BIOMARKERREC001101	matrix metalloproteinase 9 (MMP 9)	myocardial infarction	410	I21,I22	
BIOMARKERREC001102	myeloperoxidase (MPO)	myocardial infarction	410	I21,I22	
BIOMARKERREC001103	Myoglobin	myocardial infarction	410	I21,I22	
BIOMARKERREC001104	N-terminal pro-B-type natriuretic peptide (NT-pro-BNP)	myocardial infarction	410	I21,I22	
BIOMARKERREC001105	pregnancy-associated plasma protein A (PAPP-A)	myocardial infarction	410	I21,I22	
BIOMARKERREC001106	ST-2	myocardial infarction	410	I21,I22	
BIOMARKERREC001107	troponin I (TnI)	myocardial infarction	410	I21,I22	
BIOMARKERREC001108	troponin T (TnT)	myocardial infarction	410	I21,I22	
BIOMARKERREC001109	B-type natriuretic peptide (BNP)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001110	cardiac muscle cell troponin (cTn)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001111	CD40 ligand	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001112	CD40	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001113	CD40L	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001114	CK-MB	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001115	myoglobin	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001116	Copeptin (C-terminal pro-vasopressin)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001117	C-reactive protein (CRP)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001118	C-reactive protein (CRP)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001119	Cystatin C	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001120	electrocardiography (ECG)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001121	E-selectin	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001122	estimated glomerular filtration rate	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001123	GPBB	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001124	growth differentiation factor 15 (GRF-15)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001125	heart-type fatty acid-binding protein (H-FABP)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001126	heart-type fatty acid-binding protein (H-FABP)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001127	High sensitive troponin (hsTN)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001128	high-sensitivity C-reactive protein (hsCRP)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001129	IL-18	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001130	interleukin 6	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001131	ischaemia-modified albumin (IMA)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001132	matrix metalloproteinase 9 (MMP 9)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001133	MMP-9	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001134	Myeloperoxidase	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001135	myeloperoxidase (MPO)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001136	myoglobin	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001137	N-terminal pro-B-type natriuretic peptide (NT-pro-BNP)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001138	ox-LDL	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001139	placental growth factor (PIGF)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001140	placental growth factor (PIGF)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001141	High-on-treatment platelet reactivity (HTPR)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001142	immature platelet fraction (IPF)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001143	mean platelet volume (MPV)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001144	Platelet count	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001145	Platelet size	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001146	Platelet turnover	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001147	reticulated platelets	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001148	pregnancy-associated plasma protein A (PAPP-A)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001149	pregnancy-associated plasma protein A (PAPP-A)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001150	Pregnancy-associated plasma protein-A (PAPP-A)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001151	P-selectin	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001152	ST-2	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001153	troponin T (TnT)	acute coronary syndrome (acs)	411.1	I20.0	
BIOMARKERREC001154	Carotid intima-media thickness (CIMT)	coronary disease	414.0	I25.1	
BIOMARKERREC001155	coronary artery calcium (CAC)	coronary disease	414.0	I25.1	
BIOMARKERREC001156	Lp(a)	coronary heart disease	414.0	I25.1	
BIOMARKERREC001157	H-FABP	acute pulmonary embolism	415.1	I26	
BIOMARKERREC001158	H-FABP	acute pulmonary embolism	415.1	I26	
BIOMARKERREC001159	troponin T (TnT)	acute pulmonary embolism	415.1	I26	
BIOMARKERREC001160	B-type natriuretic peptide (BNP)	pulmonary embolism	415.1	I26	
BIOMARKERREC001161	NT-proBNP	pulmonary embolism	415.1	I26	
BIOMARKERREC001162	troponin T (TnT)	pulmonary embolism	415.1	I26	
BIOMARKERREC001163	troponin T (TnT)	pulmonary arterial hyperten- sion	416.0	I27.0,I27.2	
BIOMARKERREC001164	B-type natriuretic peptide (BNP)	pulmonary artery hypertension	416.0	I27.0,I27.2	
BIOMARKERREC001165	NT-proBNP	pulmonary artery hypertension	416.0	I27.0,I27.2	
BIOMARKERREC001166	B-type natriuretic peptide (BNP)	calcific aortic valve disease	424.1	I35	
BIOMARKERREC001167	C-reactive protein (CRP)	calcific aortic valve disease	424.1	I35	
BIOMARKERREC001168	Fetuin-A	calcific aortic valve disease	424.1	I35	
BIOMARKERREC001169	Homocysteine	calcific aortic valve disease	424.1	I35	
BIOMARKERREC001170	Leptin	calcific aortic valve disease	424.1	I35	
BIOMARKERREC001171	lipid	calcific aortic valve disease	424.1	I35	
BIOMARKERREC001172	NT-proBNP	calcific aortic valve disease	424.1	I35	
BIOMARKERREC001173	Osteopontin	calcific aortic valve disease	424.1	I35	
BIOMARKERREC001174	N-terminal Pro-BNP (NP)	acute congestive hf (chf)	428	I50	
BIOMARKERREC001175	high-sensitivity cardiac Troponin I (hs-cTnI)	acute heart failure (hf)	428	I50	
BIOMARKERREC001176	ST2	chronic heart failure	428	I50	
BIOMARKERREC001177	Aldosterone	heart failure	428	I50	
BIOMARKERREC001178	AlloMap	heart failure	428	I50	
BIOMARKERREC001179	Arginine vasopressin	heart failure	428	I50	
BIOMARKERREC001180	B-type natriuretic peptide (BNP)	heart failure	428	I50	
BIOMARKERREC001181	B-type natriuretic peptide (BNP)	heart failure	428	I50	
BIOMARKERREC001182	CA125	heart failure	428	I50	
BIOMARKERREC001183	Cardiac Troponin I	heart failure	428	I50	
BIOMARKERREC001184	Cardiac Troponin T	heart failure	428	I50	
BIOMARKERREC001185	C-reactive protein (CRP)	heart failure	428	I50	
BIOMARKERREC001186	C-terminal pro-endothelin-1	heart failure	428	I50	
BIOMARKERREC001187	Cystatin C	heart failure	428	I50	
BIOMARKERREC001188	endothelin-1 (ET-1)	heart failure	428	I50	
BIOMARKERREC001189	F2-isoprostanes	heart failure	428	I50	
BIOMARKERREC001190	IL-6	heart failure	428	I50	
BIOMARKERREC001191	Lp-PLA2	heart failure	428	I50	
BIOMARKERREC001192	MMP-2	heart failure	428	I50	
BIOMARKERREC001193	MPO	heart failure	428	I50	
BIOMARKERREC001194	MR-proADM	heart failure	428	I50	
BIOMARKERREC001195	MR-pro-ANP	heart failure	428	I50	
BIOMARKERREC001196	KIM-1	heart failure	428	I50	
BIOMARKERREC001197	NAG	heart failure	428	I50	
BIOMARKERREC001198	NGAL	heart failure	428	I50	
BIOMARKERREC001199	Norepinephrine	heart failure	428	I50	
BIOMARKERREC001200	NT-pro-ANP	heart failure	428	I50	
BIOMARKERREC001201	Osteoprotogerin	heart failure	428	I50	
BIOMARKERREC001202	oxLDL antibodies	heart failure	428	I50	
BIOMARKERREC001203	Renin	heart failure	428	I50	
BIOMARKERREC001204	ST2	heart failure	428	I50	
BIOMARKERREC001205	ST2	heart failure	428	I50	
BIOMARKERREC001206	sTNFR1	heart failure	428	I50	
BIOMARKERREC001207	sTNFR2	heart failure	428	I50	
BIOMARKERREC001208	TIMP-1	heart failure	428	I50	
BIOMARKERREC001209	TNF-alpha	heart failure	428	I50	
BIOMARKERREC001210	Type I collagen telopeptide	heart failure	428	I50	
BIOMARKERREC001211	brain natriuretic peptide (BNP)	heart failure (hf)	428	I50	
BIOMARKERREC001212	brain natriuretic peptide (BNP)	heart failure (hf)	428	I50	
BIOMARKERREC001213	brain natriuretic peptide (BNP)	heart failure (hf)	428	I50	
BIOMARKERREC001214	homocysteine	heart failure (hf)	428	I50	
BIOMARKERREC001215	N-terminal Pro-BNP (NP)	heart failure (hf)	428	I50	
BIOMARKERREC001216	N-terminal Pro-BNP (NP)	heart failure (hf)	428	I50	
BIOMARKERREC001217	N-terminal Pro-BNP (NP)	heart failure (hf)	428	I50	
BIOMARKERREC001218	N-terminal Pro-BNP (NP)	heart failure (hf)	428	I50	
BIOMARKERREC001219	ST2	heart failure (hf)	428	I50	
BIOMARKERREC001220	ST2	heart failure (hf)	428	I50	
BIOMARKERREC001221	ST2	heart failure (hf)	428	I50	
BIOMARKERREC001222	BNP, sodium, copeptin	heart failure (hf)	428	I50	
BIOMARKERREC001223	copeptin	heart failure (hf)	428	I50	
BIOMARKERREC001224	copeptin; hsTN	heart failure (hf)	428	I50	
BIOMARKERREC001225	Cystatin C	heart failure (hf)	428	I50	
BIOMARKERREC001226	Galectin-3	heart failure (hf)	428	I50	
BIOMARKERREC001227	Galectin-3; BNP	heart failure (hf)	428	I50	
BIOMARKERREC001228	high-sensitivity cardiac Troponin I (hs-cTnI)	heart failure (hf)	428	I50	
BIOMARKERREC001229	high-sensitivity cardiac troponin T (hs-cTnT)	heart failure (hf)	428	I50	
BIOMARKERREC001230	high-sensitivity cardiac troponin T (hs-cTnT)	heart failure (hf)	428	I50	
BIOMARKERREC001231	hs-C-reactive protein	heart failure (hf)	428	I50	
BIOMARKERREC001232	Kidney injury molecule-1 (KIM-1)	heart failure (hf)	428	I50	
BIOMARKERREC001233	KIM-1	heart failure (hf)	428	I50	
BIOMARKERREC001234	natriuretic peptide	heart failure (hf)	428	I50	
BIOMARKERREC001235	NGAL	heart failure (hf)	428	I50	
BIOMARKERREC001236	NT-proBNP, adrenomedullin, troponin, copeptin	heart failure (hf)	428	I50	
BIOMARKERREC001237	high-sensitivity cardiac Troponin I (hs-cTnI)	nonischemic congestive hf	428.0	I50	
BIOMARKERREC001238	adhesion molecule-1	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001239	ankle brachial index (ABI)	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001240	beta fibrinogen	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001241	C-reactive protein (CRP)	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001242	C-reactive protein (CRP)	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001243	intercellular adhesion molecule -1	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001244	leukocyte	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001245	interleukin 6	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001246	monocyte chemo attractant protein-1	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001247	osteoprotegerin	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001248	tumor necrosis factor alpha	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001249	monocyte chemoattractant protein-1	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001250	tissue plasminogen activator and plasminogen activator inhibitor 1	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001251	von Willebrand factor	peripheral arterial disease (pad)	443	I73	
BIOMARKERREC001252	D-dimer	venous thromboembolism (vte)	453	I80-I82	
BIOMARKERREC001253	Factor VIII (FVIII)	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001254	Factor VIII (FVIII)	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001255	IL-10	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001256	D-dimer	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001257	D-dimer	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001258	D-dimer	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001259	Factor VIII (FVIII)	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001260	fibrin monomer (FM)	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001261	fibrin monomer (FM)	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001262	FVIII	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001263	IL-1	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001264	IL-6	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001265	Inflammatory cytokines	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001266	Inflammatory cytokines	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001267	Leukocyte	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001268	Leukocyte	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001269	Microparticle (MP)	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001270	Microparticle (MP)	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001271	P-selectin	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001272	P-selectin	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001273	P-selectin	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001274	thrombin	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001275	thrombin	deep venous thrombosis (dvt)	453.4	I82.4	
BIOMARKERREC001276	ischemia-modified albumin (IMA)	ischemia	459.89	I99.8	
BIOMARKERREC001277	Aa-Val360	emphysema	492	J43	
BIOMARKERREC001278	matrix metalloproteinase 9 (MMP 9)	emphysema	492	J43	
BIOMARKERREC001279	chemokine (C-C motif) ligand 17	asthma	493	J45	
BIOMARKERREC001280	C-reactive protein (CRP)	asthma	493	J45	
BIOMARKERREC001281	H2O2	asthma	493	J45	
BIOMARKERREC001282	Nitrate	asthma	493	J45	
BIOMARKERREC001283	nitrite	asthma	493	J45	
BIOMARKERREC001284	pentane	asthma	493	J45	
BIOMARKERREC001285	EBC pH	asthma	493	J45	
BIOMARKERREC001286	endothelin-1 (ET-1)	asthma	493	J45	
BIOMARKERREC001287	eNO;  eosinophils	asthma	493	J45	
BIOMARKERREC001288	eosinophils	asthma	493	J45	
BIOMARKERREC001289	eosinophils	asthma	493	J45	
BIOMARKERREC001290	eosinophils	asthma	493	J45	
BIOMARKERREC001291	eosinophils	asthma	493	J45	
BIOMARKERREC001292	ethane	asthma	493	J45	
BIOMARKERREC001293	exhaled nitric oxide (eNO)	asthma	493	J45	
BIOMARKERREC001294	fragment of exhaled nitric oxide (FENO)	asthma	493	J45	
BIOMARKERREC001295	fragment of exhaled nitric oxide (FENO)	asthma	493	J45	
BIOMARKERREC001296	high-sensitivity C-reactive protein (hs-CRP)	asthma	493	J45	
BIOMARKERREC001297	15-hyroxyeicosetetrenoic acid (15-HETE)	asthma	493	J45	
BIOMARKERREC001298	15-lipoxygenase (15-LO)	asthma	493	J45	
BIOMARKERREC001299	cysteinyl leukotrienes (cysLTs)	asthma	493	J45	
BIOMARKERREC001300	eotaxins	asthma	493	J45	
BIOMARKERREC001301	IL-13	asthma	493	J45	
BIOMARKERREC001302	IL-4	asthma	493	J45	
BIOMARKERREC001303	IL-5	asthma	493	J45	
BIOMARKERREC001304	IL-8	asthma	493	J45	
BIOMARKERREC001305	LTB4	asthma	493	J45	
BIOMARKERREC001306	MMP-9	asthma	493	J45	
BIOMARKERREC001307	mast cells in smooth muscle	asthma	493	J45	
BIOMARKERREC001308	Smooth muscle	asthma	493	J45	
BIOMARKERREC001309	chymase-positive mast cells	asthma	493	J45	
BIOMARKERREC001310	collagens	asthma	493	J45	
BIOMARKERREC001311	subepithelial basement membrane (SBM)	asthma	493	J45	
BIOMARKERREC001312	tenascin	asthma	493	J45	
BIOMARKERREC001313	transforming growth factor b (TGF-b)	asthma	493	J45	
BIOMARKERREC001314	YKL-40	asthma	493	J45	
BIOMARKERREC001315	YKL-40	asthma	493	J45	
BIOMARKERREC001316	hs-CRP; exhaled NO	asthma	493	J45	
BIOMARKERREC001317	CO	asthma especially; children with chronic asthma	493	J45	
BIOMARKERREC001318	cysteinyl leukotrienes (cysLTs)	asthma in children	493	J45	
BIOMARKERREC001319	NO	asthma in children	493	J45	
BIOMARKERREC001320	fragment of exhaled nitric oxide (FENO)	severe refractory asthma (sra)	493	J45	
BIOMARKERREC001321	CYFRA 21-1	malignant pleural effusion	511.81	J91.0	
BIOMARKERREC001322	CO	fibrosing alveolitis	516.3	J84.1	
BIOMARKERREC001323	albumin (ALB)	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001324	Brain natriuretic peptide (BNP)	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001325	CCL18	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001326	CCL18	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001327	CCL18	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001328	CD28	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001329	CD4	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001330	CD28	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001331	CD4	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001332	CD28	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001333	CD4	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001334	Fibrocytes	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001335	KL-6	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001336	KL-6	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001337	MMP1	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001338	MMP7	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001339	MMP7	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001340	MMP7	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001341	Osteopontin	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001342	Periostin	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001343	Periostin	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001344	SP-A	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001345	SP-A	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001346	SP-D	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001347	SP-D	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001348	Tregs	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001349	Tregs	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001350	Tregs	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001351	VEGF	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001352	YKL-40	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001353	YKL-40	idiopathic pulmonary fibrosis (ipf)	516.3	J84.1	
BIOMARKERREC001354	pro-ANP	acute lung injury	518	J80	
BIOMARKERREC001355	A 17 kDa molecular weight protein	dental caries	521.0	K02	
BIOMARKERREC001356	Basic proline-rich peptide	dental caries	521.0	K02	
BIOMARKERREC001357	Total proteins	dental caries	521.0	K02	
BIOMARKERREC001358	IL-5	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001359	IL-5	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001360	mast cell products and dysregulated transcriptomes	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001361	miRNA-675	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001362	EDN	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001363	Eosinophil-derived neurotoxin (EDN)	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001364	Eotaxin-1	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001365	Eotaxin-2	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001366	Eotaxin-3	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001367	Eotaxin-3	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001368	fibroblast growth factor	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001369	FK506-binding protein 51 (FKBP51)	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001370	IL-13	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001371	IL-13	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001372	IL-5	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001373	Mast cells	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001374	MicroRNA	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001375	miR-375	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001376	miRNA-21	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001377	miRNA-223	eosinophilic esophagitis (eoe)	530.13	K20.0	
BIOMARKERREC001378	COX-2	barrett's esophagus and carcinoma	530.85	K22.7	
BIOMARKERREC001379	Ki-67	barrett's esophagus and carcinoma	530.85	K22.7	
BIOMARKERREC001380	VEGF	barrett's esophagus and carcinoma	530.85	K22.7	
BIOMARKERREC001381	kynurenine	crohn's disease (cd)	555	K50	
BIOMARKERREC001382	tryptophan	crohn's disease (cd)	555	K50	
BIOMARKERREC001383	L-arginine	ulcerative colitis (uc)	556	K51	
BIOMARKERREC001384	a-2 macroglobulin, haptoglobin, total bilirubin, g-glutamyl transferase, ALT, AST, total cholesterol, TG, fasting blood glucose.	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001385	ALT	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001386	AST	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001387	CK-18	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001388	C-reactive protein (CRP)	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001389	Fas	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001390	Fasting glucose	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001391	HA, TIMP-1, PIIINP (enhanced liver fibrosis panel; ELF panel)	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001392	homeostatic model assessment (HOMA)	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001393	hyaluronic acid (HA; hyaluronan)	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001394	IL-6	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001395	Insulin resistance	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001396	M-30	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001397	M-65	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001398	N-terminal propeptide of type III collagen (PIIINP)	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001399	TNF-alpha	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001400	Type IV collagen 7S	nonalcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001401	CK-18	non-alcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001402	uncleaved CK-18	non-alcoholic steatohepatitis (nash)	571.8	K76.0	
BIOMARKERREC001403	The regenerating gene 1a (REG 1a)	celiac disease	579.0	K90.0	
BIOMARKERREC001404	CCR1	celiac disease	579.0	K90.0	
BIOMARKERREC001405	CCR2	celiac disease	579.0	K90.0	
BIOMARKERREC001406	CCR3	celiac disease	579.0	K90.0	
BIOMARKERREC001407	CCR5	celiac disease	579.0	K90.0	
BIOMARKERREC001408	CTLA-4	celiac disease	579.0	K90.0	
BIOMARKERREC001409	HLA-DQ2	celiac disease	579.0	K90.0	
BIOMARKERREC001410	HLA-DQ8	celiac disease	579.0	K90.0	
BIOMARKERREC001411	IgA anti-DGP (antideaminated forms of gliadin peptides antibodies)	celiac disease	579.0	K90.0	
BIOMARKERREC001412	IgA anti-EMA (antiendomysium antibody)	celiac disease	579.0	K90.0	
BIOMARKERREC001413	IgA anti-tTG	celiac disease	579.0	K90.0	
BIOMARKERREC001414	IL-12A	celiac disease	579.0	K90.0	
BIOMARKERREC001415	IL-18R1	celiac disease	579.0	K90.0	
BIOMARKERREC001416	IL-18RAP	celiac disease	579.0	K90.0	
BIOMARKERREC001417	IL-2	celiac disease	579.0	K90.0	
BIOMARKERREC001418	IL-21	celiac disease	579.0	K90.0	
BIOMARKERREC001419	RGS1	celiac disease	579.0	K90.0	
BIOMARKERREC001420	soluble urokinase-type plasminogen activator receptor (suPAR)	focal segmental glomerulonephritis (fsg)	581	N00-N08	
BIOMARKERREC001421	Anti-SOD2 antibodies	membranous nephropathy (mn)	581.1	N02.2	
BIOMARKERREC001422	μ2-microglobulin	membranous nephropathy (mn)	581.1	N02.2	
BIOMARKERREC001423	anti-M type phospholipase A2 receptor antibodies (Anti-PLA2R antibodies)	membranous nephropathy (mn)	581.1	N02.2	
BIOMARKERREC001424	anti-M type phospholipase A2 receptor antibodies (Anti-PLA2R antibodies)	membranous nephropathy (mn)	581.1	N02.2	
BIOMARKERREC001425	anti aldose-reductase antibodies (Anti-AR antibodies)	membranous nephropathy (mn)	581.1	N02.2	
BIOMARKERREC001426	n-acetyl-glucosaminidase (NAG)	membranous nephropathy (mn)	581.1	N02.2	
BIOMARKERREC001427	CD80 (B7.1)	minimal change nephropathy (mcn)	581.3	N00.0,N01.0,N02.0,N03.0,N04.0,N05.0,N06.0,N07.0,N08.0	
BIOMARKERREC001428	CD80 (B7.1)	minimal change nephropathy (mcn)	581.3	N00.0,N01.0,N02.0,N03.0,N04.0,N05.0,N06.0,N07.0,N08.0	
BIOMARKERREC001429	Haemopexin	minimal change nephropathy (mcn)	581.3	N00.0,N01.0,N02.0,N03.0,N04.0,N05.0,N06.0,N07.0,N08.0	
BIOMARKERREC001430	IL-13	minimal change nephropathy (mcn)	581.3	N00.0,N01.0,N02.0,N03.0,N04.0,N05.0,N06.0,N07.0,N08.0	
BIOMARKERREC001431	acid phosphatase	patients with minimal disease under vaccine	581.3	N00.0,N01.0,N02.0,N03.0,N04.0,N05.0,N06.0,N07.0,N08.0	
BIOMARKERREC001432	Prostate-specific antigen (PSA)	patients with minimal disease under vaccine	581.3	N00.0,N01.0,N02.0,N03.0,N04.0,N05.0,N06.0,N07.0,N08.0	
BIOMARKERREC001433	Clusterin	acute kidney injury (aki)	584	N17	
BIOMARKERREC001434	creatinine	acute kidney injury (aki)	584	N17	
BIOMARKERREC001435	Cystatin C	acute kidney injury (aki)	584	N17	
BIOMARKERREC001436	cysteine rich protein 61 (CYR 61)	acute kidney injury (aki)	584	N17	
BIOMARKERREC001437	FABP	acute kidney injury (aki)	584	N17	
BIOMARKERREC001438	Fetuin A	acute kidney injury (aki)	584	N17	
BIOMARKERREC001439	IL-18	acute kidney injury (aki)	584	N17	
BIOMARKERREC001440	IL-18	acute kidney injury (aki)	584	N17	
BIOMARKERREC001441	KIDNEY INJURY MOLECULE-1 (KIM-1)	acute kidney injury (aki)	584	N17	
BIOMARKERREC001442	microalbumin	acute kidney injury (aki)	584	N17	
BIOMARKERREC001443	N-ASETIL-β-GLUOSAMINIDASE (NAG)	acute kidney injury (aki)	584	N17	
BIOMARKERREC001444	NETRIN – 1	acute kidney injury (aki)	584	N17	
BIOMARKERREC001445	NETRIN – 1	acute kidney injury (aki)	584	N17	
BIOMARKERREC001446	NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL)	acute kidney injury (aki)	584	N17	
BIOMARKERREC001447	OPN	acute kidney injury (aki)	584	N17	
BIOMARKERREC001448	RETINOL BINDING PROTEIN (RBP)	acute kidney injury (aki)	584	N17	
BIOMARKERREC001449	Sodium/Hydrogen exchanger isoform (NHE3)	acute kidney injury (aki)	584	N17	
BIOMARKERREC001450	urea nitrogen	acute kidney injury (aki)	584	N17	
BIOMARKERREC001451	α-1 MICROGLOBULIN	acute kidney injury (aki)	584	N17	
BIOMARKERREC001452	β2-microglobulin (β2-M)	acute kidney injury (aki)	584	N17	
BIOMARKERREC001453	CyC	acute kidney injury in pediatric cardiac patients	584	N17	
BIOMARKERREC001454	CyC	acute kidney injury in pediatric cardiac patients	584	N17	
BIOMARKERREC001455	IL-18	acute kidney injury in pediatric cardiac patients	584	N17	
BIOMARKERREC001456	IL-18	acute kidney injury in pediatric cardiac patients	584	N17	
BIOMARKERREC001457	KIM-1	acute kidney injury in pediatric cardiac patients	584	N17	
BIOMARKERREC001458	KIM-1	acute kidney injury in pediatric cardiac patients	584	N17	
BIOMARKERREC001459	L-FABP	acute kidney injury in pediatric cardiac patients	584	N17	
BIOMARKERREC001460	L-FABP	acute kidney injury in pediatric cardiac patients	584	N17	
BIOMARKERREC001461	NGAL	acute kidney injury in pediatric cardiac patients	584	N17	
BIOMARKERREC001462	NGAL	acute kidney injury in pediatric cardiac patients	584	N17	
BIOMARKERREC001463	Creatinine	kidney injury	584	N17	
BIOMARKERREC001464	NGF	idiopathic detrusor overactivity;neurogenic detrusor overactivity	596.51,596.51,596.51	N32.81,N32.81,N32.81	
BIOMARKERREC001465	beta3 adrenoceptor	overactive bladder	596.51	N32.81	
BIOMARKERREC001466	brainderived neurotrophic factor (BDNF)	overactive bladder	596.51	N32.81	
BIOMARKERREC001467	C-reactive protein (CRP)	overactive bladder	596.51	N32.81	
BIOMARKERREC001468	C-reactive protein (CRP)	overactive bladder	596.51	N32.81	
BIOMARKERREC001469	Fas/TNFRSF6	overactive bladder	596.51	N32.81	
BIOMARKERREC001470	MCP1	overactive bladder	596.51	N32.81	
BIOMARKERREC001471	PARC	overactive bladder	596.51	N32.81	
BIOMARKERREC001472	TARC	overactive bladder	596.51	N32.81	
BIOMARKERREC001473	nerve growth factor (NGF)	overactive bladder	596.51	N32.81	
BIOMARKERREC001474	NGF	overactive bladder	596.51	N32.81	
BIOMARKERREC001475	NGF	overactive bladder	596.51	N32.81	
BIOMARKERREC001476	PGE2	overactive bladder	596.51	N32.81	
BIOMARKERREC001477	PGF2	overactive bladder	596.51	N32.81	
BIOMARKERREC001478	C-reactive protein (CRP)	psoriasis	696	L40	
BIOMARKERREC001479	haptoglobin	psoriasis	696	L40	
BIOMARKERREC001480	IFN-γ	psoriasis	696	L40	
BIOMARKERREC001481	IL-12	psoriasis	696	L40	
BIOMARKERREC001482	IL-18.	psoriasis	696	L40	
BIOMARKERREC001483	IL-6	psoriasis	696	L40	
BIOMARKERREC001484	IL-8	psoriasis	696	L40	
BIOMARKERREC001485	P-selectin	psoriasis	696	L40	
BIOMARKERREC001486	TNF	psoriasis	696	L40	
BIOMARKERREC001487	8-hydroxy guanosine	psoriasis	696	L40	
BIOMARKERREC001488	Bak	psoriasis	696	L40	
BIOMARKERREC001489	Bax	psoriasis	696	L40	
BIOMARKERREC001490	Bcl-X	psoriasis	696	L40	
BIOMARKERREC001491	high sensitivity CRP, osteoprotegerin, matrix metalloproteinase 3; the CPII:C2C ratio	psoriasis	696	L40	
BIOMARKERREC001492	IL-1	psoriasis	696	L40	
BIOMARKERREC001493	IL-10	psoriasis	696	L40	
BIOMARKERREC001494	IL-4	psoriasis	696	L40	
BIOMARKERREC001495	IL-5	psoriasis	696	L40	
BIOMARKERREC001496	IL-23	psoriasis	696	L40	
BIOMARKERREC001497	IL-23R	psoriasis	696	L40	
BIOMARKERREC001498	Th17	psoriasis	696	L40	
BIOMARKERREC001499	leptin	psoriasis	696	L40	
BIOMARKERREC001500	lipocalin	psoriasis	696	L40	
BIOMARKERREC001501	resistin	psoriasis	696	L40	
BIOMARKERREC001502	IFN-α	psoriasis	696	L40	
BIOMARKERREC001503	IL-12	psoriasis	696	L40	
BIOMARKERREC001504	IL-2	psoriasis	696	L40	
BIOMARKERREC001505	IL-6	psoriasis	696	L40	
BIOMARKERREC001506	IL-8	psoriasis	696	L40	
BIOMARKERREC001507	LIF-1	psoriasis	696	L40	
BIOMARKERREC001508	TNF	psoriasis	696	L40	
BIOMARKERREC001509	ABCC1	psoriasis	696	L40	
BIOMARKERREC001510	ABCG2	psoriasis	696	L40	
BIOMARKERREC001511	Adiponectin	psoriasis	696	L40	
BIOMARKERREC001512	CCL19	psoriasis	696	L40	
BIOMARKERREC001513	CCR7	psoriasis	696	L40	
BIOMARKERREC001514	CD3 T-cell	psoriasis	696	L40	
BIOMARKERREC001515	CpG methylation	psoriasis	696	L40	
BIOMARKERREC001516	Elafin	psoriasis	696	L40	
BIOMARKERREC001517	human β defensin	psoriasis	696	L40	
BIOMARKERREC001518	LL-37	psoriasis	696	L40	
BIOMARKERREC001519	S100 family member	psoriasis	696	L40	
BIOMARKERREC001520	Bβ and D-dimer	psoriasis	696	L40	
BIOMARKERREC001521	C4	psoriasis	696	L40	
BIOMARKERREC001522	fibrinogen	psoriasis	696	L40	
BIOMARKERREC001523	Fibrinopeptide A	psoriasis	696	L40	
BIOMARKERREC001524	prothrombin fragments 1+2	psoriasis	696	L40	
BIOMARKERREC001525	HLA-Cw6	psoriasis	696	L40	
BIOMARKERREC001526	IL-22	psoriasis	696	L40	
BIOMARKERREC001527	IL-6	psoriasis	696	L40	
BIOMARKERREC001528	keratin 1 (K1 )	psoriasis	696	L40	
BIOMARKERREC001529	keratin 10 (K10)	psoriasis	696	L40	
BIOMARKERREC001530	keratin (K16)	psoriasis	696	L40	
BIOMARKERREC001531	keratin 6 (K6)	psoriasis	696	L40	
BIOMARKERREC001532	IFHIH1	psoriasis	696	L40	
BIOMARKERREC001533	IL23R	psoriasis	696	L40	
BIOMARKERREC001534	LCE3B/3C	psoriasis	696	L40	
BIOMARKERREC001535	NFKBIA	psoriasis	696	L40	
BIOMARKERREC001536	miR125b	psoriasis	696	L40	
BIOMARKERREC001537	miR1266	psoriasis	696	L40	
BIOMARKERREC001538	miR-146a	psoriasis	696	L40	
BIOMARKERREC001539	miR-203	psoriasis	696	L40	
BIOMARKERREC001540	miR-21	psoriasis	696	L40	
BIOMARKERREC001541	connexin 26	psoriasis	696	L40	
BIOMARKERREC001542	connexin 30	psoriasis	696	L40	
BIOMARKERREC001543	heat shock protein 60 (HSP60)	psoriasis	696	L40	
BIOMARKERREC001544	Ki67	psoriasis	696	L40	
BIOMARKERREC001545	p53	psoriasis	696	L40	
BIOMARKERREC001546	alpha 2 -antiplasmin	psoriasis	696	L40	
BIOMARKERREC001547	Plasminogen	psoriasis	696	L40	
BIOMARKERREC001548	Protein C	psoriasis	696	L40	
BIOMARKERREC001549	Th1	psoriasis	696	L40	
BIOMARKERREC001550	Th17	psoriasis	696	L40	
BIOMARKERREC001551	Th22	psoriasis	696	L40	
BIOMARKERREC001552	DHFR	psoriatic arthritis (psa)	696.0	L40.5,M07	
BIOMARKERREC001553	Dkk-1	psoriatic arthritis (psa)	696.0	L40.5,M07	
BIOMARKERREC001554	M-CSF	psoriatic arthritis (psa)	696.0	L40.5,M07	
BIOMARKERREC001555	HLA-B22	psoriatic arthritis (psa)	696.0	L40.5,M07	
BIOMARKERREC001556	nucleoporin 62 kDa	psoriatic arthritis (psa)	696.0	L40.5,M07	
BIOMARKERREC001557	osteoclast precursors	psoriatic arthritis (psa)	696.0	L40.5,M07	
BIOMARKERREC001558	IKBKB	psoriatic arthritis (psa)	696.0	L40.5,M07	
BIOMARKERREC001559	IL-11RA	psoriatic arthritis (psa)	696.0	L40.5,M07	
BIOMARKERREC001560	SHP1	psoriatic arthritis (psa)	696.0	L40.5,M07	
BIOMARKERREC001561	SIGIRR	psoriatic arthritis (psa)	696.0	L40.5,M07	
BIOMARKERREC001562	STAT3	psoriatic arthritis (psa)	696.0	L40.5,M07	
BIOMARKERREC001563	TCF7	psoriatic arthritis (psa)	696.0	L40.5,M07	
BIOMARKERREC001564	C-reactive protein (CRP)	systemic lupus erythematosus	710.0	M32	
BIOMARKERREC001565	IFNα	systemic lupus erythematosus	710.0	M32	
BIOMARKERREC001566	C-reactive protein (CRP)	systemic sclerosis (ssc)	710.1	M34	
BIOMARKERREC001567	endothelin-1 (ET-1)	systemic sclerosis (ssc)	710.1	M34	
BIOMARKERREC001568	erythrocyte sedimentation rate (ESR)	systemic sclerosis (ssc)	710.1	M34	
BIOMARKERREC001569	pentraxin 3 (PTX3)	systemic sclerosis (ssc)	710.1	M34	
BIOMARKERREC001570	endothelin-1 (ET-1)	systemic sclerosis (ssc)	710.1	M34	
BIOMARKERREC001571	soluble E-selectin (sE-selectin)	systemic sclerosis (ssc)	710.1	M34	
BIOMARKERREC001572	soluble vascular cell adhesion molecule- 1 (sVCAM-1)	systemic sclerosis (ssc)	710.1	M34	
BIOMARKERREC001573	vascular endothelial growth factor (VEGF)	systemic sclerosis (ssc)	710.1	M34	
BIOMARKERREC001574	DAS-28	sjogren's syndrome	710.2	M35.0	
BIOMARKERREC001575	IL-1Ra	sjogren's syndrome	710.2	M35.0	
BIOMARKERREC001576	iL-6	sjogren's syndrome	710.2	M35.0	
BIOMARKERREC001577	RF	sjogren's syndrome	710.2	M35.0	
BIOMARKERREC001578	HLA DRB1	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001579	LTA + 252 (A > G); LGALS2 + 3279 (C > T)	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001580	ACP1	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001581	CCL21	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001582	CCR5	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001583	HLA DRB1	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001584	HLA DRB1	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001585	HLA DRB1	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001586	HLA DRB1	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001587	IL6	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001588	IL6	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001589	MTHFR	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001590	PSRC1	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001591	F13A1 34 Val/Leu	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001592	FGB ?455 (G > A)	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001593	SERPINE1 –675, (4G/5G)	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001594	TNF-alpha	rheumatoid arthritis (ra)	714	M05-M06	
BIOMARKERREC001595	IL-15	early  osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001596	KOA1 (TGLESGHGPGDS)	knee osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001597	C-terminal cross- linked telopeptide of type II collagen (CTX-II)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001598	C-terminal cross- linked telopeptide of type II collagen (CTX-II)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001599	C-terminal cross- linked telopeptide of type II collagen (CTX-II)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001600	ADAM12	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001601	ADAM12	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001602	BMP2	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001603	CD36	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001604	NCOR2	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001605	PTGS2 (COX2)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001606	cartilage glycoprotein 39 (YKL-40)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001607	cartilage glycoprotein 39 (YKL-40)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001608	cartilage oligomeric protein (COMP)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001609	cartilage oligomeric protein (COMP)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001610	CILP	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001611	CLEC3B (TNA)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001612	ESR1	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001613	TNFRSF11B (OPG)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001614	COL2-3?4C (long) epitope	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001615	COL2-3?4C (long) epitope	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001616	COL2-3?4C (short) epitope	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001617	COL2-3?4C (short) epitope	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001618	C-propeptide of collagen type II (PIICP)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001619	C-terminal cross-linked telopeptide of type I collagen (CTX-I)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001620	Epitope 846	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001621	ESR1	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001622	IL1	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001623	glucosyl–galactosyl–pyridinoline (Glc-Gal-PYD)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001624	helical type II collagen (HELIX-II)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001625	Hyaluronic acid	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001626	Hyaluronic acid	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001627	matrix metalloproteinase (MMP)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001628	matrix metalloproteinase (MMP)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001629	matrix metalloproteinase (MMP)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001630	nine-amino-acid peptide of type II collagen (Coll 2-1)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001631	nitrated form of nine-amino-acid peptide of type II collagen (Coll 2-1 NO2)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001632	N-propeptide II of collagen type II (PIINP)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001633	N-propeptide IIA of collagen type II (PIIANP)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001634	N-terminal cross-linked telopeptide of type I collagen (NTX-I)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001635	Osteocalcin	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001636	Pentosidine	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001637	pyridinoline (PYD)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001638	tissue inhibitor of matrix metalloproteinase (TIMP)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001639	tissue inhibitor of matrix metalloproteinase (TIMP)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001640	Fibulin-3 peptide 1	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001641	Fibulin-3 peptide 2	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001642	Follistatin-like protein 1 (FSTL1)	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001643	catalase	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001644	Mn-SOD	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001645	SOD2	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001646	MMP-2	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001647	TIMP-2	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001648	TRAP	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001649	lumican	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001650	tetranectin	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001651	von Willebrand factor	osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001652	IL-8	osteoarthritis (oa)	715	M15-M19,M47	
BIOMARKERREC001653	KC	osteoarthritis (oa)	715	M15-M19,M47	
BIOMARKERREC001654	MCP-1	osteoarthritis (oa)	715	M15-M19,M47	
BIOMARKERREC001655	MMP-2	osteoarthritis (oa)	715	M15-M19,M47	
BIOMARKERREC001656	MMP-3	osteoarthritis (oa)	715	M15-M19,M47	
BIOMARKERREC001657	MMP-3	osteoarthritis (oa)	715	M15-M19,M47	
BIOMARKERREC001658	Omentin-1 (intelectin 1)	primary knee osteoarthritis	715	M15-M19,M47	
BIOMARKERREC001659	B-type natriuretic peptide (BNP)	patent ductus arteriosus	747.0	Q25.0	
BIOMARKERREC001660	NT-proBNP	patent ductus arteriosus	747.0	Q25.0	
BIOMARKERREC001661	cTni	patent ductus arteriosus	747.0	Q25.0	
BIOMARKERREC001662	cTnT	patent ductus arteriosus	747.0	Q25.0	
BIOMARKERREC001663	B-type natriuretic peptide (BNP)	persistent pulmonary hypertension of the newborn	747.83	P29.3	
BIOMARKERREC001664	NT-proBNP	persistent pulmonary hypertension of the newborn	747.83	P29.3	
BIOMARKERREC001665	copeptin	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001666	gross hematuria	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001667	male gender	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001668	proteinuria	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001669	young age	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001670	HDL-cholesterol	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001671	HTN	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001672	PKD-1	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001673	Secreted frizzled-related protein 4 (sFRP4)	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001674	sodium	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001675	glomerular hyperfiltration (GH)	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001676	renal blood flow (RBF)	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001677	total kidney volume (TKV)	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001678	urine osmolality	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001679	Angiopoietin 1	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001680	Angiopoietin 2	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001681	endothelial tyrosine kinase-2 receptor	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001682	vascular endothelial growth factor (VEGF)	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001683	heart-type fatty acidbinding protein (H-FABP)	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001684	kidney injury molecule-1 (KIM-1)	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001685	monocyte chemotactic protein-1 (MCP-1)	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001686	neutrophil gelatinase-associated lipocalin (NGAL)	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001687	β2 -microglobulin	autosomal-dominant polycystic kidney disease	753.1	Q61	
BIOMARKERREC001688	VEGF	von hippel-lindau disease	759.6	Q85.8	
BIOMARKERREC001689	Angiopoietin 1	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001690	Carbon monoxide	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001691	Clara cell secretory protein	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001692	Endostatin	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001693	Endothelial colony-forming cells	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001694	eosinophilic cationic protein	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001695	granulocyte colony stimulating factor (G-CSF)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001696	IL-10	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001697	IL-10	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001698	IL-17	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001699	IL-1b	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001700	IL-6	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001701	IL-8	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001702	KL-6	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001703	Microbes	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001704	Nitric oxide	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001705	N-terminal pro-B-type natriuretic peptide	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001706	soluble E-selectin	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001707	soluble L-selectin	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001708	spectrophotometry	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001709	Thymus	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001710	unconjugated estriol	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001711	3-cholorotyrosine	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001712	malondialdehyde	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001713	8-hydroxy-2-deoxyguanosine (8-OHdG)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001714	alpha-fetoprotein (AFP)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001715	human chorionic gonadotropin (HCG)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001716	Angiopoietin 2	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001717	endothelin-1 (ET-1)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001718	fibroblast growth factor 2 (FGF2)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001719	Bombesin-like peptide	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001720	Cathepsin K	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001721	Clara cell secretory protein	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001722	C-terminal fragment of Type I collagen (PICP)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001723	Fibronectin	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001724	human homologue of breast regression protein 39 (BRP39; chitinase-3 like protein 1; YKL-40)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001725	IL-10	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001726	IL-16	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001727	IL-1b	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001728	IL-6	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001729	TNF-alpha	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001730	IL-8	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001731	monocyte chemoattractant protein 1 (MCP-1)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001732	monocyte chemoattractant protein 2 (MCP-2)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001733	monocyte chemoattractant protein 3 (MCP-3)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001734	interferon gamma (IFNg)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001735	interferon gamma (IFNg)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001736	hepatocyte growth factor (HGF)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001737	keratinocyte growth factor (KGF)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001738	Lysozyme	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001739	macrophage migration inhibitory factor (MIF)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001740	matrix metalloproteinase 8 (MMP 8)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001741	matrix metalloproteinase 9 (MMP 9)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001742	matrix metalloproteinase 9 (MMP 9)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001743	tissue inhibitor of metalloproteinase (TIMP 1)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001744	monocyte chemoattractant protein 1 (MCP-1)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001745	neutrophil gelatinase associated lipocalin (NGAL)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001746	Nuclear factor-kappa B	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001747	parathyroid hormone related protein (PTHrP)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001748	Pepsin	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001749	placental growth factor (PlGF)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001750	plasminogen activator inhibitor 1 (PAI-1)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001751	platelet derived growth factor-BB isoform (PDGF-BB)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001752	dimethylacetals (DMA)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001753	polyunsaturated fatty acid (PUFA)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001754	regulated on activation normal T-cell expressed and secreted (RANTES)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001755	L-selectin	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001756	soluble intercellular adhesion molecule 1 (sICAM-1)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001757	soluble VEGF receptor 1 (sVEGFR1)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001758	tissue inhibitor of metalloproteinase 2 (TIMP 2)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001759	transforming growth factor beta 1 (TGFb1)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001760	transforming growth factor beta 1 (TGFb1)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001761	Trypsin -2	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001762	tumor necrosis factor beta (TNFb)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001763	type IV collagen (C-IV)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001764	vascular endothelial growth factor (VEGF)	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001765	VEGF	bronchopulmonary dysplasia	770.7	P27.1	
BIOMARKERREC001766	CD25+ T cells expressing FoxP3 and VPACR2	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001767	CD4+	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001768	cortisol	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001769	8-iso-prostaglandin F(2 alpha) isoprostane	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001770	C-reactive protein (CRP)	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001771	dipeptidyl peptidase IV	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001772	F(2)-isoprostane	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001773	granzyme	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001774	HPA axis dysfunction	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001775	IFNγ	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001776	IL-10	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001777	TNF-alpha	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001778	IFNγ	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001779	IL-17	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001780	IL-2	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001781	IL-23	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001782	TNF-alpha	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001783	IL-12	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001784	IL-1a	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001785	IL-1β	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001786	IL-4	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001787	IL-5	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001788	IL-6	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001789	LTα	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001790	IL-6	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001791	TNF-alpha	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001792	IL-13	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001793	IL-15	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001794	IL-8	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001795	lactate	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001796	LPS induced pro-inflammatory cytokines under psychological stress	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001797	mitochondria	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001798	adrenergic receptors	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001799	most sensory receptors	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001800	Natural killer (NK) cell function (NKCC)	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001801	NK cell	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001802	CD8+ T cells	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001803	NK	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001804	NR3C1	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001805	NYP	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001806	IL-10	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001807	IL12	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001808	IL-6	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001809	NYP	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001810	TNF-alpha	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001811	perforin	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001812	perforin	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001813	T cell	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001814	vitamin E	chronic fatigue syndrome/myalgic encephalomyelitis (cfs/me)	780.71	G93.3	
BIOMARKERREC001815	B-type natriuretic peptide (BNP)	asphyxia	799.0	R09.0,T71	
BIOMARKERREC001816	cTni	asphyxia	799.0	R09.0,T71	
BIOMARKERREC001817	cTnT	asphyxia	799.0	R09.0,T71	
BIOMARKERREC001818	NT-proBNP	asphyxia	799.0	R09.0,T71	
BIOMARKERREC001819	iL-1R1	hypoxia	799.02	R09.02	
BIOMARKERREC001820	L-1β	hypoxia	799.02	R09.02	
BIOMARKERREC001821	osteopontin (OPN)	tumor-related hypoxia	799.02	R09.02	
BIOMARKERREC001822	plasminogen activator-inhibitor-1 (PAI-1)	tumor-related hypoxia	799.02	R09.02	
BIOMARKERREC001823	vascular endothelial growth factor (VEGF)	tumor-related hypoxia	799.02	R09.02	
BIOMARKERREC001824	MR-proadrenomedullin	sepsis	995.91	A40,A41	
BIOMARKERREC001825	troponin T (TnT)	sepsis	995.91	A40,A41	
BIOMARKERREC001826	carbonyl sulfide	acute organ rejection	996	T86	
BIOMARKERREC001827	FOXP3	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001828	HLA-DR	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001829	CD154	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001830	ICOS	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001831	IL-6	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001832	CXCR3	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001833	IP10	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001834	Peptide/proteome panels	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001835	granzyme B	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001836	Perforin	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001837	soluble CD30	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001838	Tim-3	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001839	VEGF	rejection of renal transplants	996.81	T86.1	
BIOMARKERREC001840	cMYC	hiv+ diffuse large b-cell lymphoma (dlbcl)	042,200.0	C83.3,B20	
BIOMARKERREC001841	Bax	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001842	EGF-R; p53	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001843	DPD	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001844	ERCC1	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001845	ERCC2	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001846	GSTP1	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001847	TP	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001848	TS	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001849	UGT1A1	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001850	Lewis x (Lex)	colorectal cancer (ccr)	153,154	C18-C21	
BIOMARKERREC001851	Lewis y (Ley)	colorectal cancer (ccr)	153,154	C18-C21	
BIOMARKERREC001852	sialyl Lewis a (sLea)	colorectal cancer (ccr)	153,154	C18-C21	
BIOMARKERREC001853	sialyl Lewis x (sLex)	colorectal cancer (ccr)	153,154	C18-C21	
BIOMARKERREC001854	Tn hapten	colorectal cancer (ccr)	153,154	C18-C21	
BIOMARKERREC001855	Methylenetetrahydrofolate reductase (MTHFR)	colorectal cancer (crc)	153,154	C18-C21	
BIOMARKERREC001857	vascular endothelial growth factor (VEGF)	colorectal carcinoma	153,154	C18-C21	
BIOMARKERREC001858	MASP-2	dukes'b or dukes'c colon cancer	153,154	C18-C21	
BIOMARKERREC001859	TIMP-1	dukes'b or dukes'c colon cancer	153,154	C18-C21	
BIOMARKERREC001860	Microsatellite Instability	dukes'c colorectal carcinoma	153,154	C18-C21	
BIOMARKERREC001861	EGFR	irinotecan-refractory colorectal cancer (bond2)	153,154	C18-C21	
BIOMARKERREC001862	ERCC1	irinotecan-refractory colorectal cancer (bond2)	153,154	C18-C21	
BIOMARKERREC001863	NRP1	irinotecan-refractory colorectal cancer (bond2)	153,154	C18-C21	
BIOMARKERREC001864	VEGFR2	irinotecan-refractory colorectal cancer (bond2)	153,154	C18-C21	
BIOMARKERREC001865	CEP	metastatic colorectal cancer (mcrc)	153,154	C18-C21	
BIOMARKERREC001866	CXCR4+ CEC	metastatic colorectal cancer (mcrc)	153,154	C18-C21	
BIOMARKERREC001867	EGFR	metastatic colorectal cancer (mcrc)	153,154	C18-C21	
BIOMARKERREC001868	CEA-TPA	operated colorectal cancer	153,154	C18-C21	
BIOMARKERREC001869	CEA-TPA-CA19.9-CA72.4	operated colorectal cancer	153,154	C18-C21	
BIOMARKERREC001870	DUSP	primary colorectal cancer	153,154	C18-C21	
BIOMARKERREC001871	MIB-1	resected dukes b2 or c colon cancer	153,154	C18-C21	
BIOMARKERREC001872	metalloproteinases 1 (TIMP-1)	advanced colorectal cancer	153,154	C18-C21	
BIOMARKERREC001873	tumor type M2 pyruvate kinase (TuM2-PK)	advanced colorectal cancer	153,154	C18-C21	
BIOMARKERREC001874	activated  circulating endothelial cells (aCEC)	advanced colorectal cancer	153,154	C18-C21	
BIOMARKERREC001875	resting circulating endothelial cells (rCEC)	advanced colorectal cancer	153,154	C18-C21	
BIOMARKERREC001876	ERCC1-19007	advanced colorectal cancer	153,154	C18-C21	
BIOMARKERREC001877	GSTP1	advanced colorectal cancer	153,154	C18-C21	
BIOMARKERREC001878	XPD751	advanced colorectal cancer	153,154	C18-C21	
BIOMARKERREC001879	XRCC1 Q399R	advanced colorectal cancer	153,154	C18-C21	
BIOMARKERREC001880	Fas	advanced colorectal cancer (crc)	153,154	C18-C21	
BIOMARKERREC001881	FasL	advanced colorectal cancer (crc)	153,154	C18-C21	
BIOMARKERREC001882	FAS (CD95)	advanced colorectal carcinoma	153,154	C18-C21	
BIOMARKERREC001883	KRAS;BRAF;NRAS	chemorefractory metastatic colorectal cancer	153,154	C18-C21	
BIOMARKERREC001884	12 genes	colon cancer	153,154	C18-C21	
BIOMARKERREC001885	D18S61 (distal on chromosome 18q)	colon cancer	153,154	C18-C21	
BIOMARKERREC001886	D18S851 (near DCC and DPC4 on 18q)	colon cancer	153,154	C18-C21	
BIOMARKERREC001887	D5346 (near to APC)	colon cancer	153,154	C18-C21	
BIOMARKERREC001888	p53	colon cancer	153,154	C18-C21	
BIOMARKERREC001889	p53 antigen	colon cancer	153,154	C18-C21	
BIOMARKERREC001890	18qLOH	colon cancer	153,154	C18-C21	
BIOMARKERREC001891	hTERT	colon cancer	153,154	C18-C21	
BIOMARKERREC001892	microsatellite instability (MSI)	colon cancer	153,154	C18-C21	
BIOMARKERREC001893	P53	colon cancer	153,154	C18-C21	
BIOMARKERREC001894	SMAD4	colon cancer	153,154	C18-C21	
BIOMARKERREC001895	Thymidilate synthase (TS)	colon cancer	153,154	C18-C21	
BIOMARKERREC001896	ppGalNac-T6	colon cancer	153,154	C18-C21	
BIOMARKERREC001897	DcR3 (DD-C248)	colon cancer	153,154	C18-C21	
BIOMARKERREC001898	Reg IV (DD-C101)	colon cancer	153,154	C18-C21	
BIOMARKERREC001899	Spondin-2 (DD-P108)	colon cancer	153,154	C18-C21	
BIOMARKERREC001900	TRAIL-R2	colon cancer	153,154	C18-C21	
BIOMARKERREC001901	pro-enzyme form of human collagenase-1 (ProMMP-1)	colon cancer	153,154	C18-C21	
BIOMARKERREC001902	CEA, CA 19-9, CA 72-4	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001903	Methyl-CpG binding domain protein 4 (MBD4)	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001904	Excision repair cross complementation group 1 (ERCC1)	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001905	Thymidilate synthase (TS)	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001906	1-N-12-N-di-acetyl spermine (DiAcSpm)	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001907	a special isoenzyme of pyruvate kinase (M2-PK)	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001908	AMD1	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001909	CTSC	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001910	EIF1AX	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001911	Bax	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001912	Bcl2	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001913	p53	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001914	bile acid-induced apoptosis	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001915	KRAS	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001916	PTEN/p-AKT	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001917	PLK-2	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001918	PLK-3	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001919	PTK-7	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001920	p53	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001921	TGF-?2 receptor II	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001922	sTNF-R	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001923	pAkt	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001924	troponin T (TnT)	colorectal cancer	153,154	C18-C21	
BIOMARKERREC001925	lactate dehydrogenase 5 (LDH5)	colorectal cancer (crc)	153,154	C18-C21	
BIOMARKERREC001926	Thymidilate synthase (TS)	colorectal cancer (crc)	153,154	C18-C21	
BIOMARKERREC001927	GATA-4	colorectal cancer (crc)	153,154	C18-C21	
BIOMARKERREC001928	ADAM22, LDN 16, WNT 16	colorectal carcinoma	153,154	C18-C21	
BIOMARKERREC001929	CXCL 11, CXCL9, CXCL 10	colorectal carcinoma	153,154	C18-C21	
BIOMARKERREC001930	CA 19-9	dukes' b or c colorectal cancer	153,154	C18-C21	
BIOMARKERREC001931	CEA	dukes' b or c colorectal cancer	153,154	C18-C21	
BIOMARKERREC001932	KRAS	early colorectal neoplasia	153,154	C18-C21	
BIOMARKERREC001933	magnesium	kras wild-type colorectal cancer	153,154	C18-C21	
BIOMARKERREC001934	BRAF	metastatic colorectal cancer	153,154	C18-C21	
BIOMARKERREC001935	PI3K	metastatic colorectal cancer	153,154	C18-C21	
BIOMARKERREC001936	ALP	metastatic colorectal cancer	153,154	C18-C21	
BIOMARKERREC001937	CA125	metastatic colorectal cancer	153,154	C18-C21	
BIOMARKERREC001938	D-dimer	metastatic colorectal cancer	153,154	C18-C21	
BIOMARKERREC001939	LDH	metastatic colorectal cancer	153,154	C18-C21	
BIOMARKERREC001940	glycodelin	metastatic colorectal cancer	153,154	C18-C21	
BIOMARKERREC001941	IGF1R	metastatic colorectal cancer (mcrc)	153,154	C18-C21	
BIOMARKERREC001942	KRAS	metastatic colorectal cancer (mcrc)	153,154	C18-C21	
BIOMARKERREC001943	PTEN	metastatic colorectal cancer (mcrc)	153,154	C18-C21	
BIOMARKERREC001944	Cytokeratin 18 (CK18)	metastatic colorectal cancer (mcrc)	153,154	C18-C21	
BIOMARKERREC001945	E-cadherin	primary colon cancer	153,154	C18-C21	
BIOMARKERREC001946	TIMP-2	primary colon cancer	153,154	C18-C21	
BIOMARKERREC001947	p27 and/or DCC	stage ii - iii colorectal cancer	153,154	C18-C21	
BIOMARKERREC001948	microsatellite instability (MSI)	stage ii/iii colorectal cancer	153,154	C18-C21	
BIOMARKERREC001949	Bone specific alkaline phosphatase (bALP)	lung cancer with bone metastasis	162,198.5	C79.51,C33-C34	
BIOMARKERREC001950	N-terminal telopeptide (NTx)	lung cancer with bone metastasis	162,198.5	C79.51,C33-C34	
BIOMARKERREC001951	tartrate-resistant acid phosphatase 5b (TRAP-5b)	lung cancer with bone metastasis	162,198.5	C79.51,C33-C34	
BIOMARKERREC001952	natural killer (NK) cell function	c8161 human melanoma; capan-1 pancreatic tumor	172,140-199,210-229	C43,C00-C75,C7A,C7B,D10-D36,D3A	
BIOMARKERREC001953	A multiple marker RT-PCR assay ( c-Met; p97; MUC-18 ;GalNac )	axillary node-negative breast cancer	174,175	C50	
BIOMARKERREC001954	CEA-TPA-CA15.3	breast cancer	174,175	C50	
BIOMARKERREC001955	MCA-CA15.3	breast cancer	174,175	C50	
BIOMARKERREC001956	CK19, p1B, EGP2	breast cancer	174,175	C50	
BIOMARKERREC001957	Colony-stimulating factor-1 (CSF-1)	breast cancer	174,175	C50	
BIOMARKERREC001958	estrogen receptor coactivator AIB1 (SRC3); HER2	breast cancer	174,175	C50	
BIOMARKERREC001959	PET/TC	breast cancer	174,175	C50	
BIOMARKERREC001960	Stat5a	breast cancer	174,175	C50	
BIOMARKERREC001961	Stat5b	breast cancer	174,175	C50	
BIOMARKERREC001962	ER, PR, HER2	breast carcinoma	174,175	C50	
BIOMARKERREC001963	HER2/neu	breast carcinoma	174,175	C50	
BIOMARKERREC001964	EGFR	breast carcinoma	174,175	C50	
BIOMARKERREC001965	NF-kappa B	breast carcinoma	174,175	C50	
BIOMARKERREC001966	Vimentin	breast carcinoma	174,175	C50	
BIOMARKERREC001967	C-ERB	early breast cancer	174,175	C50	
BIOMARKERREC001968	Cyclin E1 (CCNE1)	early breast cancer	174,175	C50	
BIOMARKERREC001969	E2 (CCNE2)	early breast cancer	174,175	C50	
BIOMARKERREC001970	Fisher nuclear grade (FNG)	early breast cancer	174,175	C50	
BIOMARKERREC001971	HER2/neu	inflammatory breast cancer	174,175	C50	
BIOMARKERREC001972	p53	inflammatory breast cancer	174,175	C50	
BIOMARKERREC001973	Carbonic Anhydrase XII (CA XII)	invasive breast cancer	174,175	C50	
BIOMARKERREC001974	HER1	invasive breast cancer	174,175	C50	
BIOMARKERREC001975	HER2	invasive breast cancer	174,175	C50	
BIOMARKERREC001976	HER3	invasive breast cancer	174,175	C50	
BIOMARKERREC001977	HER2	invasive breast cancer	174,175	C50	
BIOMARKERREC001978	PR	invasive breast cancer	174,175	C50	
BIOMARKERREC001979	Bcl2	invasive breast cancer patients with smaller tumors (<2.0 cm)	174,175	C50	
BIOMARKERREC001980	cyclin D1	invasive breast cancer patients with smaller tumors (<2.0 cm)	174,175	C50	
BIOMARKERREC001981	p130	invasive breast cancer patients with smaller tumors (<2.0 cm)	174,175	C50	
BIOMARKERREC001982	cyclin E	invasive breast cancer patients with tumor > 2.0 cm	174,175	C50	
BIOMARKERREC001983	p53	invasive breast cancer patients with tumor > 2.0 cm	174,175	C50	
BIOMARKERREC001984	pRb	invasive breast cancer patients with tumor > 2.0 cm	174,175	C50	
BIOMARKERREC001985	chromogranin A (CGA)	invasive prostate cancer	174,175	C50	
BIOMARKERREC001986	Bad	locally advanced breast cancer	174,175	C50	
BIOMARKERREC001987	Bcl-XL	locally advanced breast cancer	174,175	C50	
BIOMARKERREC001988	HER2	locally advanced breast cancer (labc)	174,175	C50	
BIOMARKERREC001989	Ki67	locally advanced breast cancer (labc)	174,175	C50	
BIOMARKERREC001990	EGFR	locally advanced breast cancer (lapc)	174,175	C50	
BIOMARKERREC001991	Topo2Î	locally advanced breast cancer (lapc)	174,175	C50	
BIOMARKERREC001992	nuclear grade	node-negative breast cancer patients with er-positive tumors	174,175	C50	
BIOMARKERREC001993	percent S phase	node-negative breast cancer patients with er-positive tumors	174,175	C50	
BIOMARKERREC001994	tumor size	node-negative breast cancer patients with er-positive tumors	174,175	C50	
BIOMARKERREC001995	PgR	node-negative breast cancer patients with er-positive tumors	174,175	C50	
BIOMARKERREC001996	erbB-2	operable breast cancer	174,175	C50	
BIOMARKERREC001997	estrogen receptor (ER)	operable breast cancer	174,175	C50	
BIOMARKERREC001998	progesteron receptor (PgR)	operable breast cancer	174,175	C50	
BIOMARKERREC001999	focal adhesion kinase (FAK)	primary breast cancer	174,175	C50	
BIOMARKERREC002000	C-ERBB2	advanced breast cancer	174,175	C50	
BIOMARKERREC002001	overall tumour response (OR)	advanced breast cancer	174,175	C50	
BIOMARKERREC002002	time to progression (TTP)	advanced breast cancer	174,175	C50	
BIOMARKERREC002003	Bone specific alkaline phosphatase (BAP)	advanced breast cancer	174,175	C50	
BIOMARKERREC002004	C-terminal telopeptide of type I collagen in serum (S-CTX)	advanced breast cancer	174,175	C50	
BIOMARKERREC002005	osteocalcin (OC)	advanced breast cancer	174,175	C50	
BIOMARKERREC002006	the amino-terminal procollagen propeptides of type I collagen (P1NP)	advanced breast cancer	174,175	C50	
BIOMARKERREC002007	Laminin-5 (Ln-5)	axillary node-negative (ann) breast cancer	174,175	C50	
BIOMARKERREC002008	Maspin	axillary node-negative (ann) breast cancer	174,175	C50	
BIOMARKERREC002009	RhoC	benign and malignant breast disease	174,175	C50	
BIOMARKERREC002010	CD133+	brca1-associated human and murine breast cancer	174,175	C50	
BIOMARKERREC002011	CD44+/CD24-	brca1-associated human and murine breast cancer	174,175	C50	
BIOMARKERREC002012	Oestrogen receptor	breast cancer	174,175	C50	
BIOMARKERREC002013	HER2	breast cancer	174,175	C50	
BIOMARKERREC002014	Oestrogen receptor, progesterone receptor, HER2	breast cancer	174,175	C50	
BIOMARKERREC002015	70 genes (MammaPrint)	breast cancer	174,175	C50	
BIOMARKERREC002016	CA15-3	breast cancer	174,175	C50	
BIOMARKERREC002017	CEA	breast cancer	174,175	C50	
BIOMARKERREC002018	CEA	breast cancer	174,175	C50	
BIOMARKERREC002019	hMAM	breast cancer	174,175	C50	
BIOMARKERREC002020	tumor-derived exosome	breast cancer	174,175	C50	
BIOMARKERREC002021	[alpha]v[beta]3	breast cancer	174,175	C50	
BIOMARKERREC002022	Breast density	breast cancer	174,175	C50	
BIOMARKERREC002023	CA 15.3	breast cancer	174,175	C50	
BIOMARKERREC002024	CA 15-3	breast cancer	174,175	C50	
BIOMARKERREC002025	CEA	breast cancer	174,175	C50	
BIOMARKERREC002026	CEA	breast cancer	174,175	C50	
BIOMARKERREC002027	CEA-TPA-CA15.3	breast cancer	174,175	C50	
BIOMARKERREC002028	Checkpoint with Forkhead associated domain and RING finger (Chfr)	breast cancer	174,175	C50	
BIOMARKERREC002029	dynein	breast cancer	174,175	C50	
BIOMARKERREC002030	folliculin	breast cancer	174,175	C50	
BIOMARKERREC002031	Genomic alteration	breast cancer	174,175	C50	
BIOMARKERREC002032	HER2	breast cancer	174,175	C50	
BIOMARKERREC002033	interleukin-6	breast cancer	174,175	C50	
BIOMARKERREC002034	KL-6	breast cancer	174,175	C50	
BIOMARKERREC002035	mammographic density	breast cancer	174,175	C50	
BIOMARKERREC002036	CEA-TPA-CA15.3	breast cancer	174,175	C50	
BIOMARKERREC002037	MCA-CA15.3	breast cancer	174,175	C50	
BIOMARKERREC002038	MDR1	breast cancer	174,175	C50	
BIOMARKERREC002039	Tartrate-resistant acid phosphatase 5b (TRAP 5b)	breast cancer	174,175	C50	
BIOMARKERREC002040	TNF receptor associated protein 1	breast cancer	174,175	C50	
BIOMARKERREC002041	trefoil factor 1	breast cancer	174,175	C50	
BIOMARKERREC002042	HER2	breast cancer	174,175	C50	
BIOMARKERREC002043	estrogen receptor (ER)	breast cancer	174,175	C50	
BIOMARKERREC002044	histological grade	breast cancer	174,175	C50	
BIOMARKERREC002045	nodal status	breast cancer	174,175	C50	
BIOMARKERREC002046	number of mitotic figures per ten high power fields (MF/10HPF)	breast cancer	174,175	C50	
BIOMARKERREC002047	tumor size	breast cancer	174,175	C50	
BIOMARKERREC002048	Mac387	breast cancer	174,175	C50	
BIOMARKERREC002049	Thymidilate synthase (TS)	breast cancer	174,175	C50	
BIOMARKERREC002050	PTHrP	breast cancer (bc) patients with skeletal metastases	174,175	C50	
BIOMARKERREC002051	CMV	breast cancer before treatment	174,175	C50	
BIOMARKERREC002052	Carcinoembryonic antigen (CEA)	breast cancer micrometastase	174,175	C50	
BIOMARKERREC002053	mammaglobin-A (MAM-A)	breast cancer micrometastase	174,175	C50	
BIOMARKERREC002054	prolactin-inducible protein (PIP)	breast cancer micrometastase	174,175	C50	
BIOMARKERREC002055	Wilm??s tumor gene (WT-1)	breast cancer micrometastase	174,175	C50	
BIOMARKERREC002056	tumor grade (SBR classification)	breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy	174,175	C50	
BIOMARKERREC002057	ErbB/HER	breast cancer patients treated with trastuzumas	174,175	C50	
BIOMARKERREC002058	sTNFRII	breast cancer soon after treatment	174,175	C50	
BIOMARKERREC002059	C-reactive protein (CRP)	breast cancer survivors	174,175	C50	
BIOMARKERREC002060	glucocorticoids	breast cancer survivors	174,175	C50	
BIOMARKERREC002061	HPC	breast cancer survivors	174,175	C50	
BIOMARKERREC002062	NF-κB	breast cancer survivors	174,175	C50	
BIOMARKERREC002063	SNS	breast cancer survivors	174,175	C50	
BIOMARKERREC002064	HER2	breast carcinoma	174,175	C50	
BIOMARKERREC002065	CA 15-3	breast carcinoma	174,175	C50	
BIOMARKERREC002066	Tartrate-resistent acid phosphatase (TRACP 5b)	breast carcinoma	174,175	C50	
BIOMARKERREC002067	estrogen receptor (ER)	early breast cancer	174,175	C50	
BIOMARKERREC002068	c-erbB-2	early breast cancer	174,175	C50	
BIOMARKERREC002069	Ki-67	early breast cancer	174,175	C50	
BIOMARKERREC002070	p53	early breast cancer	174,175	C50	
BIOMARKERREC002071	ERalpha	elderly breast cancer (bc)	174,175	C50	
BIOMARKERREC002072	Hif-1?±	elderly breast cancer (bc)	174,175	C50	
BIOMARKERREC002073	p44	elderly breast cancer (bc)	174,175	C50	
BIOMARKERREC002074	KI67	er+ve, operable breast cancer	174,175,140-229,174,175	C50,C00-C96,C50	
BIOMARKERREC002075	chromosome condensation protein G (HCAP-G).	er-negative (er-) breast cancer	174,175	C50	
BIOMARKERREC002076	transforming, acidic coiled-coil containing protein 3 (TACC3)	er-negative (er-) breast cancer	174,175	C50	
BIOMARKERREC002077	CA125	her-2-positive metastatic breast cancer	174,175	C50	
BIOMARKERREC002078	CA15-3	her-2-positive metastatic breast cancer	174,175	C50	
BIOMARKERREC002079	nt-pro-BNP	her-2-positive metastatic breast cancer	174,175	C50	
BIOMARKERREC002080	Bcl2	hereditary breast cancer	174,175	C50	
BIOMARKERREC002081	p53	hereditary breast cancer	174,175	C50	
BIOMARKERREC002082	c-erbB-2	high risk stage ii and iii breast cancer	174,175	C50	
BIOMARKERREC002083	PgR	high risk stage ii and iii breast cancer	174,175	C50	
BIOMARKERREC002084	age	high risk stage ii and iii breast cancer	174,175	C50	
BIOMARKERREC002085	nuclear rade	high risk stage ii and iii breast cancer	174,175	C50	
BIOMARKERREC002086	number of lymphnodes	high risk stage ii and iii breast cancer	174,175	C50	
BIOMARKERREC002087	Mammaglobin	high-risk breast cancer	174,175	C50	
BIOMARKERREC002088	TOP2A	high-risk breast cancer	174,175	C50	
BIOMARKERREC002089	ER	locally advanced breast cancer	174,175	C50	
BIOMARKERREC002090	PgR	locally advanced breast cancer	174,175	C50	
BIOMARKERREC002091	Ki67	locally advanced breast cancer	174,175	C50	
BIOMARKERREC002092	p53	locally advanced breast cancer	174,175	C50	
BIOMARKERREC002093	ER	locally advanced breast cancer (labc)	174,175	C50	
BIOMARKERREC002094	HER2/neu	locally advanced breast cancer (labc)	174,175	C50	
BIOMARKERREC002095	circulating endothelial cell (CEC)	locally advanced breast cancer with lymphangitic spread to the chest wall	174,175	C50	
BIOMARKERREC002096	circulating progenitors cells (CEPs)	locally advanced breast cancer with lymphangitic spread to the chest wall	174,175	C50	
BIOMARKERREC002097	CA 15-3	metastatic breast cancer	174,175	C50	
BIOMARKERREC002098	CEA	metastatic breast cancer	174,175	C50	
BIOMARKERREC002099	CA 15-3	metastatic breast cancer	174,175	C50	
BIOMARKERREC002100	CA 27-29	metastatic breast cancer	174,175	C50	
BIOMARKERREC002101	CEA (carcinoembryonic antigen)	metastatic breast cancer	174,175	C50	
BIOMARKERREC002102	Circulating tumor cells	metastatic breast cancer	174,175	C50	
BIOMARKERREC002103	HER2 extracellular domain (HER2-ECD)	metastatic breast cancer	174,175	C50	
BIOMARKERREC002104	interleukin-8 (IL8)	metastatic breast cancer	174,175	C50	
BIOMARKERREC002105	nitric oxide (NO)	metastatic breast cancer	174,175	C50	
BIOMARKERREC002106	CA 15-3	metastatic breast cancer	174,175	C50	
BIOMARKERREC002107	DFI	metastatic breast cancer	174,175	C50	
BIOMARKERREC002108	ECOG	metastatic breast cancer	174,175	C50	
BIOMARKERREC002109	ER/PR	metastatic breast cancer	174,175	C50	
BIOMARKERREC002110	HER2/neu	metastatic breast cancer	174,175	C50	
BIOMARKERREC002111	Osteopontin (OPN)	metastatic breast cancer	174,175	C50	
BIOMARKERREC002112	p21; p53	metastatic breast cancer	174,175	C50	
BIOMARKERREC002113	Bcl2	metastatic breast cancer	174,175	C50	
BIOMARKERREC002114	PgR	metastatic breast cancer	174,175	C50	
BIOMARKERREC002115	MUC-1	metastatic breast cancer	174,175	C50	
BIOMARKERREC002116	circulating tumor cell	metastatic breast cancer	174,175	C50	
BIOMARKERREC002117	HER2	metastatic breast cancer (mbc)	174,175	C50	
BIOMARKERREC002118	HER2	metastatic breast cancer (mbc)	174,175	C50	
BIOMARKERREC002119	CA-15-3	metastatic breast cancer patients treated with 1st-line hormone therapy	174,175	C50	
BIOMARKERREC002120	CEA	metastatic breast cancer patients treated with 1st-line hormone therapy	174,175	C50	
BIOMARKERREC002121	HER2/neu	metastatic breast cancer patients treated with 1st-line hormone therapy	174,175	C50	
BIOMARKERREC002122	estrogen receptor (ER)	node negative breast cancer	174,175	C50	
BIOMARKERREC002123	p53	node negative breast cancer	174,175	C50	
BIOMARKERREC002124	Proliferating cell nuclear antigen (PCNA)	node-negative breast carcinoma	174,175	C50	
BIOMARKERREC002125	tumor grade	node-negative breast carcinoma	174,175	C50	
BIOMARKERREC002126	histological grade/nuclear grade (HG/NG)	node-negative invasive breast cancer of luminal type	174,175	C50	
BIOMARKERREC002127	Ki67	node-negative invasive breast cancer of luminal type	174,175	C50	
BIOMARKERREC002128	Ki67; HER2	node-negative invasive breast cancer of luminal type	174,175	C50	
BIOMARKERREC002129	erbB-2	node-negative primary human breast cancer	174,175	C50	
BIOMARKERREC002130	PAI	node-negative primary human breast cancer	174,175	C50	
BIOMARKERREC002131	PgR	operable breast cancer	174,175	C50	
BIOMARKERREC002132	ER	operable breast cancer	174,175	C50	
BIOMARKERREC002133	PgR	operable breast cancer	174,175	C50	
BIOMARKERREC002134	estrogen receptor (ER)	operable breast cancer	174,175	C50	
BIOMARKERREC002135	HER/c-erbB-2	operable breast cancer	174,175	C50	
BIOMARKERREC002136	p53	operable breast cancer	174,175	C50	
BIOMARKERREC002137	PgR	operable breast cancer	174,175	C50	
BIOMARKERREC002138	BRCA1/BRCA2	breast cancer	174,175	C50	
BIOMARKERREC002139	Ki67	post-menopausal breast cancer	174,175	C50	
BIOMARKERREC002140	BONE SIALOPROTEIN  (BSP)	primary breast cancer	174,175	C50	
BIOMARKERREC002141	c-erbB-2	primary breast carcinoma	174,175	C50	
BIOMARKERREC002142	estrogen receptor (ER)	primary breast carcinoma	174,175	C50	
BIOMARKERREC002143	progesterone receptor	primary breast carcinoma	174,175	C50	
BIOMARKERREC002144	topoisomerase II	primary breast carcinoma	174,175	C50	
BIOMARKERREC002145	LEA.135	primary breast carcinoma	174,175	C50	
BIOMARKERREC002146	Replication Error Positive Phenotype	stage i and iia breast cancer	174,175	C50	
BIOMARKERREC002147	BIRC5	stage i invasive breast cancer	174,175	C50	
BIOMARKERREC002148	CYP24	stage i invasive breast cancer	174,175	C50	
BIOMARKERREC002149	PDCD6IP	stage i invasive breast cancer	174,175	C50	
BIOMARKERREC002150	HER2/neu	stage ii and iii breast carcinoma	174,175	C50	
BIOMARKERREC002151	p53	stage ii and iii breast carcinoma	174,175	C50	
BIOMARKERREC002152	tumor cell apoptosis	triple-negative breast cancer	174,175	C50	
BIOMARKERREC002153	tumor-infiltrating lymphocytes (TIL)	triple-negative breast cancer	174,175	C50	
BIOMARKERREC002154	ER	women at increased risk for breast cancer	174,175	C50	
BIOMARKERREC002155	Ki-67	women at increased risk for breast cancer	174,175	C50	
BIOMARKERREC002156	CD31	recurrent or persistent epithelial ovarian cancer (eoc) and primary peritoneal cancer (ppc)	183,158	C48.1,C48.2,C56	
BIOMARKERREC002157	bone alkaline phosphatase (BAP)	prostate cancer patients with bone metastases	185,198.5	C79.51,C61	
BIOMARKERREC002158	N-telopeptide (NTX)	prostate cancer patients with bone metastases	185,198.5	C79.51,C61	
BIOMARKERREC002159	G1-phase Cyclins D2 (CD2)	advanced testicular germ cell tumors (gct)	186,222.0	C62,D29.2	
BIOMARKERREC002160	alpha-fetoprotein (AFP)	clinical stage a testicular nonseminomatous germ cell tumors (nsgct)	186,222.0	C62,D29.2	
BIOMARKERREC002161	human chorionic gonadotropin	clinical stage a testicular nonseminomatous germ cell tumors (nsgct)	186,222.0	C62,D29.2	
BIOMARKERREC002162	a-Fetoprotein (AFP)	disseminated nonseminomatous germ cell tumors (gcts)	186,222.0	C62,D29.2	
BIOMARKERREC002163	HCG	disseminated nonseminomatous germ cell tumors (gcts)	186,222.0	C62,D29.2	
BIOMARKERREC002164	Tumor marker half-life of HCG and AFP during the first two cycles of chemotherapy	metastatic nonseminomatous germ cell tumors	186,222.0	C62,D29.2	
BIOMARKERREC002165	alpha-fetoprotein (AFP)	non-seminomatous germ-cell tumors (nsgct)	186,222.0	C62,D29.2	
BIOMARKERREC002166	human chorionic gonadotrophin (hCG)	non-seminomatous germ-cell tumors (nsgct)	186,222.0	C62,D29.2	
BIOMARKERREC002167	alpha-fetoprotein (AFP)	primary mediastinal nonseminomatous germ cell tumor (pmnsgct)	186,222.0	C62,D29.2	
BIOMARKERREC002168	human chorionic gonadotropin	primary mediastinal nonseminomatous germ cell tumor (pmnsgct)	186,222.0	C62,D29.2	
BIOMARKERREC002169	alpha-fetoprotein (AFP)	primary mediastinal non-seminomatous germ cell tumors (pmnsgt)	186,222.0	C62,D29.2	
BIOMARKERREC002170	human chorionic gonadotropin (hCG)	primary mediastinal non-seminomatous germ cell tumors (pmnsgt)	186,222.0	C62,D29.2	
BIOMARKERREC002171	CD8+ tumor infiltrating lymphocytes (TILs)	advanced transitional cell carcinoma (tcc)	188,189	C64-C68	
BIOMARKERREC002172	Interleukin-13 Receptor alpha 2 (IL13RA2)	children with ependymoma	191,225	C71,D33	
BIOMARKERREC002173	adrenomedullin	acute myocardial infarction; heart failure	410,428,410	I21,I22,I50,I21-I22	
BIOMARKERREC002174	MR-proadrenomedullin	acute myocardial infarction; heart failure	410,428,410	I21,I22,I50,I21-I22	
BIOMARKERREC002175	Anti-topoisomerase I antibodies (ATA)	pulmonary fibrosis	515,516.3	J84.1	
BIOMARKERREC002176	C-reactive protein (CRP)	inflammatory bowel disease	555,556	K50,K51	
BIOMARKERREC002177	Hemoglobin	inflammatory bowel disease	555,556	K50,K51	
BIOMARKERREC002178	calprotectin	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002179	lactoferrin	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002180	calprotectin	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002181	lactoferrin	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002182	calprotectin	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002183	lactoferrin	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002184	calprotectin	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002185	lactoferrin	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002186	Anti-A4-Fla2	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002187	antibodies to Cbir1	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002188	anti-FlaX	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002189	antibodies to Fla- X	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002190	antibodies to Flagellin A4-Fla2	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002191	Antibodies to outer membrane porin (Anti-OmpC)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002192	Flagellin (Anti-Cbir1)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002193	Pseudomonas flourescens-associated sequence I–2 (Anti-I2)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002194	antibodies to Fla- X	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002195	antibodies to Flagellin A4-Fla2	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002196	Antibodies to outer membrane porin (Anti-OmpC)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002197	Flagellin (Anti-Cbir1)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002198	Pseudomonas flourescens-associated sequence I–2 (Anti-I2)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002199	Anti-I2	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002200	Anti-Omp C	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002201	antichitobioside carbohydrate IgA (ACCA)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002202	antilaminaribioside carbohydrate IgG (ALCA)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002203	anti-synthetic mannoside antibodies (AΣMA or AMCA)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002204	antichitobioside carbohydrate IgA (ACCA)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002205	antilaminaribioside carbohydrate IgG (ALCA)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002206	anti-synthetic mannoside antibodies (AΣMA or AMCA)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002207	Anti-neutrophil cytoplasmic antibodies (ANCAs)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002208	Anti-neutrophil cytoplasmic antibodies (ANCAs)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002209	anti-Saccharomyces cerevisiae antibodies (ASCA)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002210	anti-Saccharomyces cerevisiae antibodies (ASCA)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002211	ASCA	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002212	C-reactive protein (CRP)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002213	C-reactive protein (CRP)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002214	C-reactive protein (CRP)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002215	C-reactive protein (CRP)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002216	C-reactive protein (CRP)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002217	Erythrocyte Sedimentation Rate (ESR)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002218	Erythrocyte Sedimentation Rate (ESR)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002219	Erythrocyte Sedimentation Rate (ESR)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002220	Erythrocyte Sedimentation Rate (ESR)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002221	Erythrocyte Sedimentation Rate (ESR)	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002222	IDO1 mediated tryptophan catabolism pathway	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002223	alpha 1 anti-trypsin	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002224	alpha-2-macroglobulin	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002225	elastase	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002226	IL 10	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002227	IL1 B	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002228	IL4	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002229	leukocyte esterase	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002230	lysozyme	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002231	myeloperoxidase	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002232	TNF-alpha	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002233	alpha 1 anti-trypsin	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002234	alpha-2-macroglobulin	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002235	elastase	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002236	IL 10	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002237	IL1 B	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002238	IL4	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002239	leukocyte esterase	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002240	lysozyme	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002241	myeloperoxidase	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002242	TNF-alpha	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002243	M2-pyruvate kinase	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002244	M2-pyruvate kinase	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002245	S100A12	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002246	S100A12	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002247	S100A12	inflammatory bowel disease (ibd)	555,556	K50,K51	
BIOMARKERREC002248	TP53	patients with hepatic metastases from colorectal carcinoma	153,154,197.7	C78.7,C18-C21	
BIOMARKERREC002249	N-terminal propeptide of type I collagen (NTX)	breast cancer; prostate cancer	185,140-229,174,175	C61,C00-C96,C50	
BIOMARKERREC002250	peptide-bound collagen type I cross-links C-telopeptides (ICTP)	breast cancer; prostate cancer	185,140-229,174,175	C61,C00-C96,C50	
BIOMARKERREC002251	pamidronate	breast and prostate cancer	174,175,188	C67,C50	
BIOMARKERREC002252	C-reactive protein (CRP)	breast & prostate cancer with radiation	174,175,188	C67,C50	
BIOMARKERREC002253	IL-1Ra	breast & prostate cancer with radiation	174,175,188	C67,C50	
BIOMARKERREC002254	cross-linked N-telopeptide of type I collagen (NTX)	breast cancer with bone metastases	174,175,198.5	C79.51,C50	
BIOMARKERREC002255	cortisol	ambulatory breast cancer patients with bone metastase	174,175,198.5	C79.51,C50	
BIOMARKERREC002256	cross-laps (CTX)	ambulatory breast cancer patients with bone metastase	174,175,198.5	C79.51,C50	
BIOMARKERREC002257	deoxy-pyridinoline (DPD)	ambulatory breast cancer patients with bone metastase	174,175,198.5	C79.51,C50	
BIOMARKERREC002258	N-telopeptide (NTX)	ambulatory breast cancer patients with bone metastase	174,175,198.5	C79.51,C50	
BIOMARKERREC002259	ICTP	breast cancer patients (bc) with bone metastases (bm)	174,175,198.5	C79.51,C50	
BIOMARKERREC002260	MMP1	breast cancer patients (bc) with bone metastases (bm)	174,175,198.5	C79.51,C50	
BIOMARKERREC002261	BALP	breast cancer with bone metastases	174,175,198.5	C79.51,C50	
BIOMARKERREC002262	N-telopeptide (NTX)	breast cancer; multiple myeloma	203.0,140-229,174,175,203.0	C90.0,C00-C96,C50,C90.0	
BIOMARKERREC002263	MADS-IX	breast tumor	174,175,217	C50,D24	
BIOMARKERREC002264	CYP24, PDCP6IP, BIRC5	stage i-iii invasive ductal carcinoma	174,175,233.0	C50,D05	
BIOMARKERREC002265	NR1D1, SMARCE1, BIRC5	stage i-iii invasive ductal carcinoma	174,175,233.0	C50,D05	
BIOMARKERREC002266	N-terminal propeptide of type I collagen (PINP)	breast cancer;  prostate cancer	185,140-229,174,175	C61,C00-C96,C50	
BIOMARKERREC002267	peptide-bound collagen type I cross-links C-telopeptides (ICTP)	breast cancer;  prostate cancer	185,140-229,174,175	C61,C00-C96,C50	
BIOMARKERREC002268	Cystatin C	hf with renal dysfunction	584,585,428	I50,N17-N19	
BIOMARKERREC002269	Cystatin C	hf with renal dysfunction	584,585,428	I50,N17-N19	
BIOMARKERREC002270	UROKINASE PLASMINOGEN ACTIVATOR (UPA)	breast cancer, colon cancer	140-229,174,175,153,154	C00-C96,C50,C18-C21	
BIOMARKERREC002271	Cytokeratin 18 (CK18)	oral cancer	140-146	C00-C08	
BIOMARKERREC002272	Cytokeratin 8 (CK8)	oral cancer	140-146	C00-C08	
BIOMARKERREC002273	Vimentin	oral cancer	140-146	C00-C08	
BIOMARKERREC002274	cyclin D1	aerodigestive tract cancer	140-149,150,160,161	C00-C14,C15,C30-C32	
BIOMARKERREC002275	CD146	adenocarcinoma	140-199	C00-C75,C7A,C7B	
BIOMARKERREC002276	VEGF	advanced solid tumor	140-199	C00-C75,C7A,C7B	
BIOMARKERREC002277	p4EBP1	malignant tumor	140-199	C00-C75,C7A,C7B	
BIOMARKERREC002278	pAkt	malignant tumor	140-199	C00-C75,C7A,C7B	
BIOMARKERREC002279	pp70S6K	malignant tumor	140-199	C00-C75,C7A,C7B	
BIOMARKERREC002280	pS6K	malignant tumor	140-199	C00-C75,C7A,C7B	
BIOMARKERREC002281	TTF1	non-resectable, adenocarcinoma with bronchioloalveolar carcinoma features (adc-bac)	140-199	C00-C75,C7A,C7B	
BIOMARKERREC002282	EGFR	non-resectable, adenocarcinoma with bronchioloalveolar carcinoma features (adc-bac)	140-199	C00-C75,C7A,C7B	
BIOMARKERREC002283	K-ras	non-resectable, adenocarcinoma with bronchioloalveolar carcinoma features (adc-bac)	140-199	C00-C75,C7A,C7B	
BIOMARKERREC002284	Oxidized Free Fatty Acids (OFFA)	solid tumor	140-199,210-229	C00-C75,C7A,C7B,D10-D36,D3A	
BIOMARKERREC002285	sVCAM	solid tumors treated with angiozyme	140-199	C00-C75,C7A,C7B	
BIOMARKERREC002286	VEGF	solid tumors treated with angiozyme	140-199	C00-C75,C7A,C7B	
BIOMARKERREC002287	von Willebrand factor antigen (vWf)	solid tumors treated with angiozyme	140-199	C00-C75,C7A,C7B	
BIOMARKERREC002288	CD133	advanced cancer	140-229	C00-C96	
BIOMARKERREC002289	GAGE	microscopic human cancers	140-229	C00-C96	
BIOMARKERREC002290	ACTH	advanced cancer	140-229	C00-C96	
BIOMARKERREC002291	cortisol	advanced cancer	140-229	C00-C96	
BIOMARKERREC002292	epinephrine	advanced cancer	140-229	C00-C96	
BIOMARKERREC002293	norepinephrine	advanced cancer	140-229	C00-C96	
BIOMARKERREC002294	IL-6	advanced cancer	140-229	C00-C96	
BIOMARKERREC002295	TNF-alpha	advanced cancer	140-229	C00-C96	
BIOMARKERREC002296	EGFR	aggressive cancer treated with targeted antibodies to erbb tyrosine kinase inhibitor	140-229	C00-C96	
BIOMARKERREC002297	HER2	aggressive cancer treated with targeted antibodies to erbb tyrosine kinase inhibitor	140-229	C00-C96	
BIOMARKERREC002298	pAKT and pERK	aggressive cancer treated with targeted antibodies to erbb tyrosine kinase inhibitor	140-229	C00-C96	
BIOMARKERREC002299	circulating endothelial cell (CEC)	cancer	140-229	C00-C96	
BIOMARKERREC002300	IL-1Rα	cancer	140-229	C00-C96	
BIOMARKERREC002301	IL-6	cancer	140-229	C00-C96	
BIOMARKERREC002302	neopterin	cancer	140-229	C00-C96	
BIOMARKERREC002303	Lymphovascular invasion (LVI)	cancer	140-229	C00-C96	
BIOMARKERREC002304	the clinical tumor growth rate (CTGR)	cancer	140-229	C00-C96	
BIOMARKERREC002305	VEGF	cancer	140-229	C00-C96	
BIOMARKERREC002306	bFGF	cancer	140-229	C00-C96	
BIOMARKERREC002307	sE-Selectin	cancer	140-229	C00-C96	
BIOMARKERREC002308	sFLT-1	cancer	140-229	C00-C96	
BIOMARKERREC002309	sTIE-2	cancer	140-229	C00-C96	
BIOMARKERREC002310	VEGF	cancer	140-229	C00-C96	
BIOMARKERREC002311	COX-2	cancer	140-229	C00-C96	
BIOMARKERREC002312	eNOS	cancer	140-229	C00-C96	
BIOMARKERREC002313	IL-8	cancer	140-229	C00-C96	
BIOMARKERREC002314	VEGF	cancer	140-229	C00-C96	
BIOMARKERREC002315	DPYD	oncology	140-229	C00-C96	
BIOMARKERREC002316	MTHFR	oncology	140-229	C00-C96	
BIOMARKERREC002317	TYMS	oncology	140-229	C00-C96	
BIOMARKERREC002318	2''-deoxyuridine (dUrd)	patients treated with drugs targeted at thymidylate synthase	140-229	C00-C96	
BIOMARKERREC002319	Akt	radiation sensitivity and resistance	140-229	C00-C96	
BIOMARKERREC002320	EGFR	radiation sensitivity and resistance	140-229	C00-C96	
BIOMARKERREC002321	IGFR	radiation sensitivity and resistance	140-229	C00-C96	
BIOMARKERREC002322	Src	radiation sensitivity and resistance	140-229	C00-C96	
BIOMARKERREC002323	Src	radiation sensitivity and resistance	140-229	C00-C96	
BIOMARKERREC002324	FGF2	tumor	140-199,210-229	C00-C75,C7A,C7B,D10-D36,D3A	
BIOMARKERREC002325	ki-67	tumor	140-199,210-229	C00-C75,C7A,C7B,D10-D36,D3A	
BIOMARKERREC002326	MUC-1	tumor	140-199,210-229	C00-C75,C7A,C7B,D10-D36,D3A	
BIOMARKERREC002327	PTTG1	gastrointestinal cancer	150-159	C15-C26	
BIOMARKERREC002328	reticulocalbin 2 (RCN2)	gastrointestinal cancer	150-159	C15-C26	
BIOMARKERREC002329	Mini- and microsatellite DNA	gastrointestinal cancers	150-159	C15-C26	
BIOMARKERREC002330	Ki67	gastrointestinal stromal tumor	150-159	C15-C26	
BIOMARKERREC002331	TPX2	gastrointestinal stromal tumor	150-159	C15-C26	
BIOMARKERREC002332	human Telomerase Reverse Transcriptase (hTERT)	gastrointestinal stromal tumor	150-159	C15-C26	
BIOMARKERREC002333	natural killer (NK) cell	gastrointestinal stromal tumor	150-159	C15-C26	
BIOMARKERREC002334	circulating endothelial cell (CEC)	gist	150-159	C15-C26	
BIOMARKERREC002335	monocytes	gist	150-159	C15-C26	
BIOMARKERREC002336	KIT, PDGFRA	gist	150-159	C15-C26	
BIOMARKERREC002337	PDGFR	metastatic gastrointestinal stromal tumor	150-159	C15-C26	
BIOMARKERREC002338	heparanase	primary colon tumor	153,154,211.3,211.4	C18-C21,D12	
BIOMARKERREC002339	survivin	primary colon tumor	153,154,211.3,211.4	C18-C21,D12	
BIOMARKERREC002340	p53	squamous anal cancer	154.2,154.3	C21	
BIOMARKERREC002341	Bcl2	squamous cell anal carcinoma	154.2,154.3	C21	
BIOMARKERREC002342	cyclin A	squamous cell anal carcinoma	154.2,154.3	C21	
BIOMARKERREC002343	p53	squamous cell anal carcinoma	154.2,154.3	C21	
BIOMARKERREC002344	a novel variant of Wnt-inducible secreted protein 1 (WISP1v)	intrahepatic cholangiocarcinoma (ihcc)	155.1,156.1	C22.1	
BIOMARKERREC002345	cyclin D1	intrahepatic cholangiocarcinoma (ihcc)	155.1,156.1	C22.1	
BIOMARKERREC002346	keratin 903	intrahepatic cholangiocarcinoma (ihcc)	155.1,156.1	C22.1	
BIOMARKERREC002347	matrix metalloproteinase 9 (MMP 9)	intrahepatic cholangiocarcinoma (ihcc)	155.1,156.1	C22.1	
BIOMARKERREC002348	p27kip1	intrahepatic cholangiocarcinoma (ihcc)	155.1,156.1	C22.1	
BIOMARKERREC002349	10p14-15	thymic epithelial tumor	164.0,212.6	C37,D15.0	
BIOMARKERREC002350	MICROMETASTASES	breast cancer	174,175	C50	
BIOMARKERREC002351	p53	multiple gynecological malignancies	179-184	C51-C58	
BIOMARKERREC002352	proliferating cell nuclear antigen (PCNA)	multiple gynecological malignancies	179-184	C51-C58	
BIOMARKERREC002353	a-Fetoprotein (AFP)	germ cell cancer	183,186	C56,C62	
BIOMARKERREC002354	HCG	germ cell cancer	183,186	C56,C62	
BIOMARKERREC002355	AFP and HCG	germ cell tumor	183,186,220,222.0	C56,C62,D27,D29.2	
BIOMARKERREC002356	Cox-2	germ cell tumor	183,186,220,222.0	C56,C62,D27,D29.2	
BIOMARKERREC002357	MIB-1	germ cell tumor	183,186,220,222.0	C56,C62,D27,D29.2	
BIOMARKERREC002358	P53	germ cell tumor	183,186,220,222.0	C56,C62,D27,D29.2	
BIOMARKERREC002359	Serum Tumor Markers (STM) pre-RPLND	pn1, n2 and n3 nonseminomatous germ cell tumor (nsgct)	183,186,220,222.0,140-199,210-229	C56,C62,D27,D29.2,C00-C75,C7A,C7B,D10-D36,D3A	
BIOMARKERREC002360	Alpha-fetoprotein-concanavalin a binding	germ cell tumors (gct) and liver diseases	183,186,220,222.0,570-574	K70-K77,C56,C62,D27,D29.2	
BIOMARKERREC002361	IL6	high-grade glial tumor	191,191.5,225.0,191.9	C71.9,C71.5,D33.0,C71	
BIOMARKERREC002362	TNF-Î	high-grade glial tumor	191,191.5,225.0,191.9	C71.9,C71.5,D33.0,C71	
BIOMARKERREC002363	deoxypyridinoline (Dpyd)	bone metastatic prostate cancer	198.5,185	C61,C79.51	
BIOMARKERREC002364	deoxypyridinoline (Dpyd)	bone metastatic prostate cancer	198.5,185	C61,C79.51	
BIOMARKERREC002365	relevant bone isoenzyme evaluated by electrophoretic (EBALP)	bone metastatic prostate cancer	198.5,185	C61,C79.51	
BIOMARKERREC002366	relevant bone isoenzyme evaluated by electrophoretic (EBALP)	bone metastatic prostate cancer	198.5,185	C61,C79.51	
BIOMARKERREC002367	total alkaline phosphatase (TALP)	bone metastatic prostate cancer	198.5,185	C61,C79.51	
BIOMARKERREC002368	total alkaline phosphatase (TALP)	bone metastatic prostate cancer	198.5,185	C61,C79.51	
BIOMARKERREC002369	natural killer (NK) cell marker CD56	nasal non-hodgkin's lymphomas	200,202	C82-C85	
BIOMARKERREC002370	5-hydroxytryptamine (5-HT)	carcinoid tumor	209.4,209.5,209.6	C75,E34.0	
BIOMARKERREC002371	5-hydroxytryptamine (5-HT)	carcinoid tumor	209.4,209.5,209.6	C75,E34.0	
BIOMARKERREC002372	EGFR	carcinoid tumor	209.4,209.5,209.6	C75,E34.0	
BIOMARKERREC002373	SSR5	carcinoid tumor	209.4,209.5,209.6	C75,E34.0	
BIOMARKERREC002374	VEGF	carcinoid tumor	209.4,209.5,209.6	C75,E34.0	
BIOMARKERREC002375	VEGF-R	carcinoid tumor	209.4,209.5,209.6	C75,E34.0	
BIOMARKERREC002376	C-reactive protein (CRP)	acute graft-versus-host disease (agvhd);microangiopathic hemolytic anemia;veno-occlusive disease	280-285,283.19,279.50,573.8,282,283,773,279.5	D50-D64,D59.4,T86.0,K76.5,D55-D59,D89.8	
BIOMARKERREC002377	TNF-alpha	acute graft-versus-host disease (agvhd);microangiopathic hemolytic anemia;veno-occlusive disease	280-285,283.19,279.50,573.8,282,283,773,279.5	D50-D64,D59.4,T86.0,K76.5,D55-D59,D89.8	
BIOMARKERREC002378	albumin (ALB)	acute graft-versus-host disease (agvhd);sepsis	279.50,995.91,279.5	T86.0,A40,A41,D89.8	
BIOMARKERREC002379	Leukotriene A4 hydrolase	acute graft-versus-host disease (agvhd);sepsis	279.50,995.91,279.5	T86.0,A40,A41,D89.8	
BIOMARKERREC002380	IL-2Ra	acute graft-versus-host disease (agvhd);sepsis;veno-occlusive disease	279.50,573.8,995.91,279.5	T86.0,K76.5,A40,A41,D89.8	
BIOMARKERREC002381	IL-6	acute graft-versus-host disease (agvhd);sepsis;veno-occlusive disease	279.50,573.8,995.91,279.5	T86.0,K76.5,A40,A41,D89.8	
BIOMARKERREC002382	IL-8	acute graft-versus-host disease (agvhd); rejection; liver fibrosis in thalassemic patients; sepsis;veno-occlusive disease	279.50,573.8,995.91,571,709.2,279.5	T86.0,K76.5,A40,A41,K70.3,K71.7,K74,L90.5,D89.8	
BIOMARKERREC002383	Hematocrit packed cell volume	anemia	280-285	D50-D64	
BIOMARKERREC002384	mean corpuscular hemoglobin concentration (MCHC)	anemia	280-285	D50-D64	
BIOMARKERREC002385	mean corpuscular volume (MCV)	anemia	280-285	D50-D64	
BIOMARKERREC002386	red blood cell	anemia	280-285	D50-D64	
BIOMARKERREC002387	red cell distribution width (RDW)	anemia	280-285	D50-D64	
BIOMARKERREC002388	reticulocyte count	anemia	280-285	D50-D64	
BIOMARKERREC002389	reticulocyte proliferation index (RPI)	anemia	280-285	D50-D64	
BIOMARKERREC002390	Procalcitonin (PCT)	cancer patients with febrile neutropenia (fn)	288.0,140-229	C00-C96,D70	
BIOMARKERREC002391	quantitative electroencephalography (EEG)	dementia	290-294	F01-F07	
BIOMARKERREC002392	sTNFRI	obstructive sleep apnea	327.23,780.57	G47.3	
BIOMARKERREC002393	P-tau 231	alzheimer's disease	331.0	G30	
BIOMARKERREC002394	11C-(R)-PK11195	alzheimer's disease	331.0	G30	
BIOMARKERREC002395	123I-5IA-85380	alzheimer's disease	331.0	G30	
BIOMARKERREC002396	123I-IBVM	alzheimer's disease	331.0	G30	
BIOMARKERREC002397	123I-quinuclidinyl benzilate (123I-QNB)	alzheimer's disease	331.0	G30	
BIOMARKERREC002398	123I-5IA-85380	alzheimer's disease	331.0	G30	
BIOMARKERREC002399	123I-IBVM	alzheimer's disease	331.0	G30	
BIOMARKERREC002400	123I-quinuclidinyl benzilate (123I-QNB)	alzheimer's disease	331.0	G30	
BIOMARKERREC002401	18F-fluorodeoxyglucose (FDG)	alzheimer's disease	331.0	G30	
BIOMARKERREC002402	18F-fluorodeoxyglucose (FDG)	alzheimer's disease	331.0	G30	
BIOMARKERREC002403	2-(1-{6-[(2-[F-18]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene) malononitrile (FDDNP)	alzheimer's disease	331.0	G30	
BIOMARKERREC002404	Arterial spin labeling (ASL)	alzheimer's disease	331.0	G30	
BIOMARKERREC002405	Arterial spin labeling (ASL)	alzheimer's disease	331.0	G30	
BIOMARKERREC002406	Aβ40	alzheimer's disease	331.0	G30	
BIOMARKERREC002407	Aβ42	alzheimer's disease	331.0	G30	
BIOMARKERREC002408	pTau181	alzheimer's disease	331.0	G30	
BIOMARKERREC002409	PTau199	alzheimer's disease	331.0	G30	
BIOMARKERREC002410	PTau231	alzheimer's disease	331.0	G30	
BIOMARKERREC002411	Tau	alzheimer's disease	331.0	G30	
BIOMARKERREC002412	Aβ40	alzheimer's disease	331.0	G30	
BIOMARKERREC002413	Aβ42	alzheimer's disease	331.0	G30	
BIOMARKERREC002414	Aβ42	alzheimer's disease	331.0	G30	
BIOMARKERREC002415	Aβ42	alzheimer's disease	331.0	G30	
BIOMARKERREC002416	Aβ42	alzheimer's disease	331.0	G30	
BIOMARKERREC002417	pTau181	alzheimer's disease	331.0	G30	
BIOMARKERREC002418	Tau	alzheimer's disease	331.0	G30	
BIOMARKERREC002419	Aβo	alzheimer's disease	331.0	G30	
BIOMARKERREC002420	b-Amyloid	alzheimer's disease	331.0	G30	
BIOMARKERREC002421	chemokine C–C motif ligand 2 (CCL2; monocyte chemotactic protein-1; MCP-1 )	alzheimer's disease	331.0	G30	
BIOMARKERREC002422	choline	alzheimer's disease	331.0	G30	
BIOMARKERREC002423	creatine	alzheimer's disease	331.0	G30	
BIOMARKERREC002424	glutamate	alzheimer's disease	331.0	G30	
BIOMARKERREC002425	glutamine	alzheimer's disease	331.0	G30	
BIOMARKERREC002426	myoinositol	alzheimer's disease	331.0	G30	
BIOMARKERREC002427	phosphocreatine	alzheimer's disease	331.0	G30	
BIOMARKERREC002428	Diffusion tensor imaging (DTI)	alzheimer's disease	331.0	G30	
BIOMARKERREC002429	disproportionate atrophy	alzheimer's disease	331.0	G30	
BIOMARKERREC002430	Florbetaben (18F-BAY94-9172)	alzheimer's disease	331.0	G30	
BIOMARKERREC002431	Isoprostanes	alzheimer's disease	331.0	G30	
BIOMARKERREC002432	Isoprostanes	alzheimer's disease	331.0	G30	
BIOMARKERREC002433	longitudinal MRI volumetric data	alzheimer's disease	331.0	G30	
BIOMARKERREC002434	medial temporal lobe (MTL)	alzheimer's disease	331.0	G30	
BIOMARKERREC002435	N-acetyl aspartate (NAA)	alzheimer's disease	331.0	G30	
BIOMARKERREC002436	N-acetyl aspartate (NAA)	alzheimer's disease	331.0	G30	
BIOMARKERREC002437	Pittsburgh compound B	alzheimer's disease	331.0	G30	
BIOMARKERREC002438	florbetaben	alzheimer's disease	331.0	G30	
BIOMARKERREC002439	florbetapir	alzheimer's disease	331.0	G30	
BIOMARKERREC002440	Pittsburgh compound B (PIB)	alzheimer's disease	331.0	G30	
BIOMARKERREC002441	p-tau 181	alzheimer's disease	331.0	G30	
BIOMARKERREC002442	p-tau 199	alzheimer's disease	331.0	G30	
BIOMARKERREC002443	p-tau 231	alzheimer's disease	331.0	G30	
BIOMARKERREC002444	Regional blood oxygen level dependent (BOLD)	alzheimer's disease	331.0	G30	
BIOMARKERREC002445	tau	alzheimer's disease	331.0	G30	
BIOMARKERREC002446	Tau	alzheimer's disease	331.0	G30	
BIOMARKERREC002447	F2-isoprostanes	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002448	monoamine metabolites	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002449	transglutaminase	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002450	tryptophan pathway metabolites	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002451	8-hydroxy-2-deoxyguanosine (8-OHdG)	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002452	adenosine A2a receptor	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002453	Brain-derived neurotrophic factor (BDNF)	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002454	C7	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002455	C9	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002456	clusterin	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002457	interleukin 6	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002458	α2-macroglobulin	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002459	C-reactive protein (CRP)	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002460	huntingtin	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002461	kynurenine metabolism	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002462	cell death pathways	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002463	energy compromise	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002464	inflammation	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002465	neurotrophin alterations	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002466	oxidative stress	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002467	proteolysis	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002468	transcriptional alterations	huntington's disease	333.4,294.1	G10,F02.2	
BIOMARKERREC002469	MYSA1	myasthenia gravis; thymic hyperplasia	358.0,254.0	G70.0,E32.0	
BIOMARKERREC002470	Calcitonin gene-related petide (CGRP)	ocular allergy	360-379	H00-H59	
BIOMARKERREC002471	Eosinophil cationic protein (ECP)	ocular allergy	360-379	H00-H59	
BIOMARKERREC002472	Hemopexin	ocular allergy	360-379	H00-H59	
BIOMARKERREC002473	Hemopexin	ocular allergy	360-379	H00-H59	
BIOMARKERREC002474	HSP-70	ocular allergy	360-379	H00-H59	
BIOMARKERREC002475	Protein activated receptor-2 (PAR-2)	ocular allergy	360-379	H00-H59	
BIOMARKERREC002476	Substance P (SP)	ocular allergy	360-379	H00-H59	
BIOMARKERREC002477	Vasoactive intestinal peptide (VIP)	ocular allergy	360-379	H00-H59	
BIOMARKERREC002478	a 31st base of a base sequence	poag; normal tension glaucoma (ntg)	365.2,365	H40.02,H40-H42	
BIOMARKERREC002479	atrial natriuretic peptide (ANP)	cardiac disease in infants	390-459	I00-I99	
BIOMARKERREC002480	atrial natriuretic peptide (ANP)	cardiac disease in infants	390-459	I00-I99	
BIOMARKERREC002481	Achaete-scute complex homolog 1(ASCL1)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002482	Apolipoprotein A-I	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002483	apolipoprotein B (ApoB)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002484	Apolipoprotein C-1(APOC1)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002485	Apolipoprotein E(APOE)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002486	B-cell chronic lymphocytic leukemia/lymphoma 7B(BCL7B)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002487	B-type natriuretic peptide (BNP)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002488	C-reactive protein (CRP)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002489	Cryopyrin(NLRP3)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002490	fibrinogen	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002491	Glucokinase regulatory protein(GCKR)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002492	Glucokinase regulatory protein(GCKR)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002493	Glucokinase regulatory protein(GCKR)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002494	Growth differentiation factor 15 (GDF-15)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002495	Hepatic transcription factor-1-(HNF1A)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002496	Hepatocyte nuclear factor 4(HNF4A)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002497	High-sensitivity C-reactive protein (CRP)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002498	hsTnI	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002499	hsTnT	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002500	IL-1 family	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002501	member 10(IL1F10)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002502	IL-6 receptor(IL6-R)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002503	IL-6 receptor(IL6-R)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002504	IL-6 receptor(IL6-R)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002505	IL-6 receptor(IL6-R)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002506	intercellular adhesion molecule-1 (ICAM-1)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002507	Intercellular adhesion molecule-1(ICAM-1)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002508	Intercellular adhesion molecule-1(ICAM-1)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002509	interleukin-6	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002510	Leptin receptor(LEPR)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002511	b(NFKBIB)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002512	Nuclear factor of k light polypeptide gene enhancer in B-cells inhibitor	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002513	Patatin-like phospholipase domain-containing protein 3(PNPLA3)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002514	cytoplasmic 4(PABPC4)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002515	Poly(A) binding protein	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002516	Proteasome assembly chaperon 1(PSMG1)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002517	Protein phosphatase 1 regulatory subunit 3B(PPP1R3B)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002518	P-selectin	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002519	Regulator of G-protein signalling 6(RGS6)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002520	Retinoic acid receptor-related orphan receptor A(RORA)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002521	SH2B3 adapter protein (Lnk)(SH2B3)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002522	Soluble P-selectin(SELP)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002523	Spalt-like transcription factor 1(SALL1)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002524	Transferase A,  1-3-N-acetylgalactosaminyltransferase	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002525	transferase B,   1-3-galactosyltransferase(ABO)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002526	Transferase A,  1-3-N-acetylgalactosaminyltransferase	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002527	transferase B,   1-3-galactosyltransferase(ABO)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002528	Transferase A, 1-3-N-acetylgalactosaminyltransferase	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002529	transferase B,   1-3-galactosyltransferase(ABO)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002530	Transferase A, 1-3-N-acetylgalactosaminyltransferase	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002531	transferase B,   1-3-galactosyltransferase(ABO)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002532	vascular cell adhesion molecule	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002533	V-rel reticuloendotheliosis viral oncogene homolog A(RELA)	cardiovascular disease	390-459	I00-I99	
BIOMARKERREC002534	NT-proBNP	critically ill cardiac patient	390-459	I00-I99	
BIOMARKERREC002535	intercellular adhesion molecule 1 (sICAM-1)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002536	vascular cells adhesion molecule 1 (sVCAM-1)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002537	Asymmetric dimethylarginine (ADMA)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002538	B-type natriuretic peptide (BNP)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002539	Ca	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002540	parathyroid hormone (iPTH)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002541	Pi	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002542	circulating endothelial cell (CEC)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002543	cTnT	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002544	cystatin C	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002545	endothelial progenitor cell (EPC)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002546	E-selectin	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002547	Homocysteine	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002548	C-reactive protein (CRP)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002549	creatinine	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002550	Homocysteine	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002551	IL-6	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002552	NT-pro-BNP	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002553	osteoprotogerin (OPG)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002554	Soluble TNF-like weak inducer of apoptosis (sRANKL)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002555	pentraxin 3 (PTX3)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002556	Soluble TNF-like weak inducer of apoptosis (sTWEAK)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002557	undercarboxylated matrix-carboxyglutamic acid protein (ucMGP)	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002558	Vitamin D	cardiovascular disease (cvd) in patients with chronic kidney disease (ckd)	390-459,585.9,585.1-585.5,403	I00-I99	
BIOMARKERREC002559	ABO	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002560	ADAMTS7	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002561	ANKS1A	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002562	CDKN2A-CDKN2B-ANRIL	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002563	CELSR2-PSRC1-SORT1	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002564	COL4A1	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002565	COL4A2	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002566	Corus CAD	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002567	CXCL12	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002568	CNNM2	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002569	CYP17A1	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002570	NT5C2	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002571	HHIPL1	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002572	HNF1A	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002573	LDLR	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002574	LPA	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002575	LPA	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002576	MIA3	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002577	MRAS	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002578	PCSK9	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002579	PHACTR1	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002580	PPAP2B	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002581	PEMT	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002582	RASD1	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002583	SMCR3	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002584	SH2B3	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002585	SLC5A3-MRPS6-KCNE2	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002586	SMG6	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002587	SRR	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002588	TCF21	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002589	ATP5G1	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002590	GIP	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002591	SNF8	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002592	UBE2Z	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002593	WDR12	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002594	ZC3HC1	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002595	APOA5-A4-C3-A1	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002596	ZNF259	coronary artery disease	410-414,429.2	I20-I25	
BIOMARKERREC002597	microRNA	acute coronary syndrome,acute myocardial infarction, type 2 diabetes, hypertension, heart failure	410,401,428,410,250.00,250.02,411.1,250	I21,I22,I10,I11,I12,I13,I15,I50,I21-I22,E11,I20.0,E08-E13	
BIOMARKERREC002598	H-FABP	chronic thromboembolic pulmonary hypertension (cteph)	416.0,416.8	I27.0,I27.2	
BIOMARKERREC002599	FENO	pulmonary arterial hypertension (pah)	416.0,416.8	I27.0,I27.2	
BIOMARKERREC002600	brain natriuretic peptide (BNP)	pulmonary hypertension in systemic sclerosis (ssc-ph)	416.0,416.8	I27.0,I27.2	
BIOMARKERREC002601	N-terminal pro-brain natriuretic peptide (NT-pro-BNP)	pulmonary hypertension in systemic sclerosis (ssc-ph)	416.0,416.8	I27.0,I27.2	
BIOMARKERREC002602	H-FABP	subarachnoid hemorrhage	430,852.0,852.1	I60,P10.3,S06.6	
BIOMARKERREC002603	cholesterol	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002604	apolipoprotein A (ApoA)	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002605	apolipoprotein B (ApoB)	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002606	apolipoprotein B (ApoB)	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002607	cardiac troponin I (cTnI)	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002608	cardiac troponin T (cTnT)	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002609	C-reactive protein (CRP)	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002610	creatinine	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002611	cystatin C	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002612	fibrinogen	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002613	fibrinogen	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002614	high sensitivity C-reactive protein (hs CRP)	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002615	high density lipoprotein (HDL)	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002616	uric acid	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002617	Vitamin D	atherothrombosis	437.6,453,671.5,671.9	I80-I82	
BIOMARKERREC002618	ADMA	atherosclerosis	414.0,440	I70	
BIOMARKERREC002619	F2 isoprostanes	atherosclerosis	414.0,440	I70	
BIOMARKERREC002620	Myeloperoxidase	atherosclerosis	414.0,440	I70	
BIOMARKERREC002621	B-type natriuretic peptide (BNP)	atherosclerosis	414.0,440	I70	
BIOMARKERREC002622	CK-MB	atherosclerosis	414.0,440	I70	
BIOMARKERREC002623	Lipoprotein A	atherosclerosis	414.0,440	I70	
BIOMARKERREC002624	myoglobin	atherosclerosis	414.0,440	I70	
BIOMARKERREC002625	Osteopontin	atherosclerosis	414.0,440	I70	
BIOMARKERREC002626	troponin T (TnT)	atherosclerosis	414.0,440	I70	
BIOMARKERREC002627	Troponins I	atherosclerosis	414.0,440	I70	
BIOMARKERREC002628	ADMA	atherosclerosis	414.0,440	I70	
BIOMARKERREC002629	C-reactive protein (CRP)	atherosclerosis	414.0,440	I70	
BIOMARKERREC002630	Myeloperoxidase	atherosclerosis	414.0,440	I70	
BIOMARKERREC002631	15-lipoxygenase-2 (15-LOX-2)	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002632	Inducible nitric oxide synthase (MIM 163730	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002633	iNOS/NOS2A)	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002634	matrix metalloproteinase 9 (MMP 9)	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002635	Myeloid-related protein-14 (MIM 123886 S100A9, Mrp-14)	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002636	Myeloid-related protein-8 (MIM 123885 S100A8, Mrp-8)	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002637	MPO)	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002638	myeloperoxidase (MIM 606989	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002639	OPN	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002640	osteopontin (MIM 166490	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002641	3-Nitrotyrosine (3-NT)	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002642	Prostaglandin synthase (MIM 601699, PGIS)	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002643	PN-1	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002644	Protease nexin-1 (MIM 177010	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002645	serpine 2)	carotid artery atherosclerosis	440,414.0	I70	
BIOMARKERREC002646	Asymmetric dimethylarginine (ADMA)	premature atherosclerosis	440,414.0	I70	
BIOMARKERREC002647	Cathepsin S	premature atherosclerosis	440,414.0	I70	
BIOMARKERREC002648	Cystatin C	premature atherosclerosis	440,414.0	I70	
BIOMARKERREC002649	apolipoproteins	premature atherosclerosis	440,414.0	I70	
BIOMARKERREC002650	C-reactive protein (CRP)	premature atherosclerosis	440,414.0	I70	
BIOMARKERREC002651	fibrinogen	premature atherosclerosis	440,414.0	I70	
BIOMARKERREC002652	homocysteine	premature atherosclerosis	440,414.0	I70	
BIOMARKERREC002653	interleukins	premature atherosclerosis	440,414.0	I70	
BIOMARKERREC002654	tumour necrosis factor	premature atherosclerosis	440,414.0	I70	
BIOMARKERREC002655	Lipoprotein-associated phospholipase A2 (Lp- PLA2)	premature atherosclerosis	440,414.0	I70	
BIOMARKERREC002656	Myeloperoxidase (MPO)	premature atherosclerosis	440,414.0	I70	
BIOMARKERREC002657	MR-proadrenomedullin	community-acquired pneumonia	480-486,770.0	J12,J13,J14,J15,J16,J17,J18,P23	
BIOMARKERREC002658	MR-proANP	lower respiratory tract infections	480-519	J09-J99	
BIOMARKERREC002659	Pro-ANP	lower respiratory tract infections	480-519	J09-J99	
BIOMARKERREC002660	Perforin	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002661	HMGB1	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002662	receptor for advanced glycation end-products (RAGE)	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002663	TNF-alpha	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002664	8-isoprostane	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002665	Aa-Val360	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002666	a-defensins	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002667	b-defensins	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002668	surfactant protein A	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002669	surfactant protein D	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002670	antinuclear autoantibodies (ANAs)	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002671	CC-16	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002672	SPD	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002673	CD8t T cells	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002674	CO	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002675	C-reactive protein (CRP)	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002676	CRP, b-defensin, adiponectin, IL-6, fibrinogen, CCL18, MMP-8, prolactin	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002677	desmosine	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002678	EMMPRIN	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002679	ethane	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002680	fibrinogen	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002681	H2O2	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002682	HSP60	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002683	IL-6	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002684	immunoglobulin light-chain	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002685	PARC/CCL18	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002686	PARC/CCL18	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002687	ethane	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002688	pentane	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002689	soluble truncated form of RAGE (sRAGE)	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002690	TNF-alpha	chronic obstructive pulmonary disease (copd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002691	eotaxin	periodic exacerbations of copd (ecopd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002692	IL-10	periodic exacerbations of copd (ecopd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002693	IL12p70	periodic exacerbations of copd (ecopd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002694	IL-15	periodic exacerbations of copd (ecopd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002695	IL-8	periodic exacerbations of copd (ecopd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002696	IP-10	periodic exacerbations of copd (ecopd)	490-492,494-496	J40-J44,J47	
BIOMARKERREC002697	brain natriuretic peptide (BNP)	chronic lung disease	490-496,770.7	J40-J44,J45,J47,P27.1	
BIOMARKERREC002698	CK-18	steatohepatitis	571.0,571.8	K70.1,K76.0	
BIOMARKERREC002699	ABCB1 (MDR1)	minimal change nephropathy (mcn)  ; focal segmental glomerulonephritis (fsg)	581,580-599,580-582,581.3	N00-N08,N00-N29,N00,N01,N03,N18,N00.0,N01.0,N02.0,N03.0,N04.0,N05.0,N06.0,N07.0,N08.0	
BIOMARKERREC002700	Glycoprotein-P (CD243)	minimal change nephropathy (mcn)  ; focal segmental glomerulonephritis (fsg)	581,580-599,580-582,581.3	N00-N08,N00-N29,N00,N01,N03,N18,N00.0,N01.0,N02.0,N03.0,N04.0,N05.0,N06.0,N07.0,N08.0	
BIOMARKERREC002701	sIL-2R	minimal change nephropathy (mcn)  ; focal segmental glomerulonephritis (fsg)	581,580-599,580-582,581.3	N00-N08,N00-N29,N00,N01,N03,N18,N00.0,N01.0,N02.0,N03.0,N04.0,N05.0,N06.0,N07.0,N08.0	
BIOMARKERREC002702	1,25-OH vitamin D	chronic kidney disease	585.9,585.1-585.5,403	N18	
BIOMARKERREC002703	25-OH vitamin D	chronic kidney disease	585.9,585.1-585.5,403	N18	
BIOMARKERREC002704	1,25-OH vitamin D	chronic kidney disease	585.9,585.1-585.5,403	N18	
BIOMARKERREC002705	25-OH vitamin D	chronic kidney disease	585.9,585.1-585.5,403	N18	
BIOMARKERREC002706	asymmetric dimethylarginine (ADMA)	chronic kidney disease	585.9,585.1-585.5,403	N18	
BIOMARKERREC002707	C-reactive protein (CRP)	chronic kidney disease	585.9,585.1-585.5,403	N18	
BIOMARKERREC002708	fibroblast growth factor (FGF-23)	chronic kidney disease	585.9,585.1-585.5,403	N18	
BIOMARKERREC002709	IL-6	chronic kidney disease	585.9,585.1-585.5,403	N18	
BIOMARKERREC002710	ProBNP	chronic kidney disease	585.9,585.1-585.5,403	N18	
BIOMARKERREC002711	transforming growth factor ?(TGF-?)	chronic kidney disease	585.9,585.1-585.5,403	N18	
BIOMARKERREC002712	troponin T (TnT)	chronic kidney disease	585.9,585.1-585.5,403	N18	
BIOMARKERREC002713	NGF	interstitial cystitis; bladder pain syndrome;detrusor overactivity	188,595.1,338,595,595.1,596.51	C67,N30.1,R52,N30,N30.1,N32.81	
BIOMARKERREC002714	Asymmetric dimethylarginine (ADMA)	pre-eclampsia	642.4-642.7	O11,O14	
BIOMARKERREC002715	homocysteine	pre-eclampsia	642.4-642.7	O11,O14	
BIOMARKERREC002716	leptin	pre-eclampsia	642.4-642.7	O11,O14	
BIOMARKERREC002717	sEng	pre-eclampsia	642.4-642.7	O11,O14	
BIOMARKERREC002718	soluble Fms-like tyrosine kinase 1 (sFlt-1)	pre-eclampsia	642.4-642.7	O11,O14	
BIOMARKERREC002719	Asymmetric dimethylarginine (ADMA)	pre-eclampsia	642.4-642.7	O11,O14	
BIOMARKERREC002720	homocysteine	pre-eclampsia	642.4-642.7	O11,O14	
BIOMARKERREC002721	Pregnancy associated plasma protein-A (PAPP-A)	pre-eclampsia	642.4-642.7	O11,O14	
BIOMARKERREC002722	soluble Fms-like tyrosine kinase 1 (sFlt-1)	pre-eclampsia	642.4-642.7	O11,O14	
BIOMARKERREC002723	Placental protein 13 (PP13)	pre-eclampsia	642.4-642.7	O11,O14	
BIOMARKERREC002724	Pregnancy associated plasma protein-A (PAPP-A)	pre-eclampsia	642.4-642.7	O11,O14	
BIOMARKERREC002725	isoprostane	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002726	Anti-endothelial cell antibodies (AECA)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002727	CC Chemokine Ligand 18 (CCL18)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002728	CC Chemokine Ligand 2 (CCL2	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002729	MCP-1	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002730	monocyte chemoattractant protein-1	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002731	CD14+ producing circulating monocytes； CD45+ producing circulating monocytes； collagen I producing circulating monocytes	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002732	CD19	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002733	connective tissue growth factor (CTGF)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002734	CXC Chemokine Ligand 10 (CXCL10)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002735	CXC Chemokine Ligand 12 (CXCL12)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002736	IL-10	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002737	IL-13	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002738	IL-17	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002739	IL-22	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002740	IL-4	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002741	IL-6	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002742	Krebs Von Den Lungen 6 (KL-6)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002743	Krebs Von Den Lungen 6 (KL-6)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002744	Krebs Von Den Lungen 6 (KL-6)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002745	Matrix Metalloproteinase 7 (MMP7)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002746	MMP-9 (gelatinase B)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002747	Polymorphonuclear neutrophilic leukocyte elastase (PMN elastase)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002748	Surfactant Protein A (SP-A)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002749	Surfactant Protein D (SP-D)	systemic sclerosis associated interstitial lung disease (ssc-ild)	710.1,518.8,518.4,514,518.3,516	J80,J81,J82,J84,M34	
BIOMARKERREC002750	C-reactive protein (CRP)	cancer patients with cachexia	799.4,140-229	C00-C96,R64	
BIOMARKERREC002794	LOXL1	glaucoma; exfoliation syndrome (xfs)	365.52,365	H40.14,H40-H42	
BIOMARKERREC002795	CD11b	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002796	CD35	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002797	CD66	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002798	CD69	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002799	CD81	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002800	eosinophil	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002801	eosinophil cationic protein (ECP)	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002802	eosinophil- derived neurotoxin (EDN)	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002803	eosinophil peroxidase (EPO)	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002804	major basic protein (MBP)	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002805	CD31	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002806	L-selectin (CD62L)	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002807	PSGL-1 (CD162)	allergic and eosinophilic diseases	995.3	T78.4	
BIOMARKERREC002808	Siglec-8	allergic and eosinophilic diseases	995.3	T78.4	